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Summary
An experimental system of Mycobacterium tuberculosis growth in a carbon-limited chemostat, has 
been established using Mycobacterium bovis BCG as a model organism. In this model carbon- 
limited chemostats with low concentrations of glycerol were used to simulate possible growth rates 
during different stages of tuberculosis. A doubling time of 23 hours (D = 0.03 h-i) was adopted to 
represent the acute phase of infection whereas a slower dilution rate, equivalent to a doubling time 
of 69 hours {D = 0.01 h-i) was used to model mycobacterial persistence. Cell macromolecuiar 
(RNA, DNA, carbohydrate and lipid) and elemental (C, H, N) compositions of biomass were 
determined in the model, revealing an atypical bacterial cell containing large amounts of lipid and 
carbohydrate. The correlation of RNA content with growth rate indicated that ribosome production 
in carbon limited M. bovis BCG cells is subject to growth rate dependent control. These results also 
clearly show that the proportion of lipid in the mycobacterial cell is very sensitive to changes in the 
growth rate, probably reflecting changes in the amounts of storage lipids. This may have particular 
significance for mycobacteria during chronic TB as this stage of the disease is thought to involve a 
metabolic switch in the bacteria’s carbon source to fats. Given the importance of isocitrate lyase in 
fat metabolism and the survival of persistent bacteria, an isocitrate lyase mutant of M bovis BCG 
was constructed and used as a biological probe to test the validity of the chemostat model of TB 
persistence. The mutant strain behaved identically to the wild type at the fast growth rate but was 
attenuated for survival at the slower growth rate demonstrating that isocitrate lyase is important for 
survival in the model. Transcriptomic analysis using DNA microarrays demonstrated that 353 
genes were differentially expressed between the slow and fast growing mycobacterial cells. These 
data show a significant shift in metabolism towards scavenging nutrients from the environment and 
the upregulation of several “persistence genes" in the slow growth rate. Optimization of two- 
dimensional electrophoresis methodology allowed the cellular protein composition of BCG in the 
model to be studied. Expression of 7 proteins increased and 3 proteins decreased in the slow 
relative to the faster growing chemostat culture. Proteins identified included the ATP-binding 
protein Rv2623 and Rv2626c, proteins known to be upregulated during growth in vivo. These 
studies demonstrated the power of combining chemostat models with global system approaches 
such as proteomics, transcriptomics and fluxomics technologies in deciphering the complex 
programme of M. tubercuiosis during persistence.
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Active TB Latent TB infection
Introduction
Chapter 1. Introduction
3.1. Introduction
Despite more than a century of research into tuberculosis (TB) this disease remains the number 
one killer due to a single infectious agent making Mycobacterium tuberculosis one of the most 
successful human pathogens. A key to this bacterium’s success is its ability to establish and 
maintain a latent infection in its human host for many decades (Lillebaek et al., 2002). Latency can 
be defined as the persistence of the bacteria in the infected host in the absence of clinical 
symptoms and without the release of bacteria from the host. Reactivation of the bacteria can occur 
resulting in active tuberculosis thus producing a continuing reservoir of bacteria able to spread to 
other hosts. The control of tuberculosis is severely impeded by the global magnitude of latent 
tuberculosis. One third of the world's population are estimated to harbour persistent 
M. tuberculosis primed for reactivation and initiation of clinical disease (Dye et ah, 1999). The 
triggers for latency and reactivation are very poorly understood. Unraveling the mechanisms 
involved during the establishment, maintenance and reactivation of latent tuberculosis is an 
important goal for mycobacterial researchers. Such information will lead to the development of 
novel therapeutics, vaccines and diagnostic strategies targeted to persistent M. tubercuiosis.
1.1. Latent tuberculosis
M. tuberculosis is an almost exclusively human pathogen, which is highly adapted to life within this 
host and is foremost among bacterial pathogens in its ability to establish and maintain a latent 
infection. The natural history of the TB bacterium within humans involves a complex interplay 
between the immune system and the pathogen. Tuberculosis is most commonly transmitted by the 
inhalation of small-aerosolised cough droplets containing infectious tubercle bacilli. The 
implantation of the tubercle bacilli can lead to several potential outcomes (Fig, 1.1). In the first 
scenario the bacteria are killed and eliminated completely by the innate immune system without 
leaving a trace. This is very dependant on specific host and pathogen factors and occurs in 50- 
75% of TB contacts (Gryzbowski etal., 1975). In 25-50% of individuals exposure to M. tuberculosis 
leads to the replication of the bacteria in the pulmonary site and in the regional lymphatics 
(Gryzbowski etal., 1975). When the host immune system cannot contain the replication active 
disease occurs. This occurs in 5% of TB infected individuals and is most common in children under 
the age of 5 and adults with immuno-suppression (Enarson and Murray, 1996). By far the
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Figure 1.1. The natural history of tuberculosis.
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commonest outcome of Infection with M. tuberculosis Is, however, the development of a latent 
asymptomatic Infection.
After being Inhaled Into the lungs M. tuberculosis persists and replicates primarily within the 
Intracellular environment of the macrophage. Macrophages clearly play a central role within the 
Initial lesion, Ingesting the bacilli and transporting them to the regional lymph nodes, it Is assumed 
that M tubercuiosis Is able to survive and replicate here by disrupting phagosome acidification and 
preventing phagosome-lysosome fusion (Rhoades and Ullrich, 2000). During this Initial Infection 
the bacilli are able to escape from the macrophages causing a transient bacteraemla with 
dissemination of bacteria throughout the body. Clusters of Infected and non-lnfected macrophages 
aggregate and are surrounded by T lymphocytes to form the characteristic tuberculosis granuloma 
or tubercle that limits further replication and spread of the organism (Co et ai, 2004). In the 
majority of Immunocompetent Individuals a protective cell mediated Immune response Is mounted 
within 2-4 weeks of Infection and bacterial replication and dissemination is controlled (Dannenberg, 
1989). This corresponds to development of a positive tuberculin skin test (TST). Whilst most 
individuals are able to control the primary Infection the organism Is almost never eradicated. 
Bacteria are able to reside in human tissues quiescently leaving the host susceptible to 
subsequent disease from reactivation or re-lnfectlon (Fig. 1.1). Patients have a 2-23% lifetime risk 
from reactivated TB and this statistic rises to 5-10% per year If the patient is dually Infected with 
HIV (Honer zu Bentrup and Russell, 2001).
1.2. Diagnosis of latent TB
The only clinical evidence of M tubercuiosis during latency Is a delayed type hypersensitivity 
against mycobacterial antigens demonstrated by a TST and X-ray visualisation of old 
granulomatous lesions corresponding to the Initial site of Infection. Identification and treatment of 
people with latent TB Is an Important strategy in controlling TB especially in the Industrially 
developed world. Although the Intradermal administration of purified protein derivative that 
comprises the TST has been used for more than 60 years to diagnose latent TB this test has a 
number of disadvantages Including low sensitivity In Immunocompromised patients, cross-reactivity 
with Bacille Calmette-Guerin (BCG) vaccine and environmental mycobacteria and also several 
operational drawbacks. An enzyme linked Immunospot (ELISPOT) assay has recently been 
developed that Is both sensitive and specific In diagnosis of latent TB (Ewer etaL, 2003). The
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ELISPOT offers an attractive alternative to TST for the diagnosis of latent TB and therefore Is an 
important tool in TB control.
1.3. Physiology and location of latent TB
Controversy exists as to the location of M. tuberculosis during latency. The central dogma Is that 
mycobacteria reside extracellularly or Intracellulary within macrophages encapsulated by the 
fibrotic granulomatous lesions or pulmonary lymph nodes, which comprise the Ghon complex 
{Ghon, 1923). It has been hypothesised that the granuloma Is an environment of low oxygen 
availability and this triggers changes In the physiological state of M. tuberculosis and results In 
latent TB Infection (Wayne and Sohaskey, 2001). There is, however, no experimental evidence to 
prove that the granuloma environment Is hypoxic (Ghan and Flynn, 1999). in addition, this theory 
fails to explain the source of bacilli In cases of reactivated extra-pulmonary TB. An alternative 
hypothesis Is that haematogenous spread, which occurs during primary Infection, could result In 
the establishment of persistent M tubercuiosis anywhere In the body (BIshal, 2000).
Granuloma formation Is the trademark of Infection with M. tuberculosis. Mycobacterial granulomas 
are organised multlcellular structures consisting of collections of highly differentiated macrophages 
as well as other cells of the Immune system that restrain M. tubercuiosis (Co et ai, 2004). Although 
granulomas prevent disease by walling off the Infection and curtailing bacterial replication they also 
provide a suitable protective niche for persistent mycobacteria and therefore can be seen as 
beneficial to both the host and the pathogen. Without granulomas It Is doubtful that M. tubercuiosis 
would be such a successful pathogen as the Infection would be so deadly that It would kill Itself off 
before having the opportunity to spread widely. By persisting In the granuloma M. tubercuiosis 
survives for longer and has the ability to reactivate and spread to another host later on.
Tuberculous granulomas are highly dynamic and variable In structure and cellular accumulation 
even within the same host. A predominant feature of human tuberculous granulomas Is the 
presence of a central area of caseous necrosis surrounded by collections of epithelold cells with a 
peripheral cuff of lymphocytes consisting predominantly of lymphocytes and macrophages 
(Fenhalls et ai, 2002a). However granulomas can also be fibrotic and calcified or non-necrotlc. 
Necrotic and non-necrotlc manifestations of the granuloma are commonly Identified together In 
humans, whereas mice tend to only form non-caseating granulomas. Although direct
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measurements of granuloma have not been measured it is postulated by many that oxygen is 
limited within tuberculous granulomas and that oxygen levels decrease from the outer edge of the 
granuloma towards the centre, the central region being the most depleted of oxygen (Wayne and 
Sohaskey, 2001; Fenhalls et ai, 2002a). Mycobacteria have been located by microscopy within the 
macrophages of granulomas and In large numbers In the central caseous region when present 
(Fenhalls et a/., 2002a).
Bacterial viability In different regions of human granulomas has also been Investigated using 
RNA:RNA in situ hybridisation (Fenhalls et ai., 2002a ; Fenhalls et ai, 2002b). These studies 
demonstrated mycobacterial mRNA on the outer edges and transition zones of necrotic 
granulomas and within non-necrotlc granulomas (Fenhalls et ai., 2002a; Fenhalls et ai., 2002b). A 
major limitation of this research Is that all the patients studied had active TB and were receiving 
chemotherapy at the time of surgery and therefore this may not be a true reflection of the situation 
that occurs during a latent TB Infection. The maintenance of the granuloma Is essential for 
preventing reactivation of latent TB (Lawn et ai., 2002). If the granuloma breaks down, the caseous 
centre liquefies, permitting rampant unhlblted bacterial replication, cavity formation and classical 
pulmonary TB. Given the key Importance of granulomas In TB Infections further research Is 
required to define the precise environmental conditions and location of M. tubercuiosis within 
mycobacterial granulomas. The use of recently developed in vitro and in siiico models of human 
mycobacterial granulomas will help achieve this goal (Puissegur et ai., 2004; Segovia-Juarez et ai., 
2004).
The notion that mycobacteria! persistence occurs exclusively In granulomas has been contradicted 
by old and new research (Opie and Aronson, 1927; Flernandez-Pando et ai., 2000). In the 1920's 
Opie and Aronson (1927) used guinea pig Inoculation to demonstrate the presence of viable 
bacteria In normal lung tissue from Individuals with TB lesions who had died of other causes. More 
recently experiments using in situ PCR have detected DNA In lung tissue from patients with no 
histological evidence of TB (Hernandez-Pando et ai., 2000). In addition, mycobacterial DNA was 
detected In several types of cells aside from macrophages (Hernandez-Pando et ai., 2000). Similar 
results have also been reported In a murine model of latent TB (Arriaga et ai., 2002).
M. tubercuiosis bacilli are able to Infect and replicate Inside a wide variety of mammalian cells in 
Wtro (Castro-Garza et ai, 2002). It can be Inferred from these results that M. tubercuiosis persists 
In areas, which are definitely not hypoxic. A limitation of this study Is that PCR cannot distinguish
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between viable and dead bacilli. To overcome this problem several researchers have used 
techniques to detect mRNA which is a useful marker for cellular viability and metabolic activity (Hu 
et ai, 2002; Fenhalls et al., 2002b). These studies show that a re-evaluation of the anaerobic 
model of latency and the emphasis on the granuloma is required.
During latency M. tuberculosis must be able to persist within its host in a relatively inactive state 
but retain the potential for reactivation. The viability and physiological state of persistent 
M. tuberculosis is much debated. Central to this debate is the metabolic activity of persistent TB. 
Numerous studies have been carried out to elucidate whether the etiological agents of latent TB 
are metabolically active and constantly replicating or In an inactive spore like form. Data from 
various experiments support the existence of both states. Investigations in the early 20»^  century 
using biopsy or autopsy material revealed non-acid fast variants of M. tuberculosis (Vandiviere et 
al., 1956). A convincing explanation of this phenomenon is that host responses and drug treatment 
results in the transformation of M tuberculosis into a metabolically inactive cell wall deficient form 
which have the potential to revert to normal acid fast bacillary forms when the host immunity is 
impaired (Chandrasekhar, 1980). Identification of sporulation gene homologues in mycobacterial 
species also provides further support for the existence of physiologically inactive bacilli (Nutter and 
Dick, 1999a). The existence of non-culturable but viable mycobacterial cells has been convincingly 
demonstrated (Shleeva et al., 2002). Resuscitation of these cells could be induced by active 
compounds termed resuscitation promoting factors isolated from exponentially growing cells 
(Biketov et al., 2000).
An alternative opinion is that some level of metabolism is occurring during latency and that 
mycobacterial persistence involves a dynamic balance between bacterial replication and killing by 
the host. Several lines of evidence support this hypothesis. (1) TST reactivity persists for many 
decades in people with latent TB demonstrating that at least some persistent bacteria are shedding 
antigens. (2) Tuberculosis granulomas are dynamic structures with a continual level of 
mononuclear death and cell replacement by active recruitment and therefore it seems likely that 
some level of metabolic activity is required to survive in this heterogeneous and changing 
environment. (3) If persistent M. tuberculosis is in a metabolically inactive state why does 
chemoprophylaxis work? Statistical studies show that treatment with isoniazid reduces reactivation 
by 65-90% (Parrish etal., 1998). However, susceptibility to isoniazid requires some metabolic 
turnover. (4) Persistence in mice and frogs has been shown to require genes involved in
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metabolism and other active cellular processes (McKinney etal., 2000; Chan etal., 2002). Hu etal 
(2002) used an in vitro as well as murine TB model to show that persistent bacteria have 
transcriptional activity, which indicates an active, though possible restricted metabolism.
Considering evidence that suggests persistent mycobacteria may inhabit a wide variety of locations 
within humans an explanation of all this data is that latent TB is caused by a heterogeneous set of 
organisms in a range of replicative and metabolic states. This is supported by a study using RNA- 
RNA in situ hybridisation to detect the expression of M. tuberculosis genes in granuiomas in lung 
sections from TB patients (Fenhalls et al., 2002a; Fenhalls et al., 2002b). More work is therefore 
required to establish the metabolic activity of persistent M. tuberculosis.
1.4. Treatment and prevention of latent TB
Tuberculosis can be resolved using chemotherapy, however, current anti-TB drugs are relatively 
ineffective against persistent bacteria. Consequently prolonged treatment with combinations of 
drugs such as isoniazid, rifampicin, pyrazlnamlde and ethambutal for at least six months is 
required to cure acute disease or eliminate latent infection (Bass et al., 1994). Even latent TB 
requires months of prophylactic isoniazid treatment to reduce the risk of reactivation (Fitzgerald et 
al., 2000; American Thoracic Society/Centers for Disease Control and Prevention, 2000). The 
economic and logistic burden of administering these drug regimens in industrially undeveloped 
countries where TB is most prevalent is enormous. Patient compliance is also a major obstacle to 
effective treatment and an important factor in the development of drug resistant TB isolates. 
Despite the success of DOTS (directly observed treatment short-course) the World Health 
Organisation (WHO) reported that 2-43% of all isolates are resistant to anti-TB drugs (Barry et al., 
2000). TB drug development has been stalled by a lack of pharmaceutical interest and as a result 
no new chemotherapies have been developed In the last 30 years. New anti-TB drugs are urgently 
required which; (1) shorten drug treatment, (2) have activity against drug resistant strains and (3) 
specifically target latent TB. The Global Alliance for TB drug development (GATB) was established 
to address this need. Understanding the molecular and physiology properties of persistent 
M. tuberculosis wili allow the development of drugs targeted to latent mycobacteria and may 
therefore lead to shorter treatments for TB. This would have an important effect on cost, 
compliance and the emergence of drug resistant strains.
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Despite prolonged treatment TB can still reactivate. The failure of antimycobacteria! treatments to 
eradicate TB Is illustrated by a report In the British Medical Journal describing a patient with 
recurrent TB despite two courses of anti-tuberculosis drugs over a 50 year time period (O'Regan 
and Joyce-Brady, 2001). This shows that latent TB may persist for decades despite the 
administration of drugs, it is postulated that the bacteria are not genotypically drug resistant, 
however metabolic or physiological changes in the organism permit tolerance to common 
anti-mycobacterials (Wayne and Sramek, 1994). Clinical evidence supporting this hypothesis has 
come from experiments in which pulmonary lesions were resected from TB patients after 
prolonged drug therapy and also studies using murine models of TB (Vandiviere etal., 1956; 
McKinney, 2002).
Wayne established a link between oxygen starvation and drug resistance in vitro (Wayne and 
Hayes, 1996). In Wayne’s model of persistence the bacteria become resistant to conventional anti- 
mycobacterials and are killed by metronidazole, an antibiotic with selective activity against 
anaerobic organisms (Wayne and Sramek, 1994). However, in vivo data shows that metronidazole 
has a very small activity in chronic murine TB but under most conditions M. tuberculosis is not 
susceptible to metronidazole (Dhillon etal., 1998; Brooks et al., 1999). Despite the questionable 
bactericidal activity of metronidazole in vivo this was the first description of an anti-latency drug 
and has prompted researchers to test the activity of structurally related drugs against persistent 
M. tuberculosis (Murugasu-Oei and Dick, 2000; Stover etal., 2000; Peh et ai., 2001). The most 
promising of these is the nitroimidazole PA-824 that is being developed by the GATB (Duncan and 
Barry, 2004). PA-824 inhibits the synthesis of mycobacterial proteins and cell wall lipids and 
therefore has potent bacteriacidal activity (Stover etal., 2000). This drug has the potential to 
significantly impact on TB chemotherapy because of its demonstrated activity against replicating 
and static cultures of drug resistant and drug sensitive strains of M. tuberculosis (Stover et al., 
2000).
Treatment failure could simply be the result of the ineffectiveness of the available 
anti-mycobacterial drugs (Barry et al., 2000). Due to their toxicity first line TB drugs such as 
rifampicin and isoniazid can only be administered at levels very close to their MIC and therefore 
have a very poor therapeutic index (Barry etal., 2000). Inadequate penetration of infected tissues 
and the slow growth rate of M. tuberculosis could also be factors contributing to the length of time
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required to treat TB. What is unquestionable is that new anti-TB drugs are urgently required. This 
will require studies into the effects of chemotherapeutic agents on persistent M. tuberculosis.
The currently available vaccine Mycobacterium bovis BCG does not consistently protect against 
TB. BCG has high protective efficacy against serious disease in children but very variable 
protection against pulmonary disease in adults and therefore BCG has no appreciable effect on the 
transmission or incidence of TB (Agger and Andersen, 2002). Current estimates of the protective 
efficacy of TB range from 0% in many developing countries to 80% in the UK (Fine, 1995). The 
inadequate protection offered by BCG against pulmonary TB could be due to the attenuation of 
BCG vaccine strains over the years, the inability of BCG to stimulate the optimal blend of T cells or 
the exposure of human populations to environmental mycobacteria (Agger and Andersen, 2002). 
The BCG vaccine also has some additional disadvantages. BCG vaccination results in a positive 
TST test and therefore compromises the diagnostic efficacy of TST. This is particularly problematic 
as TST is an important tool in diagnosing latent disease. In addition, BCG is able to cause 
disseminated disease in HIV infected individuals and therefore cannot be used to protect this high- 
risk group (NInane et al., 1988; Rosenfeldt etal., 1997). Despite these significant disadvantages 
BCG Is the only registered vaccine against TB, is highly effective in animal models and remains the 
golden standard against which new vaccines are measured. An important strategy In TB vaccine 
development is the development of potent BCG-based vaccines and therefore any new information 
about the existing BCG vaccine may contribute to these studies. New TB vaccines could be 
employed to prevent reactivated TB. Development of such post-exposure vaccines will be 
facilitated by studies into the factors underlying persistent TB.
1.5. Persistence genes of M. tuberculosis
M. tuberculosis must be able to persist within the hostile human host in an altered physiological 
state but retain the potential for reactivation. The details of the molecular events controlling 
persistence and reactivation remain to be elucidated but appear to require the carefully 
orchestrated expression of specific genes and induction of metabolic pathways. Numerous genes 
have been described which may have a role in mycobacterial persistence and these include 
respiratory enzymes, stress related products, transcription factors and metabolic enzymes (DeMaio 
etal., 1996; DeMaio etal., 1997; H utter and Dick, 1998; Tabira etal., 1998; Yuan etal., 1998; 
Hutterand Dick, 1999a; Hutterand Dick, 1999b; Manabe etal., 1999; Glickman etal., 2000;
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Ramakrishnan et al., 2000; Weber etal., 2000; DesJardin etal., 2001; Zahrt and Deretic, 2001; 
Manganelli etal., 2001; Fritz etal., 2002; Malhotra etal., 2004; Voskuil, 2004; Daniel etal., 2004; 
Saini et al., 2004). However, only a few of these genes have been validated in an animal model of 
infection (McKinney et al., 2000; Glickman et al., 2000; Ramakrishnan et al., 2000; Zahrt and 
Deretic, 2001; Kaushal etal., 2002; Malhotra etal., 2004; Geiman etal., 2004).
1.5.1. Transcriptional Regulators
The M. tuberculosis genome encodes approximately 190 transcriptional factors reflecting the 
importance of regulated gene expression for the survival of this pathogen (Cole et al., 1998). In 
order to establish the different stages of TB M. tuberculosis transcriptional regulators must switch 
on or off régulons in response to specific environmental triggers. The transition from the acute to 
the chronic phase of infection Is likely to involve a profound change in gene expression co­
ordinated by specific transcription factors. Identification of “persistence transcription factors" will 
lead to the discovery of persistence genes and régulons. Studying the environmental triggers for 
these transcription factors will also help define the conditions experienced by M. tuberculosis in the 
human host. For these reasons this is a very important and active area of TB research.
Sigma factors are sub-units of RNA polymerase responsible for directing the transcription of genes 
under altered environmental conditions. Analysis of the M. tuberculosis genome identified 13 sigma 
factors and several of these have been implicated in the mediation of persistence in mycobacteria 
(DeMaio etal, 1996; Chen etal., 2000; Jenson-Cain and Quinn, 2002; Kaushal etal., 2002; 
Manganelli etal., 2002; Geiman etal., 2004; Manganelli etal., 2004). Two of these, SigF and 
SigH, although not required for the growth and survival of M. tuberculosis in the mouse, are 
required for progressive pulmonary disease and may therefore control genes expressed during the 
chronic stages of TB (Chen et ai, 2000; Kaushal et al., 2002; Geiman et al., 2004).
Two-component signal transduction systems are also important transcriptional regulators that have 
been shown to have crucial roles in the pathogenesis of many bacteria (Dziejman and Mekalanos, 
1995). Two component systems consist of a membrane-bound histidine kinase sensor protein that 
detects specific environmental stimuli. Detection results in autophosphorylation of the sensor 
protein and transfer of phosphate to the response regulator, initiating a regulatory cascade that 
results In the activation or repression of multiple genes. Data suggests that the two-component
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systems mprA-mprB and devR-devS of M. tuberculosis have a role in establishing and maintaining 
persistent TB infections (Zahrt and Deretic, 2001; Boon and Dick, 2002; Malhotra etal., 2004).
Inactivation of the response regulator MprA affected the growth of M. tuberculosis in a tissue 
specific fashion (Zahrt and Deretic, 2000). Mutants were unable to establish an initial infection in 
the spleen or maintain a chronic infection in the lungs suggesting a role for MprA-MprB in 
persistence. Although the signal(s) recognised by the sensor MprB are unknown the tissue specific 
response may provide some clues to the environmental conditions required for MprA induction.
The two-component response regulator devR was identified as one of a number of genes 
upregulated under hypoxia or exposure to nitric oxide. DevR was shown to be essential for the 
survival of M. bovis BCG in Wayne's in vitro modei of non-replicating persistence and therefore this 
gene was renamed the dormancy survival regulator (dosR) (Boon, 2002). Studies have identified a 
regulon of approximately 50 genes that are controlled by DosR and data suggests that a number of 
these genes are important during TB infection (Park etal., 2003; Voskuil etal., 2003). Disruption of 
dosR attenuated the virulence of M tuberculoisis in a guinea pig model and in another study 
rendered the mutant strain hypervirulentto mice (Zahrt and Deretic, 2000; Park etal., 2003; Parish 
etal., 2003; Malhotra etal., 2004; Malhotra etal., 2004). Although this data appears conflicting 
both results suggest a role for DosR in persistence. The DosR system may function to repress 
genes required for acute infection during chronic TB and therefore inactivation results in 
hypervirulence. In addition, DosR may be required to induce specific persistence genes thus 
explaining the attenuated phenotype. The specific ligands that are sensed by the DevR-DevS 
system in the human host are unknown but devR has been shown to be highly responsive to a 
variety of stress signals (Kendall et al., 2004a). Recently presented data also shows that, in 
addition to DosS, DosR is regulated by another sensor, Rv2027c or DosT (Roberts et al., 2004). 
These studies illustrate the need for further work on the role of DosR/DosS/DosT in the 
pathogenesis of M. tuberculosis.
Interest in the WhiB family of transcriptional factors was sparked by their homology to an essential 
sporulation gene (wb/B) of Streptomyces coe//co/or (Hutter and Dick, 1999a). Seven Whi genes 
have been identified in M. tuberculosis and one of these, WhiB3 may have a role during 
persistence. M. tuberculosis whiBZ mutants achieved normal bacterial loads In mice, but caused
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less damage to the lungs and a corresponding slower time to death than wild type (WT) strains 
(Steyn et ai, 2002).
The stringent response is a pleiotrophic bacterial global regulatory response that is triggered by a 
variety of nutritional and metabolic stresses. Mediated by the intracellular concentrations of 
hyperphosphorylated guanosine, (p)ppGpp, this response Is able to modulate the expression of a 
variety of genes with the ultimate goal of reducing protein synthesis. In M tuberculosis synthesis 
and degradation of (p)ppGpp are catalysed by the bifunctional enzyme, Relwtb. This gene is 
induced during nutrient limitation and it has been demonstrated that relMtb deletion strains of 
M. tuberculosis are attenuated for growth in vitro and also for persistence in mice (Primm et al., 
2000; Dahl et al., 2003). A role for the relm gene and the stringent response in the long term 
persistence of this pathogen is therefore proposed.
1.5.2. Metabolism
Once gaining entry Into the human host M. tuberculosis must respond to environmental changes 
by inducing enzymes and aitering metaboiic activity in order to utilise nutrients present in the host 
tissues. For an intraceilular pathogen M. tuberculosis has a surprising number of genes devoted to 
metabolism and this is probably linked to this pathogens ability to survive during the different 
stages of TB (Cole et al., 1998). The notion that M. tuberculosis has a persistence-specific 
metabolic programme was supported by the demonstration that M. tuberculosis requires the 
glyoxylate shunt enzyme isocitrate lyase to elicit a long term infection in mice (McKinney etal., 
2000). As the glyoxylate shunt (Fig. 4.1) is essential for the growth of bacteria and plants on two- 
carbon substrates such as fatty acids, the requirement for isocitrate iyase during persistence may 
reflect a shift in the diet of M. tuberculosis from carbohydrates to fats.
The dependence of persisting M. tuberculosis on the enzyme isocitrate lyase was an exciting 
discovery in TB research (McKinney etal., 2000). Expression of isocitrate lyase in M. tuberculosis 
has been shown to be upregulated during growth within macrophages, during Wayne’s model of 
non-replicating persistence and in human granulomas (Wayne and Lin, 1982; Honer zu Bentrup et 
al., 1999; Graham and Clark, 1999; Fenhalls etal., 2002b). An isocitrate lyase mutant of 
M. tuberculosis was indistinguishable from the WT in the acute stage of the infection but impaired 
for persistence in mice or macrophages (McKinney et al., 2000). This demonstrates the importance 
of this secondary metabolic pathway during long term persistence of mycobacteria. The glyoxylate
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shunt is an attractive target for drug development because it is apparently absent in human cells. 
Isocitrate lyase has also shown to be essential for persistence of another intracellular pathogen, 
Candida albicans (Lorenz and Fink 2001). The development of isocitrate lyase inhibitors may 
therefore be useful as global treatments for persisting infections (Honer zu Bentrup and Russell, 
2001).
1.5.3. Cell wail
The cell wall of mycobacteria species is unique in the bacterial world. In addition to the cell 
membrane and peptidoglycan found In other bacteria, the cell wall contains two additional layers of 
arabinogalactan and mycolic acids. Together the three component super-polymer provides 
mycobacteria with an incredible barrier against harsh environments and is also responsible for the 
characteristic acid-fast staining properties of this group of bacteria. Modifications of the mycolyl- 
arablnogaiactan can have profound consequences to the cell and emerging data suggests that 
remodelling the cell wall may be an important survival tactic of M. tuberculosis (Cox et al., 1999; 
Glickman etal., 2000; Singh etal., 2003)
The Importance of the expression and regulation of mycobacteria! cell wall molecules for the 
growth and persistence of M. tuberculosis in vivo has been supported by a number of studies 
(Glickman et al., 2000; Yamagami et al., 2001). A defect in a major component of the cell wall, 
trehalose-di-mycolate (cord factor) was shown to impact on the ability of M. tuberculosis to persist 
in mice (Glickman et al, 2000). This phenotype was caused by a mutation in the gene pea A, a 
cyclopropane synthetase, which is required for the synthesis of a single cyclopropane residue on 
the major mycolic acid residue of the celi envelope. The isolation of mutant BCG strains which 
were unable to form serpentine cords led to the discovery of the pcaA gene (Glickman et al.,
2000). Cording of mycobacteria is a well-established virulence factor, known to induce a 
granulomatous response (Yamagami et al., 2001). Inactivation of pcaA modulated the 
pathogenesis of M. tuberculoisis in a stage specific fashion in a murine model (Glickman et al., 
2000). During the acute stage of the disease increased bacterial loads were observed whilst during 
the chronic stage a small reduction in the bacterial loads was accompanied by a significant 
increase in survival of the infected mice. This identified pcaA as a “persistence factor” and 
illustrated that subtle changes in the surface of mycobacterial cells can dramatically affect the 
course of infection with M. tuberculosis. Humans do not synthesise cyclopropanated iipids and 
therefore inhibitors of enzymes such as PcaA may be effective against persistent TB infections.
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1.5.4. Antigenic variation
M. tuberculosis dedicates 8% of its genome to members of the PE/PPE family that share multiple 
tandem glycine-alanine repeats. Experiments using Mycobacterium marinum has established a 
role for some members of this family in mycobacterial persistence. Several PE/PPE genes are 
induced during the growth of M. marinum in granulomatous lesions in vivo and one PE/PPE gene, 
mag24-1, was required for long term persistence in frog granulomas (Ramakrishnan etal., 2000).
In addition, a PPE protein is a dominant antigen recognised by latent carriers (Singh etal., 2001; 
Zahrti 2003). Although the function of these genes is unknown it has been proposed that this group 
of proteins may either promote antigenic diversity or analogous to the EBNA-1 protein of Epstein 
Barr virus these repeats may be poorly visible to the immune system (Ramakrishnan etal., 2000). 
Studies have supported the hypothesis that PE/PPE are variable antigens and it is possible that a 
unique set of PE/PPE genes may therefore have a specific role in immune evasion during TB 
persistence (Banu et al., 2002).
In vitro studies have led to the identification of a plethora of additional "persistence genes" 
(Hampshire et al., 2004) (; Lee et al., 1998; Betts etal., 2002; Gupta et al., 2002; Fritz etal., 2002; 
Dahl etal., 2003; Daniel etal., 2004; Voskuil, 2004). Although the significance of these genes 
awaits confirmation in vivo their identification in model systems contributes to the understanding of 
the interaction between mycobacteria and its environment. Further in vitro and in vivo studies, 
possibly integrated into in silico models, are required to characterise the genes involved in TB 
pathogenesis and the mechanisms of TB persistence.
1.6. Models of M. tuberculosis persistence
Studies on latent tuberculosis have been hampered by a lack of appropriate experimental models. 
The design of adequate models is impeded by the paucity of knowledge about the biological 
characteristics of both the bacteria and the host environment during human latent TB. Despite the 
unavailability of an ideal animal model reproducing all aspects of latency observed In humans 
existing models, which range from mice to primates, are valuable tools for investigating the 
pathogenesis of latent TB.
Several different approaches have been taken to modelling persistent mycobacterial infection in 
animals. M. tuberculosis Is frequently studied in a murine model, however mice are much more
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sensitive to TB than humans and latent infections are not established naturally. In the Cornell 
model of murine tuberculosis a pseudo-latency state is induced by infecting mice with a high dose 
of M. tuberculosis and then treating with anti-TB drugs until no cultivatable bacteria can be 
recovered (McCune et al. 1956; Scanga et al., 1999). If the animals are then subjected to 
immunosuppressive therapy reactivation of the disease occurs. The Cornell model shares some 
parallels with latent TB in humans and has been useful for the study of latency and reactivation.
The disadvantage of this model is that latency is induced artificially and antibiotic resistance can 
make interpreting the data difficult (Orme, 2001). The untreated murine model has also been used 
to study persistent TB (Sever and Youmans, 1957; Wayne and Sohaskey, 2001). In this model a 
quiescent state can be induced naturally. Animals are infected with a iow dosage of M. tuberculosis 
and clinical latency can be maintained for 15-18 months (Brooks etal., 1999). Although this model 
does not rely on antlmycobacterials the value of this model is limited as high titres of bacilli can be 
detected throughout the animals body, a situation that Is not replicated in an infected human 
(McMurray, 2001). A very promising modification of this model has been described which uses a 
hybrid strain of mice and inoculation by tracheal injection (Arriaga etal., 2002). In this model low 
and stable bacillary counts were maintained in this model for two years without clinical symptoms 
(Arriaga et al., 2002).
Although mice models reproduce some aspects of latency, persistence in these models does not 
lead to the development of the classical caseous granulomas, an Important hallmark of human TB. 
The rabbit is a useful alternative to mice for modelling latent TB and is aiso an important animal for 
TB vaccine testing (Gomez and McKinney, 2004). Pulmonary granulomas in persistently infected 
rabbits frequently progress to necrosis and caseation (Lurie and Zappasodi, 1942; Tufariello etal., 
2003). Despite these advantages the rabbit model has not been widely applied to modelling 
persistence because it is more expensive and not as weli characterised as the mouse model. 
Recent data demonstrated that non-human primates are a useful model animal for human latent 
TB, however high costs and ethical concerns make this a totally impractical option for the vast 
majority of researchers (Capuano et al., 2003; Gormus et al., 2004).
Non-mammalian models have also been described (Ramakrishnan et al., 2000). Mycobacterium 
marinum naturally causes TB in fish and amphibians and causes granulomatous Infections with 
many morphological features in common with persistent human TB infections. Specifically, the 
goldfish and zebrafish granulomas develop the central caseatlng region of TB (Ruley et al., 2004;
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van der Sar et a!., 2004). This model has several advantages: Laboratory work on M marinum 
does not require class 3 containment facilities, it grows rapidly and easily and it is also more 
genetically tractable than M. tuberculosis. Studies using this model have yielded important 
Information concerning the pathogenesis of persistent mycobacteriosis (Bouley etal., 2001; Chan 
et al., 2002; Ruley et al., 2004). Whether this information can be transposed to M. tuberculosis is 
however questionable.
Robust in vitro models are required to investigate the pathogenesis of M. tuberculosis. In vitro 
modelling of TB persistence provides simple experimental approaches to studying the physioiogy 
and genetic basis of persistent TB. Such models are useful in the hunt for novel drug targets and 
also allow the testing of agents against latent TB. Developing adequate in vitro models of 
persistent TB in the absence of validated animal models remains an enormous challenge. In vitro 
modelers must make simplistic assumptions about the environmental variables within the human 
host, which trigger the latency response. MIcroaerophillic adaptation, nutrient starvation, 
drug-persistent and extended stationary phase models of persistent TB have been established 
(Wayne and Hayes, 1996; Betts etal., 2002; Hu etal., 2002; Shleeva etal., 2002; Florczyk etal., 
2003; Hampshire etal., 2004).
The Wayne model for non-replicating persistence in M. tuberculosis has become the gold standard 
for studying mycobacterial latency in vitro (Wayne and Hayes, 1996). In this model oxygen 
depletion triggers a defined non-replicating persistent state in the mycobacterium. Mycobacteria 
are grown in sealed slowly stirred tubes exposed to limited headspace volumes of air. As the 
culture grows exponentially oxygen is depleted from the system gradually and the organism 
becomes slowly adapted to microaerophillic and then anaerobic conditions. Key features of the 
bacteria In this model is that they are synchronised, have altered metabolic activity and show 
decreased sensitivity to rifampicin and isoniazid and sensitivity to the anaerobic antimicrobial 
metronidazole (Wayne and Sramek, 1994). Numerous proteins and genes have been shown to be 
upregulated during Wayne's model (Yuan etal., 1996; Boon etal., 2001; DesJardin etal., 2001; 
Rosenkrands ef al., 2002; Muttucumaru et al., 2004). It is important to note that Wayne's bacteria 
are in an undefined environment. Although oxygen limitation is considered to be the stimuii for the 
observed physiological state other fluctuations in the culture conditions which occur in batch 
culture such as reduced nutrient availability, pH changes etc. may be contributing to the effect.
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Alternatives to the Wayne's model to investigate the effects of low-oxygen tension on the growth of 
M. tuberculosis have been described. Yuan etal. (1996) used defined oxygen concentrations to 
investigate the expression of alpha crystallin (HspX), a protein associated with TB persistence. In 
this model M. tuberculosis was cultivated under a constant flow of an atmosphere of defined 
oxygen. Other researchers compared the effects of shallow standing versus constantly shaking 
culture conditions on the proteome of M. bovis BCG and M. tuberculosis (Florczyk etal., 2001). 
HspX was induced under shallow standing culture conditions in this study. In addition, it was 
shown that physiological levels (5%) of carbon dioxide prevented growth arrest of M. bovis BCG in 
the shallow standing cultures (Florczyk et al., 2003). These findings could indicate a role for carbon 
dioxide in persistence of M. tuberculosis. What is also apparent from all these studies is that subtle 
variations in the atmospheric culture conditions can significantly effect expression of genes and 
proteins and therefore significantly effect the experimental results (Florczyk etal., 2001; 
Purkayastha etal., 2002).
Akin to the Cornell model In mice an In vitro drug-persistent model of TB has been developed that 
involves treatment of microaerophilic cultures of M. tuberculosis with high concentrations of the 
antimycobacterial rifampicin (Hu etal., 2002). Small populations of persistent bacilli survive this 
onslaught. The drug tolerant bacilli in this model are transcriptionally active and several genes 
have been shown to be upregulated including the alternative sigma factor gene sigJ (Hu etal., 
2002; Hu and Coates, 2001). This model has also been used to test the strerllising activity of 
various quinolones that are potential new treatments for TB (Hu et al., 2003). The results 
demonstrated that moxifloxacin and gatifloxacin had the greatest activities against rifampicin 
tolerant bacteria compared with levofloxacin and ofloxacin and therefore the addition of these 
drugs to current regimens may be able to reduce the length of therapy (Hu etal., 2003). Although it 
remains to be proven that this result corresponds to a greater sterilising activity in the clinic, initial 
trials of moxifloxacin have yielded very promising data (Duncan and Barry, 2004).
Researchers have employed microarray and proteome analysis to investigate the response of 
M. tuberculosis to nutrient starvation (Betts et ai, 2002). This method is extremely simple and 
involves starving M. tuberculosis in phosphate buffered saline (PBS) in sealed static bottles. 
Although the nutrient starved cultures exhibited a global downshift in gene expression, this model 
also allowed the identification of several proteins and genes induced under these conditions, A
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disadvantage of this system is that bacilli are grown statically resulting in a heterogeneous 
population of bacteria in a variety of physiological states with varying oxygen availability.
The formation of non-culturable M. tuberculosis has been reported in cultures held In stationary 
phase in both static and agitated sealed vessels (Shleeva et al., 2002). The bacteria showed an 
altered oval morphology, had no respiratory activity and were resuscitated by resuspension in fresh 
media (Shieeva et al., 2002).
Microaerophillic adaptation, nutrient starvation, drug-persistent and extended stationary phase 
models have been very useful for studying mycobacterial persistence in batch culture. A significant 
limitation of all of these strategies is that the bacteria are in a poorly defined and fluctuating 
environment and therefore it is difficult to interpret the effects of individual parameters and 
reproducibility is a major issue. For example two independent groups monitored the gene 
expression of M. tuberculosis during Wayne’s model of non-replicating persistence and obtained 
disparate results (Voskuil et al., 2004; Voskuil, 2004; Muttucumaru etal., 2004). This compromises 
the validity of molecular, physiological and proteomic studies.
Extended stationary phase culture in a bioreactor has also been used to model TB persistence 
(Hampshire etal., 2004). This system allowed the pH, temperature and dissolved oxygen tension 
to be kept constant throughout the experiments. Although this model goes some way to address 
the problems associated with batch cultivations, the stationary phase of growth remains a very 
poorly defined condition. The mixture of cells in different states of growth and death leads to a 
fluctuating environment. Indeed by the end of 100-day culture in the extended stationary phase 
model 99% of the original culture had died, their skeletons releasing toxins and metabolites which 
would significantly impact on the physiology of the surviving organisms (Hampshire et ai, 2004).
A continuous culture system has been described for M. tuberculosis (James et ai, 2000; Bacon et 
ai, 2004). M. bovis BCG has also been cultivated successfully in a bioreactor (Lowrle et ai, 1979; 
Nyabenda et ai, 1988; Dietrich et ai, 2002). Continuous culture in a chemostat has been 
employed successfully to investigate the effects of 1% oxygen on the transcriptome of 
M. tuberculosis. These studies allowed the effect of oxygen limitation on the transcriptome of 
M. tuberculosis to be investigated at a constant growth rate and independently of any other 
environmental parameters. In addition to providing a controlled and defined environment for 
culturing mycobacteria, chemostat cultivation also provides scientists with the unique opportunity to
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study the effects of growth rate on the characteristics of mycobacteria. As slow growth rates and 
restricted availability of nutrients may be characteristics of latent TB infection, chemostat culture at 
reduced growth rates may provide a useful model for studying the mechanisms by which the 
tubercle bacilli persist.
1.7. Surrogate bacterial models of M. tuberculosis
The safety considerations required when working with M. tuberculosis places constraints on 
research into this pathogen. All procedures must be carried out in biosafety level 3 facilities. To 
overcome these experimental disadvantages researchers have employed non-pathogenic species 
for Investigations into mycobacterial persistence. The rapidly growing saprophytic Mycobacterium 
smegmatis has been used as a system for studying TB. It was demonstrated that the physiological 
response to Wayne’s model of persistence is similar to M. tuberculosis (Dick et al., 1998), leading 
to a number of studies using M. smegmatis as a model organism for mycobacterial persistence 
(Hutter and Dick, 1998; Lee etal., 1998; Murugasu etal., 1999; Smeulders etal., 1999; Keeretal., 
2000; Keer et al., 2001 ; Lim and Dick, 2002; Smeulders et al., 2004). With its free-living, fast 
growing lifestyie M. smegmatis is likeiy to be a distant relative of M. tuberculosis. Caution should 
therefore be taken when extrapolating results from this species to the human pathogen. Indeed 
some researchers believe that M. smegmatis is not an appropriate model for studying the virulence 
of M. tuberculosis (Barry, 2002).
M. bovis BCG has proved to be a very useful non-pathogenic model for the in vitro analysis of 
persistent mycobacteriosis. The BCG vaccine originates from Mycobacterium bovis attenuated by 
repeated passaging on glycerol soaked potato slices and is therefore very closely related to 
M. bovis and M. tuberculosis. The genome of M. bovis BCG and M. tuberculosis exhibit a high 
degree of homology sharing 99.9% of DNA (Behr et al., 1999; Mattow et al., 2001b). The difference 
between the two organisms is that BCG contains a number of well-defined deletions (Behr et al., 
1999). M. bovis BCG also mimics M. tuberculosis in it’s ability to persist in the body and is also 
able to cause reactivation disease in the immunocompromised host (Mackay etal., 1980; 
Abramowsky etal., 1993). Researchers have demonstrated similarities between the physiological, 
molecular and metabolic responses of M. bovis BCG and that of the tubercle bacillus in Wayne’s 
model (Lim etal., 1999; Hutter and Dick, 2000; Murugasu-Oei and Dick, 2000; Fritz etal., 2002). 
For these reasons M. bovis BCG was investigated during this research project.
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Glycerol was chosen as the carbon source during this research project as both M. bovis BCG and 
M tuberculosis are able to grow copiously on medium containing glycerol. M. bovis, however, is 
unable to use glycerol as a sole carbon source. It was presumed that the lesion In glycerol 
metabolism observed for M. bovis was corrected during the creation of M. bovis BCG (Cole et ai, 
1998). Recently the genetic basis for the differences in glycerol metabolism was elucidated 
(Keating et ai, 2005). It was found that M. bovis lacks pyruvate kinase activity as a result of a 
single nucleotide polymorphism in the gene pykk As pyruvate kinase catalyses the final 
irreversible step in glycolysis this mutation blocks glycolytic intermediates from feeding into 
oxidative metabolism and also disrupts the link between the pentose phosphate pathway and 
pyruvate. It was demonstrated that M. tuberculosis and M. bovis BCG both have a functioning 
pyruvate kinase and are therefore able to metabolise glycerol (Keating et ah, 2005). The serial 
passaging of M. bovis on glycerinated medium must therefore have selected for the correction of 
the pykk mutation. Examination ot pykk gene in M. bovis, M. bovis BCG and M. tuberculosis has 
confirmed this hypothesis (Keating et al., 2005).
Studying M bovis BCG may help formulate hypotheses about pathogenic mechanisms of 
persistent TB, which can then be tested in M. tuberculosis. In addition, studies into the persistence 
of M. bovis BCG may lead to the development of safer vaccine strains attenuated for latency and 
reactivation. As multivalent recombinant vaccines using M. bovis BCG as a delivery system for 
viral, bacterial or protozoan antigens have been described such information could have a large 
impact on disease prevention (Fuerstefa/., 1991; Araujo etal., 2000; G rode etal., 2002).
1.8. Global systems approach to studying mycobacterial 
persistence
Despite significant progress in understanding the pathogen M tuberculosis the persistence of this 
organism remains a poorly defined phenomenon. The comprehensive characterisation of the 
genes and pathways that are important to M. tuberculosis in the persistent phase of infection is an 
enormous challange and will require the use of a range of different techniques and models. The 
mapping and sequencing of genomes has led to the development of new technologies that allow 
the determination of global changes occurring In response to genetic and environmental 
perturbations. These "omic" technologies promise to revolutionise bioiogical research and have 
already proved extremely useful in the identification of genes and gene products involved in 
mycobacterial persistence.
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The genome sequence of M tuberculosis provided clues to the lifestyle of this pathogen and also 
highlighted the versatility of this pathogen. With a range of transcriptional regulators and enormous 
anabolic and catabolic capabilities this organisms is well-equipped to survive diverse environments 
(Cole et ai, 1998; Cole, 1999). Lipid metabolism is obviously incredibly important to this pathogens 
survival as it dedicates 8% of its genome to this activity. In addition to genes dedicated to lipid 
synthesis, the M. tuberculosis genome also encodes an array of lipolytic genes supporting 
evidence that lipids are an important carbon source in human tissues (Wheeler and Ratledge, 
1988). In addition, retention by M. tuberculosis and M. leprae of a complete network of anabolic 
genes suggests that the host environment is nutrient limited (Cole et ai, 1998;Cole etal., 2001). 
Availability of the genome sequence also advanced research into persistence by Identifying genes 
that might be involved in this process. Examples Include identification of the Whi family of 
transcriptional regulators and the relmtb gene (Avarbock etal., 1999; Hutter and Dick, 1999a).
Although the availability of the genome sequences of several mycobacteriai species has provided 
a comprehensive list of the components of these bacteria the biological function of many of these 
genes remains uncharacterised. In addition to functional classification, the major challange is to 
determine how genes, protein and metabolites interact to generate a particular phenotype. The 
experimental methods of transcrlptomics. proteomics and the emerging discipline of metabolomics 
have been developed to systematically and globally characterise the basic properties of gene 
products and their interactions and therefore adress some of these issues. Combining these 
techniques therefore provides a very powerful strategy for investigating mycobacterial persistence.
1.9. Overall objectives of the project
The ultimate aim of this research project is to identify mechanisms and markers that are important 
to the function of M. bovis BCG whilst growing in a chemostat model of TB persistence. This was 
achieved by: (1) Defining the physiology of mycobacteria whilst growing in the chemostat model of 
persistence; (2) Deleting genes implicated in persistence and investigating the phenotype of these 
mutants in the model; (3) Examining the proteome and transcriptome of chemostat grown M. bovis 
BCG.
Chapter Two
Adaptation of Mycobacterium bovis BCG 
to a chemostat model of TB persistence
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2.1. Introduction
The chemostat is an invaluable tool in microbiology. During continuous culture in a chemostat 
microbes are grown at a rate set by the experimenter. In addition to the control of growth rate other 
related parameters are precisely controlled. Continuous culture therefore allows defined 
environments to be established which can be manipulated easily to more closely mimic the natural 
conditions of the bacteria in the host. The chemostat has proved to be an excellent environment for 
modelling the in vivo behaviour of bacteria (Cozens et ai, 1986; McKenney and Allison, 1997; 
Hassan et al., 1999; Tappe et al., 1999). The application of continuous culture technology to TB 
research has enormous potential. The chemostat can be used to Investigate the effects of growth 
rate and nutritional status of mycobacteria on gene expression, metabolism and susceptibility to 
antmicrobials. In addition, the chemostat provides a virtually unlimited source of mycobacterial 
cells in a defined state, which are ideal for molecular and physiological studies.
2.1.1. Chemostat theory
Continuous culture refers to a culture of growing microorganisms constantly supplied with fresh 
medium whilst the volume (V) of the culture is kept constant by an overflow system. The most 
commonly used continuous culture system is a chemostat (Fig. 2.1) (Monod, 1950; Novick, 1950; 
Herbert ef al., 1956; Herbert, 1961). In a chemostat, culture medium is pumped at a constant rate 
into the vessel. The flow rate (f) of the media is set by the experimenter to give a desired dilution 
rate (D). The dilution rate is the number of culture volumes passing through the chemostat per unit 
of time and equals the flow rate divided by the culture volume (V) (Equation 2.1.).
D = -p (Equation 2.1)
The chemostat controls growth rate by limiting the availability of a growth substrate. The medium 
contains a fixed concentration of the limiting substrate, all the other nutrients being present in 
essentially excess amounts. By adjusting the feed rate the growth rate can be adjusted to 1-90% of 
the maximum growth rate for the organism. When a dilution rate is set the cells will initially grow as 
in a batch culture at the maximum specific growth rate (pimax) until a substrate in the medium
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becomes limited. If the specific growth rate (pi) of the organism is less than the dilution rate, cell 
density will decrease because cells are washed out of the vessel faster than they grow.
Controller
Condensor <
Perslstaltic
pump
Inoculation port
Sampling port
Media vessel
Waste vessel
Figure 2.1. Schematic diagram of a chemostat. The arrows show the inflow and outflow of 
media. The condenser is used to prevent evaporative loss from the central vessel.
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If the cultures specific growth rate Is greater than the dilution rate, the cell density wiil increase untii 
a substrate within the medium becomes growth limiting. Eventually the cells adjust to the rate of 
nutrient supply so that the specific growth rate equals the dilution rate i.e. D = pi. This balanced 
growth is known as steady state and may be maintained indefinitely. During steady state the 
physiology of the cells remains constant, cellular processes being controlled by the concentration 
of the limiting substrate.
The standard mathematical models for microbial growth in continuous culture were developed 
during the 1940’s and 1950's by Monod and his contemporaries and provide the framework for the 
study of microbial growth (Monod, 1950; Novick, 1950; Powell, 1956; Pirt, 1975). The starting 
hypothesis of the Monod model is that the specific growth rate of a microorganism is dependent on 
the concentration of the limiting nutrient (S) according to Michaelis-Menten type kinetics (Equation 
2.2) (Monod, 1950). Ks,the half saturation constant is the concentration of the limiting substrate at 
which half the maximal specific growth rate is achieved.
g
W = pi max —— -  (Equation 2.2)Ks +  S
A chemostat Is a self-adjusting system, which will reach steady state as long as the dilution rate is 
less than the maximum specific growth rate and does not exceed the critical dilution rate (Dc) 
(Equation 2.3). The term S r is the substrate concentration in the inflowing medium. Provided that 
Sais greater than Ksthen the critical dilution rate is approximately equal to the maximum specific 
growth rate i.e. Dc « pi max.
f  \Dc -  pi max ---------- (Equation 2.3)
V Ks -H Sr J
The steady state concentrations of bacteria and substrate in the culture vessel for any value of the 
dilution rate can be predicted mathematically using two equations. Equation 2.4 describing the 
steady state concentration of the substrate (S) and Equation 2.5 describing the steady state 
concentration of cells (x). Y is the yield constant and can be calculated using Equation 2.6. 
Therefore if the growth constants pimax.Ks are known, these formuiae can be used to predict 
completely the behaviour of the continuous culture running under steady state conditions.
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S = Ks - (Equation 2.4)
^  J L l mux D J
x = y { s R - (Equation2.5)
Y =  m a s s  o f  o r g a n is m  f o r m e d  ^ .S )
m a s s  o f  s u b s t r a te  c o n s u m e d
The total output from a continuous culture unit can also be calculated from Equation 2.7. 
Output = Dx = DY (&  -  Ks ^  ^  ]  (Equation 2.7)
Figure 2.2 shows a typical curve for some experimental values for £  coli (Herbert et ai, 1956; 
Herbert, 1961). As can be seen from the curve the concentration of the organism has a maximum 
value when the dilution rate is zero and the substrate concentration (S) is also zero. As the dilution 
rate increases the substrate concentration increases and the concentration of the organism 
decreases. At the critical dilution rate, which approximates the maximum specific growth rate, the 
concentration of organisms becomes zero and the amount of substrate equals the concentration of 
substrate in the reservoir feed or Sr.
Although numerous other kinetic models have been developed the classical Monod model still 
remains extremely useful for predicting the steady state performance of bacteria and has proved to 
be in agreement with the majority of experimental data (Wojcik and WIelunski, 1979; Postma et al,, 
1986; Ahn etal., 1998; Kovarova and EglI, 1998; Lendenmann and Egli, 1998; Vara etal., 2002; 
Wick et al., 2002; Ellermeyer et al., 2003). Theoretical modelling of continuous culture may be of 
particular use with a slow growing organism such as M. tuberculosis where it is infeasible to 
perform continuous culture experiments covering a wide range of dilution rates. By collecting data 
from several continuous culture experiments mathematical models will allow predictions of the 
behaviour of M. tuberculosis at a range of growth rates and in the presence of varying substrate 
concentrations. Such modelling couid be used to formulate ideas about how M. tuberculosis grows 
and responds to environmental changes in vivo.
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Figure 2.2. Monod plot of chemostat growth. Theoretical relations of the dilution rate (D) and the 
steady state values of cell concentration (x = blue line), substrate concentration (s = black line), 
doubling time (to = green line) and output (D* = red line). Data was calculated from Equations 2.4 
and 2.5 with the following growth constants Pmax = 1 0  h '\ Y = 0.5 g g I'^and Kg= 0.2 g l ’ and Sr = 
10 g r \  Figure from Herbert et al, (1956).
2.1.2. Continuous culture vs batch culture
Classical batch cultivations are the foundation for the majority of in vitro mycobacterial research 
projects because they are extremely simple to perform and allow a wide range of selective growth 
conditions to be investigated. However, during unrestricted growth in batch, cells can only be 
studied at the maximum specific growth rate in a constantly changing and therefore undefined 
environment. Continuous culture techniques, although less popular than the traditional batch 
culture, have been successfully applied in the research of many pathogenic bacteria (Ruijter et a!., 
1990; Wu and Livermore, 1990; James etal., 1995; James and Keevil, 1999; James et al., 2000). 
In contrast to batch culture, chemostat culture allows researchers to study bacteria at sub-optimal 
growth rates in highly defined conditions. Batch and continuous culture experiments have yielded 
invaluable data on the physiology of bacteria. Both methods have advantages and limitations, 
which need to be discussed in the context of this study.
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The growth cycle of bacteria during batch cultivation has well-established physiological points of 
reference. Bacteria initially have a lag period of unbalanced synthesis during which the chemical 
composition of cells necessary for exponential (log) growth is established. During the exponential 
phase cells are grown at their maximum growth rate (pmax). By consuming nutrients and releasing 
toxic chemicals the cells constantly modify the batch culture environment until it no longer supports 
rapid growth. The culture eventually stops growing and enters the stationary phase of growth. 
These growth phases have been useful in studying mycobacteria (Yuan etal., 1996; Cunningham 
and Spread bury, 1998; Armitige etal., 2000; Shleeva etal., 2002). TB researchers have used the 
stationary phase in particular to model TB persistence (DeMaio et al., 1996; Herbert et ai, 1996;
Hu and Coates, 1999b; Hu and Coates, 2001). However, the stationary phase of batch cultures is 
a highly variable phenomenon. Multiple sub-populations of cells will be present, a proportion of 
bacteria will be growing, a proportion will be in stasis and some cells will be dead. This makes it 
difficult to attribute any changes observed in stationary phase to all the cells sampled and also 
affects experimental reproducibility.
Chemostat culture is a technique devised specifically to grow microbes under constant, carefully 
controlled conditions. During continuous culture the organism grows at a specified rate and 
automated adjustments made in response to on-line monitoring enable rigorous control of culture 
pH, dissolved oxygen concentration and temperature resulting in a defined environment. Analysis 
of cells in steady state growth in a chemostat can therefore be divided equally amongst all the cells 
present in the sample to yield estimates of content or activity per cell present. Data from chemostat 
cultivations is therefore more precise, reproducible and statistically significant than those obtained 
from batch cultivations (Hayes et al., 2002; Piper et al., 2002; Boer et al., 2003).
During continuous culture the terms lag, log, stationary phase and death phase have no meaning. 
This is because in a steady state chemostat growth is occurring continuously and cannot be 
segregated into phases. This could be considered as a disadvantage of using a chemostat to 
model a stage of bacterial infection such as TB persistence, which has been associated with non­
replicating or extremely slow growing organisms (Opie and Aronson, 1927; Loring, 1956; Shi et 
al., 2003).
The constancy of physiochemical conditions in chemostat cultivations and the fluctuating 
environments of batch cultures both represent artificial situations, which do not accurately reflect
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the in vivo situation of most bacteria including mycobacteria. Nevertheless it has been argued that 
growth in carbon-limited continuous culture method may be more relevant for modelling organisms 
in nature than batch cultivations {Kovarova and Egli, 1998). Continuous culture systems have been 
successfully applied to studying the properties of conditions associated with slow growth such as 
the stringent response (Chesbro etal., 1979; Arbige, 1982; Frankena, 1988). In addition. Bacillus 
subtilis may sporulate at slow growth rates in a chemostat and therefore the chemostat can be 
used to mimic harsh environmental conditions, which may exist in vivo (0. Avignone-Rossa, 
personal communication). These same principles can be applied to the modelling of mycobacterial 
persistence.
Mutation can have disastrous effects on the operation of a continuous culture. During chemostat 
culture organisms are competing for a single substrate and this provides a strong selective 
pressure. Any spontaneous mutants that have a selective advantage over the parent strain will be 
preferentially retained within the chemostat. In lengthy chemostat runs this could lead to the 
original strain being completely supplanted by a spontaneous mutant {Powell, 1958). The 
spontaneous appearance of mutants during prolonged continuous cultures is well documented. 
However, it is very difficult to assess how much of a problem mutation and adaptive selection are 
during routine chemostat cultivations (Herbert etal., 1956). A few studies have been performed but 
much of the work has concentrated on using the chemostat as a tool for inducing mutations and 
therefore culture conditions have been optimised in order to make mutations favourable (Powell, 
1958; Harder and Kuenen, 1977; Kovarova and Egli, 1998). Herbert etal. (1956) posit that mutants 
are less likely to build up in chemostat culture than in a batch culture because the majority of 
mutations occurring during the course of a continuous culture experiment will be washed out of the 
culture vessel before they have the time to divide, unlike during batch cultivation where mutant 
strains will be retained. Close monitoring of chemostat cultures by microscopy and culture, in 
addition to determining the maximum specific growth rate and yield for the strains at the end of a 
chemostat experiment will help detect mutant organisms with altered growth rates. In addition, this 
strategy will identify any contaminants in the system.
Batch cultivations are relatively simple to perform, inexpensive and require basic laboratory 
equipment and technical expertise. In contrast, chemostat culture experiments are much more of a 
challenge to the experimenter. Successful chemostat experiments require a fundamental 
knowledge of the continuous culture process as well as its total growth kinetics. Bioreactors are
Chapter 2. A chemostat model of TB persistence 29
expensive pieces of equipment and scientists require training in order to use them properly. These 
features are significant disadvantages of chemostat cultures. However, from a different perspective 
the extra planning and training required to perform continuous culture experiments can also be 
considered a positive feature as this can lead to more profound scientific research.
In spite of the technical hurdles associated with this technique, continuous culture in a chemostat 
provides scientists with the unique possibility to study the effects of growth rate on bacteria under 
fixed nutritional conditions. This is a significant advantage over traditional batch culture. The use of 
chemostats in TB research has enormous potential for unraveling the response of mycobacteria to 
different environmental conditions and this data can be used to make predictions about how this 
group of bacteria behaves in vivo.
2.1.3. Mycobacteria and chemostats
An exciting development in the field of TB research is the use of bioreactors for the cultivation of 
mycobacteria. Early experiments with Mycobacterium avium illustrated the technical difficulties 
associated with establishing continuous cultures of mycobacteria (McCarthy, 1983; McCarthy et 
a!., 1987). The slow growth rate of pathogenic mycobacteria, problems associated with clumping of 
bacilli and safety considerations have all provided obstacles for researchers attempting chemostat 
cultures. As a result only very few projects have utilised the chemostat for growing this group of 
organisms (Lowrie etal., 1979; McCarthy, 1983; McCarthy etal., 1987; James etal., 2000; Bacon 
et al., 2004).
James and colleagues have successfully cultivated M. tuberculosis at a high specific growth rate in 
a chemostat using a complex nutrient rich medium (James et al., 2000; Bacon et al., 2004). The 
nature of the growth iimiting nutrient was not investigated during this study (James etal., 2000). 
Nutrient iimitation is likeiy to be a feature of the microenvironment of M. tuberculosis in vivo as the 
growth substrates avaiiable are dependent on the host’s metabolic activities. Whilst the 
environmental milieu encountered by persisting M. tuberculosis remains relatively undefined and 
hotly debated, evidence suggests that the phagosomal environment is carbohydrate poor and that 
carbon acquisition pathways are altered in persistent mycobacteria (Schnappinger efa/., 2003; 
McKinney et al., 2000). Dissecting the response of mycobacterial populations to carbon limitation 
at different growth rates in a chemostat may therefore reveal important information about persistent
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mycobacteria. The chemostat allows a multitude of different growth conditions and growth rates to 
be investigated and therefore will be a versatile instrument for studying mycobacteria and offers an 
attractive approach to modelling persistence.
2.1.4. Aims
The purpose of this study was to develop a chemostat culture model system for investigating 
mycobacterial persistence. It is postulated that slow growth rates and carbon limitation may be 
characteristics of persisting M. tuberculosis in vivo. The first goal of this work was therefore to 
establish continuous culture of M bovis BCG in a chemostat at reduced growth rates mimicking 
possible in vivo conditions. Antibiotic tolerance is a hallmark of mycobacteria in other models of 
persistence and may occur in vivo (Handwerger and Tomasz, 1985; Wayne and Sramek, 1994; 
Wayne and Hayes, 1996; Parrish ef a/., 1998; Betts et ai., 2002; Hu et ai., 2002). To compare the 
activity of antimicrobial agents against chemostat cultured M. bovis BCG was therefore a second 
objective of this study.
2.2. Materials and methods
2.2.1. Bacterial strains
M. bovis BCG Pasteur, which was originally purchased from the American Type Culture Collection 
(ATCC) 35748 was used during this study. Small aliquots of seed stocks were maintained in 10% 
glycerol at -80“C.
2.2.2. Culture media
Middlebrook 7H11 agar and Middlebrook 7H9 broth containing 5% (v/v) OADC enrichment media 
supplement (Becton Dickenson), 0.5% glycerol was used to grow cultures from frozen stocks and 
enumerate the number of culturable bacteria in chemostat samples. Brain Heart Infusion agar 
(BHI) was used to assess the culture purity (Becton Dickenson). Initial experiments trialed the 
chemically defined Sauton's medium (4 g |-1 L-asparagine, 2 g M citric acid, 0.5g M MgS04, 0.5 g l-i 
K2HPO4, 0.05 g M ferric ammonium citrate and 23 ml I*'' glycerol) for cultivation of M. bovis BCG in 
continuous culture (Sauton, 1912). Roisin’s minimal media was also evaluated (Roisin M. Owens, 
personal communication). Roisin’s was prepared as follows: KH2PO4,1 g M; Na2HP04,2.5 g M;
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NH4CI, 5.9 g M; K2SO4, 2.0 g h; ZnCb, 0.08 mg M; FeCb, 0.4 mg |-1; CuCb, 0.02 mg M; MnCb,
0.02 mg M; Na2B4Û7, 0.02 mg I NH4M0 O4, 0.02 mg M; glycerol, 5 ml M (v/v).
Tween 80 was added as a dispersal agent at concentrations up to 0.2% (v/v). To prevent 
excessive foaming in the fermenter antifoam was added at 0.1 - 0.05% (Breox FMT 30). The effect 
of adding biotin (0.5 mg H), sodium pyruvate (0.5%) and glucose (10 mM) on growth was 
assessed. The pH was adjusted to 6.9 (Sauton's) or pH 6.6 (Roisin’s) and either autoclaved at 
121“0 for 30 minutes or filtered through a 0.2 pm Sartorius filter.
2.2.3. Growth curve experiments
Batch cultures were grown in Sauton’s, Roisin’s or 7H9 medium in glass flasks containing a 
Teflon™-coated magnetic baron a magnetic stirrer. Cultures were inoculated with 2% (v/v) of late 
log phase culture (O D eoo=  1.0). Cell growth was monitored daily by measuring the optical density 
at 600nm (Pharmacia Biotech Ultraspec 200 UV visible spectrophotometer).
2.2.4. Continuous culture of M. bovis BCG
M. bovis BCG was grown as nutrient limited steady state cultures in benchtop bioreactors with a 
two litre total volume vessel fitted with a sealed titanium top plate (Photograph 2.1). The culture 
system was operated as a chemostat by controlling nutrient addition from the medium reservoir 
using a Gilson Minipuls3 peristaltic pump, while a constant volume of one litre was maintained via 
an overflow tube attached to another pump (Watson Marlow). Medium delivery was monitored 
daily. The culture was stirred using an impeller set between 250-1000 rpm. Culture conditions were 
continuously controlled by either Biolab Fermentation System (Braun) or the Adaptive Biosystem 
Voyager system (Adaptive Biosystems Ltd), linked to sensor probes inserted into the culture vessel 
through sealed ports in the top plate. The temperature was measured with a Biolab temperature 
probe and kept constantly at 37°C with a heating rod. Culture pH was monitored using an Ingold 
pH electrode (Broadley-James Corporation) and maintained at 6.6 by the automatic addition of 
either 1M sodium hydroxide or 1M hydrochloric acid. The oxygen concentration was monitored with 
a polargraphic oxygen electrode (Broadley-James Corporation) and was controlled at 70-100% by 
feedback control of the agitation rate. Air was pumped through a filter into the headplate at a 
constant rate of 0.11 minute -T Effluent gas was passed through a cooling condenser to minimise 
evaporative loss and analysed continuously using an infrared (carbon dioxide) and electrochemical
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galvanic (oxygen) analysers (Adaptive Biosystems Dual Gas Tandem sensor, Adaptive Biosystems 
Ltd)
Inoculum cultures were grown in 100 ml of modified Roisin's medium (see section 2.2.2.) in glass 
flasks containing Teflon-coated magnetic baron a magnetic stirrer until late exponential phase 
(ODeoo = 1.0). Prior to inoculation the purity of the culture was confirmed by microscopy and 
culture. This BCG preculture was transferred into the vessel through the inoculum port.
After inoculation the culture was grown as a closed system until the ODeoo reached approximately
1.0. Continuous culture was then begun at a known dilution rate of 0.03 h-^  (equivalent to a 
doubling time, td of 24 hours) or 0.01 h-t (td = 69 h). Cultures were allowed to operate for at least 
four volume changes to ensure the cultures had reached steady state. This was confirmed by 
constancy in oxygen consumption and carbon dioxide and biomass production. Once the steady 
state was reached cells were harvested for analysis.
2.2.5. Culture analyses
Samples were collected at regular intervals from the culture system to monitor growth. Culture 
samples were withdrawn from the chemostat by a tube submerged in the culture broth, and 
collected into a sterile bottle kept in an ice bath. The optical density of culture samples was 
recorded at 600 nm (ODeoo) in a Pharmacia Biotech Ultraspec 200 UV visible spectrophotometer 
against a water reference. Biomass was determined according to the method described by Lynch 
and Bushell (1995).
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Photograph 2.1. Benchtop bioreactor.
Acid fastness was determined by a modified Ziehl-Neelsen stain (BDH) according to the 
manufacturer’s protocol. Viable counts were measured by plating 100 pi aliquot of decimal 
dilutions in sterile Ringer’s solution plus 0.01% (v/v) Tween 80 onto Middlebrook 7H11 agar. 
Mycobacterial colonies were enumerated after 3-4 weeks incubation at 37"C. The purity of the 
chemostat culture during the experiments was monitored by daily Gram staining and culturing of 
samples on Brain Heart Infusion agar (see section 2.2.2.).
2.2.6. Metabolite analysis
Samples were collected on ice and harvested by centrifugation for 13,000 x g for 15 minutes at 
4’C. The cell pellet was washed twice in PBS and then stored at -80“C. The supernatant was 
filtered through a 0.2 pm syringe filter and stored at -20“C until analysed. The glycerol in the 
supernatant and fresh media was assayed using a commercial assay kit that employs a
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glycerokinase coupled enzyme assay system {Boehringer Mannheim). Phosphate and ammonia 
were quantified by reflectometry (Rqflex, Merck).
2.2.7. Drug susceptibility testing
Rifampicin, isoniazid and metronidazole were obtained from Sigma. Stock solutions of rifampicin 
(2 mg mb'*) were prepared in methanol and metronidazole (4 mg mM) was dissolved in 50% (v/v) 
acetic acid. The cultures were harvested from steady state chemostat cultures (section 2.2.4). 
Antibiotic susceptibility testing was performed on samples removed directly from the growth 
chamber of the chemostat.
2.2.7.1. Microplate antibiotic assay
The survival of continuously cultured cells in the presence of antibiotics was tested in 96 well (well 
volume = 2 ml) flat bottom microtitre plates (Helena Biosciences). In each plate 495 pi aliquots of 
the cultures were distributed without dilution into all the wells. To investigate the effects of 
clumping on antibiotic susceptibility the cultures were filtered using a 5 pm syringe top filter 
(Sartorius Ltd) prior to distribution into the wells (R. Hernandez-Pando, personal communication)
5 pi of a 100 X drug solution was added to the test wells. Rifampicin was added at four final 
concentrations of 0.1,1.0,10 and 100 pg mM. Metronidazole was added at two final 
concentrations of 12 and 120 pg mM. Drug free controls were included. As an additional control a 
sterile solution of methylene blue was added to drug free cultures at a final concentration of 1.5 pg 
mM. This allowed a visual indication of the oxygen levels within the wells of the assay plate. The 
plate was covered using a standard sticky microtitre plate seal. To allow gaseous exchange within 
the assay plate the seal was pierced using a sterile needle at the position of each well. The 
cultures were incubated on a shaker at 250 rpm at 37°C for four days. For viability estimation 
bacteria were diluted and 100 pi plated onto 7H11 plates containing OADC. Colony forming units 
were enumerated after an incubation period of at least three weeks at 37°C in plastic bags.
2.2.7.2. 7H11 agar proportion method
Chemostat cultivated M bovis BCG cells were also tested in triplicate by the proportion method on 
7H11 agar medium according to standard procedures (Inderlied and Nash, 1996). Aliquots of
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several dilutions of chemostat-cultured cells were transferred to 7H11 plates containing anti­
tuberculosis drugs and drug free control agar. The drug concentrations were: Rifampicin at 0.1,
1.0,10 and 100 pg mM and metronidazole at 12 and 120 pg mM. The proportion of resistant 
organisms in the inoculum was calculated by comparing the number of colonies growing on the 
drug free medium (minimum required = 50) with the number growing on the drug free medium. If 
>1% of the inoculum was found to grow in the presence of the concentration used, the culture was 
regarded as drug resistant.
2.3. Results
Previous studies have reported continuous culture of M. tuberculosis in a complex chemically 
defined medium and cultivation of M. bovis BCG in a bioreactor (James et a/., 2000; Dietrich et ai., 
2002; Bacon et ai., 2004). It was the aim of this project to establish controlled and highly 
reproducible conditions for the continuous culture of M bovis BCG in a simple chemically defined 
carbon-limited medium.
2.3.1. Preliminary chemostat cultures and medium 
development
Sauton's medium was chosen initially as the base medium for the growth of M. bovis BCG in a 
chemostat because it is defined, inexpensive and conventionally used for the preparation of BCG 
vaccine and also cultivation of auxotroph mutants of mycobacteria. Preliminary chemostat 
experiments showed that there were several disadvantages in using Sauton's medium for 
continuous culture. Firstly it was found that Sauton's was not a very reliable medium for the 
cultivation of M. bovis BCG in bioreactors. Several chemostat experiments were unsuccessful as 
the organism failed to grow. Secondly, the cells grew in large clumps and rapidly formed biofilms 
on the vessel wall and probe surfaces. Excessive biofilm formation is problematic in continuous 
culture, as steady states will be perturbed by the release of cells from the biofilm. Thirdly, analysis 
of the supernatant confirmed that Sauton's was a phosphate-limited culture medium. Glycerol was 
detected in excess in the supernatants at every dilution rate tested whereas phosphate was only 
present in trace amounts (data not shown). This is consistent with phosphate being the limiting 
substrate in Sauton's medium. Carbon limitation may have a physiological relevance to 
M. tuberculosis in vivo and therefore a carbon-limited medium was desirable for this study. In 
addition, Sauton's contains four sources of carbon: glycerol, asparagine, citric acid and Tween 80.
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This would complicate metabolite analysis. For these reasons alternatives to Sautons medium 
were investigated.
Roisins medium was developed for the cultivation of M smegmatis (Roisin M. Owens, personal 
communication). It is inexpensive, minimal, chemically defined and unlike Sauton's contains only 
one source of carbon plus Tween 80. The medium composition was modified slightly for the 
cultivation of M. bovis BCG by the addition of the vitamin biotin. This additive enhanced the growth 
of M. bovis BCG (results not shown).
To analyse the ability of Roisin’s medium to support the growth of M. bovis BCG, bacteria were 
grown in batch culture for 6 days (Fig. 2.3). Short lag phase and fast rates of growth were 
observed. The maximum specific growth rate for BCG in Roisin’s was estimated to be 0.033 h"\ 
This was calculated by measuring the growth rate during the log phase. The value of the yield (Y) 
was estimated to be 0.32 g bacteria (dry mass) per gram of glycerol. This was determined by 
calculating the glycerol concentration and the dry mass of bacteria from batch culture samples at 
two different times during log phase. Metabolite analysis of filtered supernatant fluids showed that 
ammonia and phosphate remained In excess throughout the growth cycle whereas glycerol was 
rapidly consumed (Fig. 2.3).
Initial bioreactor experiments showed that Roisin’s medium was suitable for the continuous culture 
of mycobacterium species. Biofilm formation was very minimal and analysis of culture supernatant 
confirmed that Roisin’s was carbon-limited. Roisin’s was therefore selected as the base medium 
for the continuous culture of M. bovis BCG.
In preliminary chemostat experiments growth of BCG was performed with Roisin’s medium 
containing 0.05% (v/v) Tween 80 which is a commonly employed dispersal agent. This 
concentration of detergent combined with stirring at a rate of 1000 rpm was sufficient to dissociate 
bacteria at higher dilution rates. However, reduction of the dilution rate to 0.01 h-i resulted in the 
clumping of mycobacterial cells. A concentration of 0.2% (v/v) Tween 80 was required to minimise 
aggregation at all dilution rates. As a result of high concentrations of Tween 80, antifoam had to be 
incorporated into the medium to prevent foaming.
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Figure 2.3. Batch cultivation of M. bovis BCG in Roisin’s medium. A 10% late logarithmic (log) 
phase culture was prepared and inoculated into the bioreactor. The cultures were operated as a 
batch for 5 days. Samples were removed daily and filtered supernatants were assayed for the 
metabolites glycerol (red line), ammonia (blue line) and phosphate (green line). Cell growth was 
monitored by measuring turbidity (yellow line). Average values and standard deviations are 
shown.
2.3.2, Preparation of Inoculum
It was found that cells from batch cultures grown statically were unsuitable for establishment of 
continuous culture. Such cultures immediately formed biofilms on the vessel wall and probe 
surfaces. Rotary shaking of M. bovis BCG resulted in a high mortality of cultures. Continuous 
culture was successfully achieved if the inoculum was cultivated with magnetic stirring. Under 
these conditions clumping of the bacilli was minimised. The inoculum was grown to late log phase 
(ODeoo > 1.0) before inoculating into the chemostat. Younger inocula were not suitable for initiating 
continuous culture. A minimum of 10% inoculum was required for successful growth in the 
bioreactor. After inoculation, cultures were operated in batch mode with a stirring speed of 250 rpm 
until late log phase before initiating continuous culture and increasing the stirring speed to 
1000 rpm. It was found that a high stirring speed before the culture was established resulted in 
excessive foaming and deposition of bacteria on the vessel walls above the body of the culture. 
Premature commencement of continuous culture resulted in “washout” of the culture.
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2.3.3. Continuous culture of M. bovis BCG In Roisin’s 
medium
After the batch culture phase the flow of medium from the feed reservoir was begun. The flow rate 
was monitored daily and maintained by adjusting the pump. A dilution rate of 0.03 h-i was Imposed 
on the cells. This rate was equivalent to a doubling time of 23.1 hours and is below the specific 
maximum growth rate for M bovis BCG in Roisin’s medium (see section 2.3.1). In addition, James 
et al. (2000) reported optimum growth of M. tuberculosis at this dilution rate. The results of a typical 
continuous culture at a 0.03 h-i dilution rate are illustrated in Fig. 2.4.
As the bacteria adjusted to the introduction of fresh nutrients to the vessel there were fluctuations 
in the growth measurements. After nine days little variation occurred. Once continual culture was 
established the biomass ranged from 0.46 g M to 0.5 g I with an average of 0.48 g I The 
turbidity, biomass and carbon dioxide values correlated with each other for most sampling times 
(Fig. 2.4).
Steady state cells were long rods with a typical acid fast staining pattern. Cultures were a mixture 
of single cells and small clumps of up to 10 cells.
2.3.4. Development of a chemostat model for persistent TB
It is postulated that in vivo persistent TB may be replicating at very low growth rates in carbon- 
limited conditions. In an attempt to mimic possible in vivo conditions M. bovis BCG was 
continuously cultured In a carbon-limited chemostat at low dilution rates. Preliminary experiments 
estimated the minimum generation time of BCG in the bioreactor at 659 hours, which 
corresponded to dilution rates of 0.001 h (results not shown). Extremely low dilution rates were 
not investigated further as such cultures would take a several months to reach steady state. A 
doubling time of 23 hours was adopted in this study to represent the acute phase of infection. This 
growth rate has recently been demonstrated experimentally in the lungs of mice during early 
infection (Shi et a!., 2003). A slower doubling time of 69 hours was also investigated to model 
mycobacterial persistence. Steady state BCG cells grown at a slow dilution rate of 0.01 h 
(td = 69h) were compared with continuous cultures at a higher growth rate of 0.03 h-"" (td = 23h).
The average growth characteristics of BCG at these growth rates (Table 2.1) demonstrated that 
both dilution rates yielded high amounts of viable bacteria and biomass.
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Figure 2.4. Continuous culture of M. bovis BCG. A 10% late logarithmic (log) phase culture was 
prepared and inoculated into the bioreactor. The cultures were operated as a batch until late log 
phase. Continuous culture was then begun at a dilution rate of 0.03 h '\ Samples were removed 
daily starting on the commencement of continuous culture (0 days) and assayed for biomass 
(blue line) and turbidity (green line). Carbon dioxide production in the off gas was measured 
using a Dual Gas Tandem sensor analyser (red line). Average values and standard deviations 
are shown.
Chapter 2. A chemostat model of TB persistence 40
Table 2.1. Steady state growth characteristics of M. bovis BCG grown in a carbon limited 
chemostats at the dilution rates of 0.03 h'^  and 0.01 h'\
Symbol
Dilution rate (h ") D 0.03 0.01
Flow rate (i h F 0.03 0.01
Doubling time (h' )^ td 23.10 69.31
Duration of experiment (days) - 22 44
CFU (xlO^mr^) 5.11 14.8
Bacterial concentration (g dry weight 1'^ ) X 0.32 2.2
Output of bacteria (g h' )^ Fx 0.0096 0.022
Glycerol concentration in reservoir feed (g 1'^ ) S r 6.3 6.3
Glycerol concentration in culture (g 1'^ ) s 5.16 0.21
Yield constant (g bacteria g glycerol'^) Y 0.30 0.36
* Values represent averaged data from two independent chemostat experiments. Cultures were 
allowed to stabilise until the carbon dioxide and biomass production remained constant. All 
assays were performed a minimum of three times.__________________________________________
2.3.5. The Monod model and continuous culture of M. bovis 
BCG
In order to compare the results obtained during the continuous culture of M, bovis BCG with those 
predicted by the Monod model the theoretical curves shown in Fig. 2.5 were plotted from Equations 
2.4 and 2.5 using the values p max = 0.033 h-'' and Y= 0.34 g g M obtained in batch culture 
experiments (Fig. 2.3). Ks was calculated as 0.503 using Equation 2.8 (Herbert etal., 1956). The 
concentration of glycerol in the reservoir medium (Sr) in Roisin’s medium is 6.3 g M.
Ks=  S JÀ max — Z) _ (Equation 2.8)
The experimental results presented in Table 2.1 were also plotted onto Fig. 2.5. The results are in 
agreement with the theoretical predictions, discrepancies being less than the experimental errors 
between the biological replicas. The steady state concentration of organism drops quite steeply 
between the two dilution rates, the curve extrapolating to complete washout at a dilution rate of 
0.031 h-i (estimated Dc). The observed data for the lower dilution rate (D  = 0.01 h-i) shows the 
greatest deviation from the predicted value and bacterial concentrations are slightly higher than the 
expected theoretical values. From the data presented in Table 2.1 it can also be observed that the
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yield constant is decreased at the higher dilution rate of 0.03 h \  this is in accordance with other 
published data (Herbert et al., 1956).
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Figure 2.5. A Monod plot of the chemostat growth of M. bovis BCG. A comparison of the 
theoretical predictions and experimental results. The theoretical values of bacterial concentration 
(x = blue line) substrate concentration, (S = black line), doubling time (td = green line) and output 
(Dx = red line) were calculated from Equation 2.4 and 2.5 using growth constants p max = 0.033 
h"’ and Y= 0.34 g g 1'^  obtained in batch culture experiments. Ks was calculated as 0.503 using 
Equation 2.7 and S r = 6.3 g I \  The experimental results depicted as solid black circles are listed 
in Table 2.1. Average values and standard deviations are shown.
2.3.6. Antimicrobial susceptibility testing
In this study the bacteriocidal activity of antimicrobial agents against the slow and fast growing 
chemostat cultures comprising the chemostat model of persistence were investigated because 
evidence suggests that altered drug susceptibility patterns may be a characteristic of persistent 
M. tuberculosis (Wayne and Sramek, 1994; Parrish et el., 1998; Betts et al., 2002; Hu et al., 2002). 
Antibiotic susceptibility testing of chemostat cultures was performed on samples removed directly 
from the growth chamber of the chemostat. This is a strategy which has been used by others 
(McKenney etal., 1994; McKenney and Allison, 1997).
Two different approaches were used to investigate the effects of the antibiotics rifampicin and 
metronidazole on chemostat grown M. bovis BCG. These drugs were chosen because rifampicin is
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a first line anti-mycobacterial drug, which has been reported to have good bacteriocidal activities 
against persistent bacilli during the treatment of pulmonary tuberculosis. And metronidazole has 
been shown to be active against cells in Wayne’s model of non-replicating persistence (Wayne and 
Sramek, 1979; Wayne and Sramek, 1994; Wallis etai, 1999; Mitchison, 2000). Firstly, the 
chemostat cultures were tested for their survival in the presence of the drugs using a microplate 
style assay. Cells were removed from the chemostat and distributed without dilution into a 
microtitre tray. Drugs were added at the desired concentration and the plate was incubated at 37°C 
with shaking. A four-day time point was selected as the duration of exposure for experiments. 
Wayne and colleagues used this time period to screen drugs for the ability to kill mycobacteria 
during the non-replicating model of mycobacterial persistence (Wayne and Hayes, 1996). In 
addition, it has been shown that drug concentrations start to decline after this time point (Herbert et 
al, 1996).
Figure 2.6 shows the effect of rifampicin and metronidazole on culture viability compared with 
antibiotic free controls after four days incubation. The effects on the antimicrobial drugs were 
calculated as proportional decline compared with the control culture after four days incubation. For 
rifampicin at all four concentrations tested, similar survival patterns were observed whereby 
susceptibility increased with increasing growth rate. A significant difference was observed between 
the survival of the chemostat grown cells in the presence of rifampicin. The slow growing 
chemostat cells (D = 0.01 h-'’) were more tolerant than the fast growing cells (D = 0.03 h-i) to 
rifampicin. All concentrations of rifampicin tested reduced the viable count of the fast growing BCG 
cells (D = 0.03 h-1) by more than 99.99%, whereas, smaller reductions in CFU counts were 
observed in slowly growing BCG cells (D = 0.01 h-i). A small number of the slow growing cells 
(0.01%) even survived concentrations of up to 100 pg of rifampicin, 1000 times the MIC for 
M. bovis BCG (Durek etal, 2000).
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Figure 2.6. The survival of chemostat cultured BCG after exposure to rifampicin and 
metronidazole. Chemostat cultures at the dilution rates of 0.03 h'^  (C23) and 0.01 h'^  (C69) were 
treated with rifampicin at 0.1 |ig ml'^  (blue bars), 1 |ig ml’’ (light green bars), 10 ^g mf’ (dark 
green bars) and 100 ng ml ’ (vary dark green bars), metronidazole at 12 ng ml ’ (light yellow 
bars) and 120 pg ml ’ (dark yellow bars) and including antibiotic free controls (red bars). The 
viability of the bacteria was estimated by enumeration of the colony forming units after four days 
incubation. The experiments were repeated twice and each experiment was carried out with 
triplicate cultures. Standard deviations from two independent experiments are shown.
BCG cells from the chemostat at the fast dilution rate of 0.03 h-i (td = 23 h) were completely 
resistant to metronidazole at a concentration of 12 pg mM, however, 120 pg m| i killed 99.86% of 
this culture. In contrast, metronidazole had some bacteriocidal activity on the slow growing BCG at 
both concentrations tested. The reduction in viable count of the slow growing culture in the 
presence of metronidazole was 33.45% and 52.94% at a concentration of 12 and 120 pg mM 
respectively.
As metronidazole is a drug commonly used against anaerobic and microaerophillic organisms it 
was important that the oxygen levels were not depleted during the course of the experiment. To 
ensure the cultures remained oxygen sufficient experiments were undertaken in microtitre wells 
that contained twice the volume of headspace air per volume of medium (0.5 ml of culture were 
added to wells with a total volume of 2 ml) and the microtitre plate cover was also pierced to allow 
gaseous exchange. In addition, methylene blue was added to control wells to monitor oxygen
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levels throughout the experiment. During the four day incubation the methylene blue in the control 
wells showed no decolourisation, indicating that these cultures remained aerobic for the duration of 
the experiment. To rule out the possibility that microaerophillic conditions were created within the 
interior of clumps of organisms, experiments were also performed using chemostat cultures, which 
had been filtered through 5 pm filters. This method is commonly employed when preparing single 
cells for animal incoluation (R. Hernandez-Pando, personal communication). Filtering made no 
difference to the sensitivity of the cultures to metronidazole {results not shown).
The agar proportion method employed in this study is a standard assay for measuring the 
susceptibility of mycobacteria to antibiotics (Inderlied, 1996). This is a qualitative test, which gives 
a sensitive or resistant answer with no indication of a time course of the bacteriocidal activity. At 
both growth rates the continuous cuitured cells were susceptible to rifampicin with an MIC of less 
than 0.01 pg ml-'' whereas the cultures were deemed resistant to metronidazole at the lower 
concentration of 12 pg mM and sensitive to the higher concentration of the drug, with an MIC of 
between 12 pg mM and 120 pg mM (Table 2.2.). Interestingly the fast growing cultures, although 
still classed as susceptible to 120 pg ml-'' metronidazole, showed a lower susceptibility as 
compared with the slow growth rate. Only 7.51% of the slow growing cells culture survived as 
compared with 58.48% of the fast growing cells.
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Table 2.2. Activities of Rifampicin and metronidazole against continuous cuitured 
M. bovis BCG determined by the agar proportion method
Dilution rate (h"’) Drug SIR
0.03 Rifampicin 0.1 0.15 S
1 0 S
10 0 S
100 0 S
Metronidazole 12 58.48 R
120 0 S
0.01 Rifampicin 0.1 0.14 S
1 0 S
10 0 S
100 0 S
Metronidazole 12 7.51 R
120 0 S
Percent survival is expressed in terms of a drug free control plate. The results are the 
mean of two independent chemostat experiments. Each determination was carried out a 
minimum of three times.
2.4. Discussion
A major limitation of batch cultivation is that the cells are gmwn in an environment that is constantly 
changing with time as a result of bacterial metabolism. The excretion of by-products and depletion 
of nutrients from the media results in an undefined environment, which could have an 
unpredictable impact on the physiology of the organism. Continuous culture in a chemostat allows 
bacteria to be grown at a fixed growth rates and in a defined environment. The results here 
describe an experimental system for growing M. bovis BCG continuously in a carbon-limited 
chemostat and the application of this system to modelling mycobacterial persistence.
M bovis BCG was continuously cultivated in a chemostat with a modified Roisin’s medium. The 
media was refined by the additions of biotin. This additive significantly improved the growth of BCG 
and this corroborates other reports (Andersen et ai., 1991). High growth rates of M. bovis BCG 
were achieved in the chemostat. Continuous culture of M. tuberculosis has been previously 
reported at a dilution rate of 0.03 h-'' (td = 24 h) (James et al., 2000). This was also achieved in this
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study. Continuous culture of M. bovis BCG has only been reported at a slow doubling time of 43 
hours (Lowrie etai, 1979).
Continuous culture has allowed a detailed analysis of the energetics and stoichiometry of bacterial 
growth and a complete mathematical theory of this model has been developed (Monod, 1950; 
Herbert etai, 1956; Herbert, 1961). Overall, there is good agreement between the bacterial growth 
predicted by the Monod model and the experimental results presented here. The data from the 
chemostat cultures at a dilution rate of 0.03 h-i produced the closest fit to the predicted steady 
state bacterial concentrations. The very slight deviations observed for the slower growth rate are 
likely to be due to oscillations in the population density caused by the very slow imput of medium 
(Tappe et ai, 1999). The yield constant (Y) varied from the value found in batch cultivations. This 
phenomenon has been reported in other studies and is related to a change in the maintenance 
energy requirement (Herbert ef a/., 1956; Russell, 1986; Pirt, 1987; Tappe eta!., 1999). The 
maintenance coefficient (qm) is the energy required by the cell for fundamental reactions that do 
not support growth but prevent death. At low growth rates mycobacteria may require extra 
maintenance energy for combusting internal resources such as cell-derived lipids. The 
maintenance requirements of M. tuberouiosis may have particular significance in the latency 
process.
A study in which BCG was cultivated in Sauton’s as a batch culture in a bioreactor demonstrated 
that cells showed an enhanced persistence in mice as compared to surface-pellicle grown controls 
whilst maintaining efficacy as a vaccine (Dietrich et ah, 2002). It was the aim of this study to 
develop an experimental system for mycobacterial persistence in the chemostat. In this model two 
growth rates were investigated to simulate possible growth rates at different stages of infection. A 
low growth rate of 0.01 h (td= 69 h) is proposed to correspond to a persistent mycobacterial 
infection whilst the higher growth rate of 0.03 h-i (td = 23 h) is representative of cells during active, 
disease (Shi ef a/., 2003).
The state of bacterial growth at sites of latent TB is not fully understood. Models of persistence 
have focused on inducing a static state in which mycobacteria are not growing or dying (Wayne 
and Hayes, 1996; Betts etai, 2002). A key difference in the chemostat model described here is 
that the bacteria are multiplying, albeit very slowly. There is some evidence to support 
mycobacterial turnover//? vivo (Parrish etai., 1998; Bouley etai., 2001; Hu etal., 2002). It is
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plausible that during latency a dynamic steady state exists in which the bacteriocidal rate balances 
the rate of multiplication (Young, 2001). Alternatively several experiments have concluded that 
persisting mycobacteria are in a static phase and seldom divide (Opie and Aronson, 1927; Rees 
and D'arcy Hart, 1961). However, mycobacteria have the task of surviving in a cell line with a 
limited life span. The mycobacterial residence is therefore a dynamic structure subject to 
continuous adjustments by the host. Mycobacteria will have to therefore respond to these 
environmental changes and it seems likely that some balanced growth will occur. The chemostat 
model will reveal characteristics of slow growing mycobacteria, which may be correlated with 
persistent bacilli in vivo. Slow growth rates and nutrient limitation may mimic the in vivo 
environment of persistent mycobacteria and therefore studies such as this one will reveal important 
clues about the physiology of this state.
Evidence suggests that tuberculosis latency and antibiotic resistance are closely associated 
phenomena and alterations in drug susceptibility have been documented in other models of TB 
persistence (Wayne and Hayes, 1996; Parrish etal., 1998; Betts etal., 2002; Hu etal., 2002). 
Determining antibiotic susceptibility from models of mycobacterial persistence in a meaningful 
fashion is difficult. The main issues relate to comparing cells in totally different physiological states 
and caution should be taken when interpreting data from such experiments. For this reason it was 
decided to use two different methods to Investigate the bactericidal activities of antimicrobials 
against BCG in the chemostat model of persistence. Using simple survival experiments, which 
have been adopted by others, a dose dependent effect was observed with rifampicin with an 
increased survival in the 0.01 h-i chemostat cells as compared with the faster growing 0.03 h-^  
cells after four days incubation with the drug (Wayne and Hayes, 1996; Betts, 2002). Tubercle 
bacilli in Wayne’s microaerophillic stationary phase model of persistence show a similar 
susceptibility pattern to the slow growing chemostat cells in this study (Wayne and Hayes, 1996). 
The fluctuating growth environment of Wayne's batch culture mode! complicates interpretation of 
the data. Here only growth rate has been altered, keeping all the other parameters constant. The 
effects observed in the microaerophillic model may in fact be due to changes in growth rate rather 
than oxygen depletion. Rifampicin tolerance was also reported in the starvation model of 
persistence but in this case the starved cells showed a greater tolerance to rifampicin than the slow 
chemostat cells (Betts etal., 2002). This is as expected as the cells in the nutrient starvation model 
are replicating very slowly.
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As an alternative strategy, a conventional agar proportion method was employed (Inderlied, 1996; 
Yew etal., 2001). Although this is a standard method for measuring drug activity on 
M. tuberculosis, this method has not been used by any of the other persistence modellers. This is a 
qualitative test, which determines the MIC without providing any information about the antibiotic 
activity over time. The results show that the chemostat cultures do not differ in their sensitivities to 
rifampicin and show an MIC of less than 0.1 pg mM. This is in agreement with other studies (Durek 
efa/.,2000).
The difference in the rate of rifampicin activity between different growth rates is of interest. These 
data indicate that the tolerance is phenotypic, as the cells do not differ in their MIC value for this 
drug. Phenotypic tolerance results when antibiotic sensitive bacteria are in a growth phase that 
reduces or delays the bacteriocidal activities of antibiotics. This phenomenon has been used to 
explain the tolerance of mycobacteria to drugs in vivo and also occurs in other pathogens 
(Handwerger and Tomasz, 1985; Wallis etai., 1999). The mechanisms of phenotypic tolerance 
are uncertain but this study shows a relationship between growth rate and drug tolerance. A slow 
growth rate and restricted availability of nutrients may be characteristics of M. tuberculosis in vivo 
and could be major contributors to phenotypic tolerance. Growth rate could affect antibiotic activity 
in a number of ways. Slowly growing mycobacteria may possess a thickened cell wall, which may 
effect the penetration of antibiotics to their targets (Brown et al., 1990). It has been well 
documented that the composition of the cell wall of bacteria is different in slow growing bacteria 
and their quickly growing counterparts (Brown et al., 1990). A thickening of the cell wall of M. bovis 
BCG and M tuberculosis cultured under anaerobic conditions has been observed and could 
contribute to the antibiotic tolerance observed in Wayne’s model of non-replicating persistence 
(Cunningham and Spread bury, 1998). In addition, the activities of the biochemical target of 
rifampicin (RNA polymerase) are likely to be proportional to growth rate and metabolic activities. 
Such mechanisms may partly explain why TB treatment takes so long. This is particularly pertinent 
to the TB infected lung where nutrient limitation may be a critical determinant of M. tuberculosis 
physiology.
The most surprising finding to emerge from this study was that aerobic cultures of M. bovis BCG 
showed some sensitivity to metronidazole. Although fast growing chemostat cells were insensitive 
to this drug at a concentration of 12 |ig mM, 120 }ig mM metronidazole was bactericidal against 
fast growing cells. This result was confirmed by the agar proportion method. In contrast, slow
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growing cells showed some sensitivity to both concentrations of metronidazole after four days 
incubation with the drug. Metronidazole is a drug used to treat anaerobic and microaerophillic 
bacterial and parasitic pathogens (Samuelson, 1999). The mode of action is well characterised in 
anaerobic organisms and involves the conversion of the inactive prodrug form of metronidazole by 
nitroreduction to a cytotoxic form which damages DMA. In microaerophillic organisms the action of 
this drug is still not fully understood and hotly debated (Mendz and Megraud, 2002). In Wayne’s 
model of non-replicating persistence bacilli only become sensitive to metronidazole in anaerobic 
conditions (Wayne and Sramek, 1994; Wayne and Hayes, 1996). Lim etal. (1999) reported similar 
results with M. bovis BCG. The mechanism of metronidazole action was presumed to be 
analogous to that in anaerobic bacteria. The results of this study are therefore a conundrum. An 
important difference between these experiments and those reported by others is the methods used 
to determine drug sensitivity. In this study cells were removed from the chemostat or batch culture 
and incubated with antibiotics for a fixed time period. In Wayne’s model of persistence aerobic and 
anaerobic cultures are incubated with the drug for different lengths of time (Wayne and Sramek, 
1994).
Here metronidazole sensitivity appears to be affected by the growth rate of mycobacteria. A 
recently developed metronidazole analogue PA-824 is effective in active growing and static 
cultures of mycobacteria as well as in mice (Stover et ai, 2000). Susceptibility of microaerophillic 
bacteria to metronidazole is thought to involve a unique mode of action (Mendz and Megraud,
2002). It is speculated that metronidazole sensitivity of mycobacteria may also involve a novel 
mechanism. Interestingly studies have reported the macrophage induction of acg, encoding a 
putative classical nitroreductase (CNR) of M. tuberculosis (Purkayastha et ai, 2002). CNR 
homologues in Helicobacter pylori are thought to mediate metronidazole activity by activating the 
metronidazole prodrug (Sisson et al., 2002). It is possible that the CNR-like protein of 
M. tuberculosis may perform a similar role. As acg is co-regulated with the a-crystallin gene, HspX, 
which is known to be upregulated during Wayne’s model of persistence and during stationary 
phase, metronidazole sensitivity could be a feature of slowly growing mycobacteria (Yuan et al., 
1996; Tabira etai., 1998; Purkayastha etal., 2002). These results emphasise the need for further 
work into the nature of metronidazole susceptibility in mycobacteria. Such work will be useful in 
dissecting the relationship between antibiotic sensitivity and persistence.
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Susceptibility testing of mycobacteria is routinely performed in batch cultures (Woods, 2000). 
These tests do not always correlate with therapeutic efficacy (McCune et a/., 1956). Chemostat 
culture has already proved useful in testing the activity of antimicrobial agents against other 
clinically relevant bacteria (Millar and Pike, 1992; McKenney etai, 1994; McKenney and Allison, 
1997; Hassan et ai, 1999). A major limitation of this study is that the cells were removed from the 
chemostat and then exposed to antibiotics. A more accurate approach would be to add the drugs 
directly to the chemostat. This strategy, which has been performed by others, was not adopted 
here as these terminal experiments would be very time consuming (Cozens ef aL, 1986; Millar and 
Pike, 1992). This study demonstrates that the chemostat is a useful tool for investigating the 
effects of growth rate and nutrient limitation on the susceptibility of mycobacterium species, which 
would allow more accurate predictions of the in vivo susceptibility pattern. This would be 
particularly useful in measuring the activities of new anti-mycobacterial agents and could lead to 
the identification of agents that will rapidly eradicate persistent M. tuberculosis.
The results describe an experimental system for studying mycobacterial persistence in a 
chemostat that is radically different from other published models. The bacteria in this model are in 
a defined environment and replicating at a known rate. This allows the effect of growth rate on the 
physiology of mycobacteria to be easily studied. As a reduced growth rate may be a feature of the 
bacteria in vivo, this model will be useful for studying M. tuberculosis persistence.
Chapter Three
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3.1. Abstract
An experimental system of Mycobacterium tuberculosis growth in a carbon-limited chemostat, has 
been established using Mycobacterium bovis BCG as a model organism. In this model carbon- 
limited chemostats with low concentrations of glycerol were used to simulate possible growth rates 
during different stages of tuberculosis. A doubling time of 23 hours (D = 0.03 h-^ ) was adopted to 
represent the acute phase of infection whereas a slower dilution rate, equivalent to a doubling time 
of 69 hours {D = 0.01 h-^ ) was used to model mycobacterial persistence. This chemostat model 
allowed the specific response of the mycobacterial cell to carbon limitation at different growth rates 
to be elucidated. Cell macromolecular (RNA, DNA, carbohydrate and lipid) and elemental (C, H, N) 
compositions of biomass were determined in steady state cultures, revealing that carbohydrates 
and lipids comprised more than half of the dry mass of the BCG cell, with only a quarter of the dry 
weight consisting of protein and RNA. Consistent with studies in other bacteria, the specific growth 
rate impacts on the macromolecular content of BCG and the proportion of lipid, RNA and protein 
increase significantly with the growth rate. The correlation of RNA content with growth rate 
indicates that ribosome production in carbon-limited M. bovis BCG cells is subject to growth rate 
dependent control. The results also clearly show that the proportion of lipid in the mycobacterial 
cell is very sensitive to changes in the growth rate, probably reflecting changes in the amounts of 
storage lipids. Finally this study demonstrates the utility of the chemostat model of mycobacterial 
growth for functional genomics, physiology and systems biology studies.
3.2. Introduction
With three million people dying from tuberculosis annually Mycobacterium tuberculosis remains a 
formidable pathogen. Tuberculosis ranks in the top ten causes of global mortality and morbidity 
and is the number one leading cause of infectious disease (World Health Organisation, 2003). 
Fundamental to this organism’s success is its ability to adapt and survive harsh environmental 
conditions in order to establish and maintain long term infections within its human host. 
Modification of the mycobacterial cell in response to changes in the environment is crucial to this 
adaptive process, however detailed information about how M. tuberculosis changes its 
macromolecular composition in response to its environment and growth rate is lacking.
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The genome sequence of M. tuberculosis has been available since 1998 (Cole et aL, 1998). 
Although information obtained from the genome sequence provides a new and valuable insight into 
the biology of the tubercle bacillus, the genome itself provides few clues as to how the pathogen 
responds to its environment by changing its cellular composition. One of the principal tasks of post- 
genomic biology of M. tuberculosis Is to understand how the genome orchestrates the structure 
and dynamics of the cell in response to changes in the environment. This task requires an 
integration of information at the transcriptome (transcriptomics), proteome (proteomics) and 
metabolome (metabolomics). There is a need to understand biological processes by integrating all 
three levels of cellular information (systems biology), and therefore the system under study must 
be defined. An inventory of the macromolecular content of the mycobacterial cell in specific 
conditions will help define the system under study and the reaction of this pathogen to the 
environment more precisely. This represents a first step towards a systems biology approach to 
understanding the TB bacillus
Quantitative descriptions of the chemical composition of the mycobacterial cell are limited to a few 
studies performed many years ago (Winder and Rooney, 1968; Youmans and Youmans, 1968; 
Winder and Rooney, 1970a; Winder and Rooney, 1970b; Winder and Goughian, 1971). These data 
in combination with standard mathematical models has allowed mycobacterial researchers to make 
useful predictions concerning the chemical composition of an "average" mycobacterial cell (Colston 
and Cox, 1999; Cox, 2003; 2004). However, this recipe does not correspond to a defined 
physiological state as the experiments were performed using batch culture systems. A major 
limitation of batch culture is that the cells are grown in an environment that is constantly changing 
with time as a result of bacterial metabolism. The excretion of by-products and depletion of 
nutrients from the medium results in an undefined environment, which has an unpredictable impact 
on the physiology and growth rate of the organism. In addition, batch cultivations yield no 
information about how the macromolecular content varies with growth rate and specific 
environmental conditions and are therefore not amenable to systems biology approaches to 
modelling cellular physiology such as metabolic flux analysis (MFA) (Sanford et al., 2002). MFA is 
a key technique in metabolic engineering, allowing metabolic phenotypes to be defined in terms of 
the carbon flux through a metabolic network using mathematical modelling and computer 
simulation. As it is becoming apparent that intricate and controlled regulation of metabolic 
processes in response to the host environment is a critical component of the pathogenic strategy of 
M. tuberculosis (McKinney etai, 2000) information on the flux through the major pathways using
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MFA will be an important strategy for understanding the changes in metabolism related to the 
virulence of this organism.
Chemostat cultivation has made it possible to study the physiological impact on bacteria of specific 
nutritional conditions at different growth rates. This makes the chemostat an invaluable tool for 
investigating the macromolecular composition of the bacterial cell. The application of continuous 
culture technology to TB research has enormous potential. The chemostat can be used to 
investigate the effects of growth rate and nutritional status of mycobacteria on gene expression, 
metabolism and physiology. In addition, the chemostat provides a virtually unlimited source of 
mycobacterial cells in a defined state, which are ideal for functional genomics, physiology and 
systems biology studies.
The slow growth rate of pathogenic mycobacteria, problems associated with clumping of bacilli and 
safety considerations have all provided obstacles for researchers attempting chemostat cultures.
As a result only very few projects have utilised the chemostat for growing this group of organisms 
(Lowrie etai., 1979; McCarthy, 1983; McCarthy etal., 1987). A continuous culture system has 
been described for M. tuberculosis and has recently been successfully employed to investigate the 
effects of 1% oxygen on the transcriptome of M. tuberculosis (James et aL, 2000; Bacon et aL, 
2004). This study allowed the effect of oxygen limitation on the transcriptome of M. tuberculosis to 
be investigated at a constant growth rate and independently of any other environmental 
parameters (Bacon etal., 2004). Mycobacterium bovis Bacillus Calmette-Guerin (BCG) has also 
been cultivated successfully in a bioreactor (Lowrie et aL, 1979; Nyabenda et aL, 1988; Dietrich et 
aL, 2002). These studies investigated mycobacterial growth at one specific growth rate. However, 
chemostats also provide reasearchers with the unique opportunity to investigate the effects of 
different growth rates on bacteria. A recent study investigating the transcriptional response of 
E. coli demonstrated that the impact of slow growth rates on bacteria may be far greater than the 
effects of nutrient limitation (Hua et aL, 2004). Furthermore growth rate is a critical issue in the 
physiology and pathogenesis of M. tuberculosis. Firstly the organism grows much slower than most 
other microbes that have been studied, with a doubling time that does not exceed one division 
every 16 hours. Secondly infection with M. tuberculosis is characterized by two distinct phases, an 
acute phase of the disease in which the organism is assumed to be growing at or near its 
maximum rate and a persistent asymptomatic infection in which the bacteria are either growing 
extremely slowly or existing in a non-growing state. Dissecting the response of mycobacterial
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populations at different growth rates in a chemostat may therefore reveal important information 
about the physiological state of mycobacteria when growing in the host and offers an attractive 
approach to modeling persistence.
To overcome the safety considerations when working with M tuberculosis the vaccine strain 
M. bovis BCG has been used as a model organism in this study. The BCG vaccine originates from 
M. bovis attenuated by repeated passaging in vitro and is therefore very closely related to 
M. tubercuiosis. The genome of M. bovis BCG and M. tuberculosis exhibit a high degree of 
homology sharing 99.9% of DNA (Mattow et ai, 2001b). The principal genetic difference between 
the two organisms is that BCG contains a number of well-defined deletions (Behr et ai, 1999).
M. bovis BCG mimics M. tubercuiosis in its ability to persist In the body and is also able to cause 
reactivation disease In the immunocompromised host {Passwell ef a/., 1976; Mackay et ai, 1980; 
Abramowsky et al., 1993; Ninane et al., 1988; Rosenfeldt et al., 1997; Talbot et al., 1997). Indeed, 
survival and persistence of the live BCG vaccine is necessary to elicit protective immunity. 
Researchers have demonstrated similarities between the physiological, molecular and metabolic 
responses of M. bovis BCG and that of the tubercle bacillus (Urn et ai., 1999; Mutter and Dick, 
2000; Murugasu-Oel and Dick, 2000; Fritz et al., 2002). Studying M. bovis BCG may help formulate 
hypotheses about pathogenic mechanisms of TB, which can then be tested in M. tubercuiosis.
It is postulated that slow growth rates and carbon limitation may be characteristics of 
M. tubercuiosis in vivo. In an effort to mimic possible in vivo conditions a chemostat model system 
of mycobacterial growth has been developed using M. bovis BCG as a surrogate for 
M. tubercuiosis. The bacteria in this model are in a defined glycerol-limited environment and 
replicating at known sub-optimal growth rates. Therefore this system will be useful for modelling 
mycobacterial disease. Seminal experiments with Escherichia coii have demonstrated that the size 
and composition of the bacterial cell are sensitive functions of growth rate and that the composition 
of the environment is paramount In determining both the viability and the rate of bacterial growth 
(Dennis and Bremer, 1974; Bremer and Dennis, 1996). To determine whether remodelling of the 
mycobacterial cell also occurs in response to changes in the growth rate, the macromolacular 
composition of M, bovis BCG was investigated in the chemostat model of mycobacterial growth. 
This Is the first study to investigate the influence of specific growth rate In chemostat culture on the 
physiological behaviour of mycobacteria and provided valuable information to elucidate changes in 
metabolic flux distributions and cell adaptation.
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3.3. Materials and methods
3.3.1. Bacterial strains
M. bovis BCG Pasteur, which was originally purchased from the American Type Culture Collection 
(ATCC) 35748 was used in this study. Small aliquots of seed stocks were maintained in 10% (v/v) 
glycerol at-80“C.
3.3.2. Media
MIddlebrook 7H11 agar and Middlebrook 7H9 broth containing 5% (v/v) OADC enrichment media 
supplement (Becton Dickenson) and 0.5% (v/v) glycerol were used to grow cultures from frozen 
stocks and for counting the number of culturable bacteria in chemostat samples. Brain Heart 
Infusion agar (BHI) was used to assess the culture purity (Becton Dickenson). Roisln’s minimal 
medium was used for the cultivation of M. bovis BCG in continuous culture (R. M. Owens, personal 
communication). Roisin’s was prepared as follows: KH2PO4.1 g M; Na2HP0 4 , 2.5 g M; NH4CI, 5.9 
g M; K2SO4, 2.0 g l-i; ZnCb, 0.08 mg M; FeCb, 0.4 mg M; CuCb, 0.02 mg H; MnCb, 0.02 mg M; 
Na2B4 0 7 , 0 .0 2  mg 1 N H 4M0 O4, 0.02 mg M; Tween 80, 0.2% (v/v); Biotin, 0.5 mg M; glycerol, 5 ml 
H; antifoam (Breox FMT 30), 0.05% (v/v). The pH was adjusted to pH 6.6 and sterilised by filtration 
through a 0.2 pm Sartorius filter.
3.3.3. Continuous culture of M. bovis BCG.
M. bovis BCG was grown in glycerol limited steady state cultures in two litre bioreactors fitted with 
a sealed titanium top plate. The culture system was operated as a chemostat by controlling nutrient 
addition from the medium reservoir using a Gilson Minlpuls3 peristaltic pump, while a constant 
volume of 1 litre was maintained via an overflow tube attached to another pump (Watson Marlow). 
Medium delivery was monitored daily. The culture was stirred using an Impeiler set between 750- 
1000 rpm. Culture conditions were continuously controlled by either a Biolab Fermentation system 
(Braun) or the Adaptive Biosystem Voyager system (Adaptive Biosystems). The temperature was 
measured with a Biolab temperature probe and kept constantly at 37°C with a heating rod. Culture 
pH was monitored using an Ingold pH electrode (Broadley-James) and maintained at pH 6.6 by the 
automatic addition of either 1M NaOH or 1M HCI. The dissolved oxygen concentration was
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monitored with a polarographic oxygen electrode (Broadley-James) and was controlled at 70-100% 
by feedback control of the stirring rate. Air was pumped through a filter into the headplate at a 
constant rate of 0.11 min Effluent gas was passed through a cooling condenser to minimise 
evaporative loss and analysed continuously using an Infrared (CO2) and electrochemical galvanic 
(O2) analysers (Adaptive Biosystems Dual Gas Tandem sensor).
Inoculum cultures were grown in 100 ml of modified Roisin's medium in glass flasks containing a 
Teflon-coated magnetic baron a magnetic stirrer until late exponential phase (ODeoo =1.0). This 
BCG preculture was transferred into the vessel through the inoculum port. After inoculation the 
culture was allowed to grow batchwise until the ODeoo reached approximately 1.0. Continuous 
culture was then started at a known dilution rate of 0.03 h-i (equivalent to a doubling time, td of 24 
hours) or 0.01 h-^  (td = 69 h). Four volume changes were allowed to ensure the cultures had 
reached steady state, confirmed by constancy in oxygen consumption, carbon dioxide and 
biomass production. Once the steady state was reached cells were harvested for analysis. In order 
to minimise the chances of a spontaneous mutant supplanting the original strain of BCG each 
chemostat culture was performed independently.
3.3.4. Culture analyses
Culture samples were withdrawn from the chemostat by a tube submerged in the culture broth, and 
collected into a sterile bottle kept in an ice bath. The optical density of culture samples was 
recorded at 600 nm (ODeoo) using a Pharmacia Biotech Ultraspec 200 UV visible 
spectrophotometer against a water reference. Biomass was determined according to the method 
described by Lynch and Bushell (1995). Acid fastness was determined by a modified Ziehl-Neelsen 
stain (BDH) according to the manufacturer’s protocol. Viable counts were measured by plating 100 
|j| aliquot of decimal dilutions in sterile Ringer's solution plus 0.01% (v/v) Tween 80 onto 
Middlebrook 7H11 agar. Mycobacterial colonies were enumerated after 3-4 weeks incubation at 
37“C. The purity of the chemostat culture during the experiments was monitored by daily Gram 
staining and culturing of samples on Brain Heart Infusion agar.
3.3.5. Chemical assays
Samples were collected on ice and harvested by centrifugation at 13,000 x g for 15 minutes at 
4'C. The supernatant was filtered through a 0.2 pm syringe filter and stored at -20“C until
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analysed. The glycerol in the supernatant and fresh medium was assayed using a commercial 
assay kit that employs a glycerokinase coupled enzyme assay system (Boehringer Manheim). 
Phosphate and ammonia were quantified by reflectometry (Rqflex, Merck). The cell pellet was 
washed twice in PBS and then stored at -80“C. Prior to analysis samples were dried for at least 12 
hours in an Edwards Modulyo freeze dryer and stored in an evacuated dessicator.
3.3.6. Macromolecular composition
The macromolecular composition of cellular biomass was determined from freeze-dried cell pellets. 
Total carbohydrates were assayed by the phenol reaction using glucose as a standard (Dubois et 
al., 1956; Winder and Rooney, 1970b). Total protein was extracted using two different methods: (1) 
Cells were boiled in 0.5M sodium hydroxide for 10 minutes; (2) Celis were resuspended in a 
protein solubilisation buffer containing 9M urea, 2% (wt/v) CHAPS (3-3- 
chloromidopropyldimethylammoniol-proane sulphonate), 2% (wt/v) SB 3-10 (3- 
[Decyldmethylammonio] propane sulfonate) and transferred to 2 ml ribolysor tubes containing 0.5g 
of glass beads (Sigma). The mixture was vortexed for 30 seconds, cooled on ice for 10 minutes, 
and lysed using a Ribolyser (Hybaid) (speed setting of 6.5 for 30 s x 4) with careful cooling in 
between cycles. The cell free supernatant was collected by centrifugation at 4,000 x g for 10 
minutes at 14'C. Total cellular protein was measured by the Lowry method (Lowry et al., 1951) and 
by the PlusOne 2-D Quant Kit (Amersham). Bovine serum albumin was used as a standard and 
was included with each set of samples.
The extraction procedure for DNA was performed as described by Winder et al. (1967) and 
measured by the phenylalanine reaction using calf thymus DNA (Sigma) as a control (Winder and 
Denney, 1956). For the RNA extraction 20 ml of culture sample was rapidly withdrawn from the 
chemostat by a tube submerged in the culture broth and directly injected into a sterile bottle 
containing 80 ml of GTC solution (5 M guanidinium thiocyanate, 0.5% (v/v) sodium N-lauryl 
sarcosine, 25 mM tri-sodium citrate and 0.1 M DTT). RNA was then prepared essentially as 
described by Stewart et al. (2002). To remove contaminating DNA, samples were digested with 2 
units DNase I for 30 minutes at 37°C (Ambion). The enzyme and divalent cations were then 
removed using DNase Inactivation Reagent (Ambion). Total RNA concentrations were measured 
using the RiboGreen RNA quantification kit (Molecular Probes) according to the manufacturers 
instructions and expressed relative to dry weight.
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Lipid extractions were performed as described by Winder and Goughian (1967) replacing the final 
benzene treatment with an ethanol-ether (3:1) extraction at 60°C for 10 minutes. Carbon (C), 
hydrogen (H) and nitrogen (N) composition of dried biomass and lipid extractions were determined 
by a CHN-elemental analyser CE-440 (Exeter Analytical). All chemical determinations were 
performed a minimum of three times from two independent chemostat cultivations. A standard 
error of the mean of less than 10% was achieved for all assays with a mean standard error of 
5.29%.
3.4. Results
3.4.1. Chemostat culture
The first goal of this study was to develop and optimise conditions for growing BCG continuously in 
a fermenter. James and colleagues have successfully cultivated M tubercuiosis using a complex 
nutrient rich medium containing several carbon sources and an almost full complement of amino 
acids, but this medium is unsuitable for physiological studies due to difficulties in identifying the 
growth limiting substrate (James et ai., 2000; Bacon et ai., 2004). For physiological studies in 
chemostat cultures it is desirable to use defined media, containing ingredients that can be easily 
monitored throughout the experiment. For this reason Roisin's medium was investigated in this 
study as the base medium for the growth of M. bovis BCG. Roisin's has significant advantages 
over other media described for culturing mycobacteria in a chemostat as It is inexpensive, minimal, 
chemically defined and contains only one source of carbon plus Tween 80 as a dispersal agent. In 
addition the carbon, nitrogen and phosphate sources are easily measured using simple assays and 
therefore continuous cultivation of mycobacteria in this medium Is amenable to other 
physiologically relevant studies, such as metabolic flux analysis.
The medium composition was modified slightly for the cultivation of M. bovis BCG by the addition 
of the vitamin biotin, which is known to enhance the growth of M. bovis BCG (Andersen et ai, 
1991). Initial experiments investigated the ability of Roisin's medium to support batch growth of 
M. bovis BCG in a bioreactor. Short lag phases and fast rates of growth were observed (data not 
presented). Results indicated that maximal specific growth rate for BCG in Roisin's medium, 
calculated by measuring the growth rate during the log phase of growth, was approximately 
0.033h \  corresponding to a doubling time of 21 hours. Analysis of the composition of the growth
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medium indicated that phosphate and ammonia remained in excess throughout the growth cycle, 
whereas glycerol was only present in trace amounts, confirming that Roisin's was a glycerol-limited 
culture medium. Whilst the environmental milieu encountered by persisting M. tubercuiosis remains 
relatively undefined and hotly debated, evidence suggests that the phagosomal environment is 
carbohydrate poor and therefore Roisin's provided an appropriate medium for modeling 
mycobacterial disease {McKinney et ai., 2000).
Steady state BCG cells grown at a slow dilution rate of 0.01 h (td = 69 h) were compared with 
cells growing at a higher growth rate of 0.03 h-'> (td = 23 h). A doubling time of 23 hours was 
adopted In this study to represent the acute phase of Infection. This growth rate has recently been 
demonstrated experimentally in the lungs of mice during eariy infection (Shi et a!., 2003). The 
slower dilution rate of 0.01 h-i is proposed to correspond to a persistent mycobacterial infection. 
The average growth characteristics of BCG at these growth rates, once the steady state has been 
reached, (Table 3.1), are in good agreement with Monod’s standard mathematical model for 
microbial population dynamics in the chemostat (for reviews of the model see Kovarova and Egli, 
1998). There were 5.1 times as many cells per gram in cultures grown at the fast growth rate (td = 
23 h) as in cultures grown at the slower growth rate (td = 69 h). This is consistent with the fast 
growing mycobacterial cells being much larger than slower growing cells (Dennis and Bremer, 
1974). The yield constant (defined as the mass of bacteria formed divided by the mass of substrate 
consumed) decreased at the higher dilution rate, as is usually observed (Herbert et ai., 1956).
The macromolecular composition of microbial cells has been shown to change with environmental 
conditions and specific growth rate (Dennis and Bremer, 1974; Bremer and Dennis, 1996). Here 
the macromolecular composition of BCG cells was experimentally determined at two different 
growth rates in the carbon-limited chemostats (Table 3.1). A large percentage (63-67%) of the dry 
cell weight of BCG was found to be carbohydrate and lipid, whereas a much smaller percentage of 
the biomass is made up of protein, RNA and DNA. Mycobacterial cell composition was therefore 
shown to be very different to that of E.coii. In E. coii 75-91 % of the dry weight is protein and nucleic 
acids, with carbohydrates, lipids, soluble metabolites and salts comprising the remaining dry mass 
(Bremer and Dennis, 1996). However, in common with E. coii, it was found that the sum of the 
percentage dry weights of protein, RNA and DNA was Independent of growth rate (Churchward, 
Bremer, and Young, 1982).
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Table 3.1. Characteristics and composition of M. bovis BCG grown in 
continuous culture at two growth rates
Units
Dilution rate h" 0.01 0.03
Doubling time h'"' 69.30 23.10
Optical density (600nm) 1.91 0.83
CPU 10® ml'^ 163 4.64
Bacterial concentration G dry wt T’ 2.2 0.32
Yield constant g bacteria g glycerol'^ 0.30 0.36
Protein content % 22.91 21.40
RNA content % 1.28 3.58
DNA content % 3.21 2.19
Carbohydrate content % 29.20 21.91
Lipid Content % 33.90 44.82
Values represent averaged data from two independent chemostat 
experiments. Cultures were assumed to be in the steady state when carbon 
dioxide and biomass production remained constant. All assays were 
performed a minimum of three times._________________________________
The proportion of protein measured by two independent methods was identical and showed that 
the protein content of a mycobacterial cells remains relatively constant at 21-22% (wt/wt); it falls 
slightly as the growth rate increases. The validity of the protein data was further confirmed by the 
results of the elemental (CHN) analysis. This protein concentration is much lower than predicted by 
Cox (53.70%) (Colston and Cox, 1999; Cox, 2003; 2004) but is in the same magnitude as the 
concentration reported for Mycobacterium tubercuiosis (Youmans and Youmans, 1968). These 
data also show that the pools of RNA and lipid increased with the specific growth rate, whereas the 
pool of carbohydrate decreased. The greatest change was observed in the RNA component 
reflecting the increasing concentration of ribosomes at higher growth rates (Bremer and Dennis, 
1996). The sum of the proportions of protein, RNA, DNA, lipid and carbohydrate correspond to 90- 
93% of the total dry weight; the remaining 7-10% can be accounted for by soluble metabolites and 
salts (Bremer and Dennis, 1996).
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3.4.2. A stoichiometric composition model for M. bovis 
BCG
To obtain a detailed inventory of the mycobacterial cell a macromolecular composition model was 
constructed and the elemental composition of the component macromolecules calculated. This is a 
strategy which has been employed by others and is an important step in the development of a 
metabolic network such as those used in metaboiic flux analysis (Dauner and Sauer, 2001). The 
average amino acid composition of the protein component was obtained from the Horizontal Gene 
Transfer Database website (URL: http://www.fut.es/~debb/HGT/) (Garcia-Vallve, 2003). RNA and 
DNA compositions were calculated assuming a GC content of 65.6% and the constituents of the 
average carbohydrate were calculated from Winder et ai. (1970b)(Cole et al., 1998). The elemental 
composition of lipids was obtained experimentally by determining the CHN values for extracted 
lipids. Using the resulting composition model (Table 3.2) the elemental biomass compositions were 
calculated from the macromolecular biomass data and compared to experimentally determined 
CHN data. At growth rates of 0.01 h-^  and 0.03 h-\ a composition of C1.000H2.046N0.109O 0.720? 0.005S 
0.002X (Mr = 27.43 g mol ■'’) and C1.000H2.038N0.107O o.aioP 0.007S 0.001 X  (Mr = 28.93 g mol ■'*), 
respectively were calculated, X  denoting less important elements. These values are in good 
agreement with the experimentally determined values of C1.000H1.97N0.114 (Mr = 26.15 g mol ■’') and 
C1.000H1.915N0.1124 (Mr = 29.43 g mol *'•) thus validating the results.
3.4.3. The mycobacterial cell
To estimate the size and intracellular concentrations of the mycobacterial cell and also to facilitate 
comparison with other published data it was necessary to convert the macromolecular and 
elemental data from per gram of dry weight to per cell. However, as viable counts are a notoriously 
inaccurate measure of cell number in mycobacteria due to clumping, cell numbers were estimated 
using the quantity of DNA in the biomass (Table 3.1) (Churchward etal., 1982; Cox, 2003). All 
values needed for the calculations were experimentally determined except for the number of 
genomes per cell, which was calculated using the equation G = (to/C In2) {[2(C + D/ to]/ to -2 
(D)}(Churchward et al., 1982; Hiriyanna and Ramakrishnan, 1986; Colston and Cox, 1999). This 
equation was derived to calculate the number of genomes In the cell during balanced growth in 
terms of the doubling time (td), the time taken to replicate the genome (C) and the period of time 
between the end of DNA synthesis and cell separation (D)(Churchward etal., 1982). A C period of 
10.33 hours has been measured for M. tuberculosis and although no data is available for the D
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period, it has been estimated to be approximately 6 hours (Hiriyanna and Ramakrishnan, 1986; 
Colston and Cox, 1999; Cox, 2003). The number of genomes per cell was calculated as 1.12 at a 
dilution rate of 0.01 h-"" and 1.40 at a dilution rate of 0.03 h T
Table 3.2. Stoichiometric model of M. bovis BCG macromolecular compartments. 
Amino acids and nucleotides are represented by their three letter codes
Amino acids^ DNA" Carbohydrate"
% (wt/wt) % (wt/wt) % (wt/wt)
Ala 9.41 dAMP 17.42 Trehalose 7.78
Arg 10.87 dCMP 30.81 Polysaccharide 4.67
Asp 2.43 dGMP 34.83 Glucose 13.97
Asn 6.18 dTMP 16.95 Mannose 8.14
Cys 0.97 Oligosacharide 0.12
Glu 3.63 6-0-methyIglucose 0.83
Gin 6.53 RNA^ Galactose 0.84
Gly 5.47 % (wt/wt) Arabinose 19.86
His 2.86 AMP 18.53 Ribose 1.55
lie 4.41 CMP 31.12 Galactose 3.91
Leu 10.18 GMP 34.98 Glucosamine 32.73
Lys 2.46 UMP 16.37 Muramic acid 4.49
Met 2.27 Glycerol 1.11
Phe 3.83
Pro 5.43 Lipid"
Ser 4.71 % (wt/wt)
Thr 5.62 Carbon 52.75
Trp 2.45 Hydrogen 1.64
Tyr 3.04 Nitrogen 9.54
Val 8.25 Oxygen 36.07
®The amino acid composition of an average M. tuberculosis protein was 
calculated from data on the website http://www.fut.es/~debb/HGT/ (Garcia-Vallve, 
2003).
* RNA and DNA compositions were calculated with a GC content of 65.6% (Cole 
etal., 1998).
G The constituents of an average carbohydrate were calculated from data of 
Winder and Rooney (1970b).
^The elemental lipid composition was determined experimentally using a CHN 
analyzer (this paper).
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The amount of RNA reflects number of ribosomes in the cell and therefore in accordance with 
expectations the RNA content per ceii increases from 2.11 fg per cell atp = 0.01 h-i to 9.96 fg per 
cell at ja= 0.03 h-i to accommodate the growth rate demand (Table 3.3). There are no data on the 
relative concentration of mRNA, tRNA and rRNA in mycobacteria but in £  coii the relative content 
is 2%, 15% and 83% respectively (Bremer and Dennis, 1996). Although at very low growth rates 
the tRNA content Increases at the expense of rRNA, rRNA levels are considered to be relatively 
constant at most growth rates (Skjold et ai., 1973). Using these values and the molecular weight of 
RNA in a M. tuberculosis ribosome the number of ribosomes per cell could be estimated (Cole et 
ai, 1998). In addition, under steady state growth and assuming negligible or constant protein 
turnover ribosome efficiency can be shown to equal p.P/R, where p is specific growth rate and P 
and R are the amount of cellular protein and ribosome content (number) (Bremer and Dennis, 
1996). According to such calculations, the slow growing cells contained 687 ribosomes with an 
efficiency of 0.00055 (fg protein synthesised per ribosome per hour), and the fast growing cells 
contained 3880 ribosomes with an efficiency of 0.00056. The ribosomal efficiency is 21 times lower 
than the maximum efficiency reported for £  coii and appears to be independent of growth rate, a 
characteristic which has been reported for other bacteria (Schaeter et al., 1958; Rosset et al.,
1966; Sykes and Young, 1968)
Lipid and carbohydrate make up a large proportion of the BCG cell. At a specific growth rate of 
0.03 h-i the cells contained 124.80 fg and 57.31 fg of each respectively. Values of 54 fg 
carbohydrate and 76 fg lipid were reported by Winder and Rooney (1970b) for M. bovis BCG 
growing in batch cultivation. As data here shows that the lipid content decreases with the growth 
rate, the differences in these observations are likely to be a reflection of the growth rate and culture 
conditions of the experiments. The correlation between growth rate and the lipid content of 
M. bovis BCG reflects a change in the pool of intracellular reserves, which may have particular 
significance for mycobacteria when growing in the host.
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Table 3.3. Macromolecular properties of carbon ilmited 
M. bovis BCG cells cultured at two specific growth rates in 
a chemostat
Units
Dilution rate h" 0 .0 1 0.03
Doubling time (to) h'^ 69.30 23.10
Genomes per celi^ 1 .1 2 1.40
DNA per ceil* fg 5.35 6.73
RNA per cell fg 2.24 9.96
Ribosomes per cell" 686.58 3879.61
Protein per cell fg 37.74 72.07
Carbohydrate per cell fg 49.06 60.93
Lipid per cell fg 57.31 124.79
RNA: Protein 0.059 0.138
RNA:DNA 0.419 1.480
®The number of genomes per cell was calculated using the 
formula G = (tp/C In2) {[2(C + D/ to]/ to -2  using the 
values C=10.33 h and 5=6 h (Churchward etal., 1982; 
Hiriyanna and Ramakrishnan, 1986; Colston and Cox, 
1999).
^The weight of the genome was calculated as 4.79 fg (Cole 
etal., 1998).
"The numbers of ribosomes were calculated on the basis 
that rRNA comprises 83% of total RNA and that each 
M. bovis BCG ribosome consists of 4790 nucleotides (Cole 
etal., 1998; Cox, 2004).
3.5. Discussion
A model experimental system for studying mycobacterial growth in carbon-limited chemostats was 
developed during this study, allowing for a complete description of the changes in the cells’ 
(macro)molecular composition at different physiological states. In this model two growth rates were 
investigated to simulate possible growth rates at different stages of TB infection. A fast growth rate 
of 0.03 h"^  (td = 23 h) is representative of cells during active disease whilst a slower growth rate of 
0.01 h -1 (td = 69 h) is proposed to correspond to a persistent mycobacterial infection (Shi et al.,
2003). This model provided ideal conditions for analysing the physioiogy of mycobacteria at 
different growth rates and these results provide the first reliable descriptions of the effects of 
growth rate on the macromolecular and elemental composition of the mycobacterial cell. In
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addition, the stoichiometric model of macromolecular cellular composition constructed in this study 
allows the precursor requirements for M. bovis BCG to be predicted and is therefore an important 
first step in the development of a metabolic flux network for the tubercle bacillus.
In recognition of the importance of this topic a theoretical framework was recently developed to 
examine the growth of M. bovis BCG using macromolecular compositions from a limited amount of 
data reported in the 1970’s (Winder and Rooney, 1970a; Cox, 2003; 2004). The general growth 
related trends in the proportions of protein, RNA and DNA for M. bovis BCG presented in this study 
follows a very similar pattern to the behaviour predicted by the mathematical model (Cox, 2003). 
There are however significant discrepancies between the previous observations with batch 
cultured M. bovis BCG and the results presented here (Winder and Rooney, 1970a). Most 
significantly the amounts of protein and RNA in continuously grown cultures are less than those 
previously predicted and as a consequence the macromolecular composition equations derived by 
Cox (2003; 2004) were found not to apply to chemostat grown M bovis BCG cells.
It is difficult to interpret the significance of this discrepancy. The data used in the previous study 
were obtained from cells cultured for 6 days prior to sampling and therefore as observed by Winder 
and Rooney (1970a) the bacteria were not in exponential growth phase. This compromises the 
validity and accuracy of the data, In contrast, the bacterial cells at the steady state reached in the 
chemostat are physiologically homogenous, evenly distributed in a glycerol-limited environment 
and are all replicating at a controlled rate. Therefore the overall macromolecular composition 
determined for the whole population can be averaged over all the cells in the population.
The RNA to protein ratio is a rough measure of the physiological state of cells. The significance of 
this ratio lies in its close relationship to the ribosome synthesis rate, which is a measure of the 
metabolic activity the cell devotes to ribosome synthesis, it has been demonstrated here that the 
RNA: protein ratio increases with growth rate, a property that has been reported for other bacteria 
and reflects changes in the rRNA concentrations of the cell. The notion that ribosomes function at 
a constant maximum efficiency and that an increase in growth rate can only be achieved by 
increasing ribosome concentration has become a central dogma in bacterial physiology. The 
relative constancy of the ribosome efficiencies calculated for M. bovis BCG is in accordance with 
this theory. The earlier studies by Winder and Rooney (1970a) suggested that BCG maintain a 
constant level of ribosome synthesis and may not be capable of altering cellular ribosome levels by
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regulating synthesis. Cross species experiments have shown that the two promoters of the rrn 
operon of M. tuberculosis are both subject to growth rate dependent control (GRDC) in the 
environment provided by M. smegmatis, although other investigators have demonstrated that the 
rate of rRNA transcription initiation did not vary between the logarithmic and stationary phase of 
growth, leading the authors to conclude that GRDC of rRNA does not occur in M. tubercuiosis 
(Merchand et ai, 1998; Verma et ai., 1999). The current study indicates that this is not the case, as 
the amount of RNA alters significantly as a function of growth rate, suggesting that the BCG rrn 
promoters are subject to GRDC under carbon limiting conditions.
Mycobacteria dedicate large amounts of energy towards making lipids for the construction of the 
cell wall and also for storage purposes. Lipid was the main component of the carbon-limited cells 
and the fast growing cells contained twice as much lipid as the slow growing cells. Research has 
shown that the total lipid content both increases and decreases during the growth of mycobacterial 
cultures (Chandramoull, 1974; Ratledge, 1982). This is likely to be a consequence of changes in 
availability of carbon, which can be converted into lipid. The lipid composition values obtained for 
chemostat-grown cells from carbon-limited cultures in this study are therefore likely to represent 
the minimum proportions of lipid required to maintain cellular metabolic and structural requirements 
at the imposed growth rate. The increased lipid composition observed at the fast growth rate may 
reflect a build up of energy reserves, which could be relevant to the survival of mycobacteria during 
persistence.
Nutrient limitation is likely to be a feature of the microenvironment of M. tubercuiosis in vivo as the 
growth substrates available are dependent on the host’s metabolic activities. Although 
investigations of intracellular survival of various auxotrophic mutants can give clues to nutrient 
availability inside the host, the precise composition of each niche can only be guessed (Jackson et 
ai, 1999; Sambandamurthy et ai, 2002). Carbon was chosen as the rate limiting nutrient in this 
study as evidence suggests that the phagosomal environment is carbohydrate-limited 
(Schnappinger et ai, 2003). The effect of starvation on mycobacterial cell physiology has 
previously been studied by simply resuspending cells in phosphate buffer (Betts et ai, 2002). More 
recently the effects of nutrient depletion on the transcriptome of M. tubercuiosis has been 
investigated using extended stationary phase culture in a bioreactor (Hampshire etal., 2004). This 
system allowed the pH, temperature and dissolved oxygen tension to be kept constant throughout 
the experiments. Although this model goes some way to address the problems associated with
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flask batch cultivations, the stationary phase of growth remains a very poorly defined condition.
The mixture of celis in different states of growth and death leads to a fluctuating environment. 
Indeed by the end of 100-day culture in the extended stationary phase model 99% of the original 
culture had died, with the concomitant release of toxins and metabolites that would impact on the 
physiological state of the surviving organisms {Hampshire et aL, 2004). In contrast, the effect of 
carbon-limitatlon can be studied in isolation In the chemostat model provided by this study. The 
specific response of the cell to carbon limitation can therefore be elucidated.
Another important issue to be addressed is the calcualtion of the distribution of metabolic fluxes 
under the different physiological conditions studied. MFA is a powerful methodology for the 
analysis of metabolic pathways. This technique has already proved to be an invaluable tool in 
metabolic engineering and has been used to successfully to identify novel pathways in bacteria, 
providing an enormous potential in functional genomics (Fischer and Sauer, 2003). MFA calculates 
intracellular fluxes using a combination of mathematical and experimental modelling. The minimum 
requirements for MFA are; (1) assembly of a metabolic flux network; (2) cultivation of the organism 
under steady state conditions; (3) specific measurements including the macromolecular 
composition of biomass and extracellular metabolites. This study describes an appropriate system 
(i.e. chemostat cultures) for performing metabolic flux analysis and also provides data that could be 
used as input to a metabolic flux network. In addition, the stoichiometric model of macromolecular 
cellular composition contributed to a metabolic flux matrix that is currently under development in 
our laboratory. MFA has never been attempted using M. tuberculosis, however, given the 
importance that shifts of metabolism might have to the virulence of this pathogen this technique 
could have a significant impact on mycobacterial research.
Models of persistence have focused on inducing a static state in which mycobacteria are not 
growing or dying, however the state of bacterial growth at sites of latent TB is unknown (Wayne 
and Hayes, 1996; Betts et al., 2002). Slow growth rates and nutrient limitation may mimic the in 
vivo environment of persistent mycobacteria and therefore studies such as the one presented here 
will reveal important clues about the physiology of this state. This model could also be particularly 
useful for testing the sterilising activities of new anti-tubercular drugs targeted towards persistent 
mycobacteria.
This study provides a macromolecular composition of glyceroi iimited BCG ceiis at specific and 
well defined growth rates. Extending these studies to include additional growth rates and other
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carbon sources would allow more detailed understanding of how organisms structure their cells in 
response to their environment. It has been proposed that M. tuberculosis primarily metabolises 
lipid in the host {Segai and Bioch, 1956; Wheeler and Ratledge, 1988). Investigating the 
physiological state of lipid limited mycobacterial cells will therefore be an important extension of 
this work and may help define the status of the M. tuberculosis cell in vivo.
Chapter Four
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4.1. Introduction
As more information is unveiled about the pathogenic mechanisms of M. tuberculosis it Is 
becoming apparent that intricate and controlied regulation of metabolic processes is critical in 
establishing and maintaining persistence in the human host. Understanding the environmental 
factors which force switches in bacterial metabolism as weli as tracking the flux of carbon through 
the major pathways is of vital importance for understanding mycobacterial pathogenesis and will 
also provide clues for the development of therapies for TB.
4.1.1. The glyoxylate shunt
Research into secondary metabolic pathways has intensified with the revelations that several 
pathogens require an active glyoxylate shunt for long term persistence in the host (McKinney et a!., 
2000; Lorenz and Fink, 2001). The glyoxylate shunt allows bacteria to grow on fatty acids, which 
are thought to be an important energy source in mammalian tissues (Wheeler and Ratledge,
1988).
The enzymes isocitrate lyase and malate synthase mediate the glyoxylate shunt (Fig. 4.1). 
Isocitrate lyase cleaves isocitrate to succinate and glyoxylate and malate synthase condenses the 
glyoxylate formed with acetyl coenzyme A (acetyl coA) to yield malate. The glyoxylate shunt 
ensures the bypass of two carboxylation steps of the tricarboxylic acid (TCA) cycle and converts 
two molecules of acetyl coA to generate one molecule of succinate which can be fed into 
biosynthetic pathways (Kornberg and Krebs, 1957). As lipids are a source of acetyl CoA and 
succinate is the precursor for the synthesis of glucose the glyoxylate shunt allows M. tuberculosis 
and other bacteria to synthesise carbohydrates from fat.
The provision of carbon skeletons is, however, not the only proposed function of the glyoxylate 
shunt. This pathway is also suggested to have an anapleurotic role (Kornberg and Krebs, 1957). 
When the TCA and glyoxylate shunt run simultaneously, acetate or fatty acids can supply celis with 
energy, precursors for carbohydrate synthesis and replenish the intermediates for the biosynthesis 
of various compounds including amino acids (Kornberg and Krebs, 1957).
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Figure 4.1. The glyoxylate shunt. This pathway is essential for carbon anapleurosis in the Krebs 
cycle during growth on two-carbon substrates such as fatty acids and also provides an adequate 
supply of TCA cycle intermediates for biosynthetic purposes when nutrients are scarce. The key 
enzyme in the shunt is isocitrate lyase, which converts isocitrate into succinate and glyoxylate.
The carbon flux through the branch point of the TCA and glyoxylate cycles is controlled by the 
activities of isocitrate lyase and isocitrate dehydrogenase, which compete for their common 
substrate, isocitrate (Nimmo etal, 1987). The identification of rate limiting steps in metabolic 
pathways that are unique to pathogens is an important strategy in the development of drugs.
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Isocitrate lyase and the glyoxylate shunt are present in prokaryotes, lower eukaryotes and some 
hibernating animals but are apparently absent from humans {Davis etal., 1990; Jones etal., 1999; 
Honer zu Bentrup and Russell, 2001). The glyoxylate shunt is an appealing target for the control of 
human infections such as tuberculosis.
4.1.2. The glyoxylate shunt of Mycobacteria
Interest in the glyoxylate shunt of M tuberculosis dates back to the early 1980’s when Larry Wayne 
first proposed that this pathway is operative during persistence of this organism (Wayne and Lin, 
1982). Genetic confirmation of this hypothesis came twenty years later when Mckinney et al.
(2000) demonstrated that an isocitrate lyase deletion strain of M. tuberculosis was attenuated for 
persistence in mice. Isocitrate lyase mutants behaved like the wild type (WT) during the first few 
weeks of the disease but then were cleared from the body after the onset of specific immunity in 
the chronic stage of infection. M. tuberculosis also requires the id  gene to maintain itself within the 
macrophage (Graham and Clark, 1999; McKinney et ai, 2000). This led to the hypothesis that 
persistent M. tuberculosis requires an active glyoxylate shunt for consuming lipids in order to 
maintain their waxy coat and stay alive. The sources of these lipids could originate from the host 
tissues or from the abundant lipids in the mycobacterial cell envelope that could be catabolised 
under conditions of nutrient limitation.
Isocitrate lyase activity has been shown to be upregulated in the Wayne's model of mycobacterial 
persistence, in stationary phase cultures and also during growth within macrophages (Seshadri et 
al., 1976; Wayne and Lin, 1982; Graham and Clark, 1999; Hampshire etal., 2004). This gene is 
also expressed in human tuberculous granulomas (Fenhalls etal., 2002b). Macrophage activation 
and growth in acetate or fatty acids are important triggers of isocitrate lyase activity, though the 
specific environmental factors inducing isocitrate lyase in the human host are not known. It is 
presumed that isocitrate lyase is directing the flux of carbon into the glyoxylate shunt allowing 
persistent M. tuberculosis to switch to a diet of host or self derived lipids. However this is not 
proven. Wayne and co-workers posited that the glyoxylate generated by isocitrate lyase is 
converted into glycine, consuming NADH in preparation for a metabolic downshift during periods of 
anoxia (Wayne and Sohaskey, 2001). The physiological function and specific environmental 
triggers of isocitrate lyase therefore requires further investigation.
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4.1.3. Isocitrate lyase genes of mycobacteria
Two isocitrate lyase genes have been identified in M. tuberculosis H37Rv, /c/and aceA 
(http://www.sanger.ac.uk/)(Cole etal, 1998). There is high genomic conservation between the id 
gene (Rv 0467) of M tuberculosis with those from other bacteria (Vereecke et al., 1994; Pagan et 
al., 1998). AceA has a much lower homology to other isocitrate lyases and consists of two adjacent 
genes with a single base pair overlap resulting in two open reading frames (ORF) (aceAa/RV1915 
and aceAib/Rv1916; Sanger database) which are thought to represent pseudogenes (Honer zu 
Bentrup et al., 1999). This is in contrast to the arrangement of the aceA gene of M. tuberculosis 
CSU93 (MT1966: The Institute for Genomic Research Database), M. bovis, M. avium and 
M. leprae which have a single ORF (Honer zu Bentrup et al., 1999; Cole et al., 2001; Gamier et al., 
2003). Both the Id gene and aceA of M tuberculosis CSU93 encode functional enzymes.
However, the enzymes differ significantly in stability and substrate affinity (Honer zu Bentrup et al., 
1999). Honer zu Bentrup et al. (1999) demonstrated that ICL had a higher maximum activity ( V m a x )  
and lower K m  value than AceA. Therefore AceA may play a subordinate role in M. tuberculosis 
(Honer zu Bentrup et ai, 1999). Indeed aceA was unable to rescue an id M. smegmatis mutant for 
growth on two-carbon substrates or prevent the death of an id  mutant of M. tuberculosis during 
chronic TB infection in mice (McKinney etal., 2000).
While isocitrate lyase has been studied in M. tuberculosis and M. avium there is no information 
about the arrangement or activities of the isocitrate lyase genes of M. bovis BCG. BCG, like 
M. tuberculosis, persists for lengthy periods and isocitrate lyase activity is likely to be a driving 
force in this persistence. A better understanding of the role of isocitrate lyase in the persistence of 
M. bovis BCG may provide a new insight into the metabolic basis for persistence and BCG 
pathogenesis and may also ultimately reveal strategies, which are shared with M tuberculosis.
4.1.4. Aims
Mckinney etal. (2000) demonstrated that disruption of/d did not compromise the growth of 
M. tuberculosis during batch cultivation or in Wayne’s model of persistence. In order to investigate 
the survival of an A id  mutant in the chemostat model of TB persistence an unmarked id knockout 
mutant was constructed using M. bovis BCG.
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4.2,1.
4.2. Materials and methods 
Bacterial strains and plasmids
M, bovis BCG strain Pasteur ATCC 35748 was mutated in this study. Escherichia coii strain DH5a 
was used as a host for all plasmid constructions (Sambrook et al., 1989). The characteristics of the 
plasmids employed are listed in Table 4.1.
Table 4.1. Plasmids used In the study
Vector Description Marker genes Reference
p2 NIL Gene manipulation vector Kan Parish andStoker, 2000b
PG0AL19 Casette vector Hyg, lac Z, p nspeo-sacB Parish andStoker, 2000b
p2NIL/c/ Gene manipulation vector Kan This study
pUS/c/ Suicide delivery vector Kan, Hyg, lac Z, p hspeo- This study
sacB
p2NILace Gene manipulation vector Kan This study
pUSace Suicide delivery vector Kan, Hyg, lac Z, p hspeo- This study
sacB
4.2.2. Media and culture conditions
E. coii was grown in solid or liquid Luria-Bertani (LB) medium as described by Sambrook et ai. 
(1989). Mycobacterial cells were propagated in Middlebrook 7H9 broth or 7H11 agar containing 5% 
(v/v) OADC enrichment media supplement (Becton Dickenson), 0.5% (v/v) glycerol plus 0.05%
(v/v) Tween 80 for liquid cultures. For mycobacteria, when selection was required, kanamycin at 
20 |ig mM, X-gal at 50 pg ml-'' and sucrose at 2% (wt/v) were added to the culture media. All 
bacterial strains were grown at 37‘C in glass flasks containing a Teflon™ coated magnetic bar on a 
magnetic stirrer. Chemostat cultivation of M. bovis BCG strains was performed as detailed in 
section 2.2.4. Growth curves were performed in Roisin’s medium (see section 2.2.2 for recipe) 
containing either glycerol or sodium acetate as the carbon source at a final concentration of 0.5% 
(v/v) and 0.1% (wt/v) respectively. Viable counts were measured by plating 100 p\ aliquot of 
decimal dilutions in sterile Ringer's solution plus 0.01% (v/v) Tween 80 onto Middlebrook 7H11 
agar. Mycobacterial colonies were enumerated after 3-4 weeks incubation at 37‘C.
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4.2.3. DNA preparation
Mycobacterial DNA was prepared using a standard phenol chloroform extraction. Cell pellets were 
mixed with equal volumes of 1 X Tris-EDTA (TE) containing RNase and phenol chloroform in a 
Ribolyser tube and cooled on ice for one minute. Cells were lysed using a Ribolyser (Hybaid) at 
setting 4 for 20 seconds. After centrifugation the aqueous layer was removed. After further 
chloroform and phenol chloroform extractions the DNA was precipitated in isopropanol and the 
precipitate was dissolved in 10mM Tris-EDTA buffer (pH 8.5). The approximate quantity and 
quality of the prepared DNA was estimated by resolving on a 0.8% agarose gel in TAE buffer by 
electrophoresis.
Plasmid DNA was prepared using Qiaprep spin miniprep Kit (Qiagen), which uses the modified 
alkaline lysis method of Birnboim and Doly (1979).
4.2.4. DNA manipulations
PCR was performed in standard 20 )al reactions containing, 1 mM dNTPs, 2 nmoles of each 
primer, PCR buffer (including 1.5 mM MgCb), 1 pi of the extracted DNA and 0.5 units of Taq DNA 
polymerase (FastTaq, Roche). Amplification consisted of 30 cycles of dénaturation at 95”C for 5 
minutes, annealing at 60°C for 30 seconds and elongation at 71 “C for 2 minutes. The reaction was 
finished by one 5 minute incubation at 72’C using a Hybaid Omnigene Temperature thermocycler. 
PCR products were electrophoretically separated on 1.0% agarose gels in 1 x TAE using a 100 bp 
DNA ladder (Gene ruler, MB! Fermentas) as a size marker. Gels were stained with ethidium 
bromide (0.1 pg ml-'') and viewed under UV illumination. Table 4.2 lists the primers employed 
during this research project.
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Table 4.2. Primers used for PCR
Primer Sequence Restriction site
/C/-HR1 F GATCCTGCAGCAAGCGTGCTGCGATTGG Psfl
/C/-HR1 R GATCAAGCTTCAAATTTTGCGAAGTCGCCC Hind III
/C/-HR2F GATCAAGCTTCGGCTACTTCGACCGGATTG Hind III
/C/-HR2R GATCGGTACCTTCTTTCCCAACTGGCCCGC Kpn 1
i d f AGCAGGAATGGGACACGAACG N/A
Id  R ACGCGCTCATCTGGTTCTGG N/A
ace -HR1F GATCAGTACTACCTACGGTCGGCTACCG Sea 1
ace -HR1R GATCAAGCTTACGGACCGAGTGTATCCC HIndlW
ace -HR2 F GATCAAGCTTAAAGCGGCTGATGACCCT Hind III
ace -HR2 R GATCGGTACCAACAGTGGCGATGGAAGC Kpn 1
ace F CAACCTGATCCGCCGCTTCG N/A
ace R GCGAGATCGGCGGTCTTGGT N/A
Ligations, transformations and selection of recombinants were carried out according to standard 
protocols (Sambrook etal., 1989). Restriction enzyme-digested plasmids were isolated with a 
QIAquick gel extraction kit (Qiagen).
4.2.5. Construction of delivery vector
Suicide vectors were constructed using the cloning strategy described by Parish and Stoker (2000) 
illustrated in Fig. 4.2. For the id  deletion PCR was used to amplify two separate 1 Kb DNA 
fragments containing /c/-HR1 and /c/-HR2 from M bovis BCG and representing regions flanking the 
id  gene (Fig. 4.3). /c/-HR1 and /c/-HR2 were amplified using the primers listed in Table 4.2. 
Recognition sites for restriction endonucleases were introduced into the primer sequences to allow 
rapid cloning in a predicted orientation. For the unmarked /c/deletion, two separate fragments were 
cloned into p2NIL (Fig. 4.2). First a 632 bp Pst l-Hind III deletion was made in the p2NIL vector and 
a 1Kb Pst l-Hind ill fragment of/c/-HR1 was cloned into this site. This was followed by a 1.0 Kb 
Hind lll-Kpn I fragment of /c/-HR2 to generate the p2NIL/c/. The final delivery vector was generated 
by cloning the Pac I cassette from pG0AL19 into the p2N!L-/c/construct to give pUS/c/ (Fig. 4.2j.
An identical strategy was used for the aceA deletion. The homology regions, aceHRI and aceHR2 
were amplified using PCR (Table 4.2; Fig. 4.6) and cloned into p2NIL. pUSace was then made by
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cloning the Pad cassette of pG0AL19 into this construct. In the selection of the aceHR2 fragment 
the region of major polymorphic tandem repeats (MPTR) contained within the PPE gene Rv1917c 
were avoided (Fig. 4.6) (Sampson et ai, 2001). The pUSace plasmid was used to delete the aceA 
gene in the id  mutant in order to generate a double id-ace mutant.
4.2.6. Transformation of M. bovis BCG
\
Logarithmic cultures of M. bovis BCG (O D eoo  = 1.0) were harvested and washed in an equal 
volume of 10% (v/v) glycerol (pre-warmed to 37"C). The washing procedure was repeated, halving 
the volume of 10% glycerol each time. The competent cells were finally resuspended in 1 ml of 
10% glycerol (Parish and Stoker, 1998). Vector DMAs were treated by UV irradiation in a 
stratalinker 1800 (Stratagene) at 100mj cm-2 prior to transformation to inhibit illegitimate 
recombination events. This treated DNA was added to 200 pi of cells and electroporated 25 pF, 
1000 Q, 2.5 V using a Bio-Rad Gene Puiser at room temperature. Cells were recovered in 5 ml 
Middlebrook 7H9/OADC and incubated at 37°C for 12-24 hours before plating onto 7H11/OADC 
containing 20 pg mM kanamycin and 50 pg ml-i X-gal. Plates were incubated at 37“C for 3-4 
weeks. Kanamycin resistant blue colonies (single cross-overs) were subcultured into 7H9/GADC 
media to allow the second crossover event to occur. These cells were then plated onto 2% (wt/v) 
sucrose plates plus X-Gal to identify sucrose resistant white colonies.
4.2.7. Genotypic analysis
To verify the expected genotype PCR and Southern analysis were carried out. For the id mutant 
PCR using the primers icI-HRI F and icl-HR2 R (sequences specific to the regions flanking the 
deletion site. Fig. 4.3) and also ICLF and ICLR (sequences specific to the id gene. Fig. 4.3) were 
carried out as described in section 4.2.4. In addition, genomic DNA was hybridised to a 1.076 Kb 
probe corresponding to the id gene and also a 3.37 Kb probe (HR) corresponding to the entire 
ORF of id and the flanking regions HR1 and HR2. Genomic DNA from the ace mutant was 
hybridised to a probe corresponding to a 829bp region in the centre of the ace gene (Fig. 4.6). 
PCR analysis was also carried out using primers, which flanked the deletion site (ace-HRIF and 
ace-HR2R). PCR and Southern analysis was also carried out to confirm the double id-ace mutant 
using several sets of primers and probes.
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Digoxigenin labelled probes were generated using a random priming reaction according to the 
suppliers’ protocol (Roche). Digested genomic DNA was electrophoresed through 0.8% agarose 
gels and after denaturing in 0.5 M NaOH/1.5M NaCI and neutralising in 0.5M Tris HCI (pH 7.5)/3 M 
NaCI, DNA products were transferred onto nylon membranes. After fixing the DNA to the 
membranes by UV cross linking, the membranes were pre-hybridised with hybridisation buffer (5 x 
SSC (standard saline citrate), 0.1% N-lauryl sarcosine, 0.02% SDS and 1% blocking solution) for 
one hour. Pre-hybridisation buffer was replaced with fresh solution containing heat denatured 
digoxigenin-labeled probe (15 ng mM). After overnight hybridisation at 68°C the membranes were 
washed twice with 2 x SSC and 0.1% SDS at room temperature for 5 minutes and twice more 
under high stringency conditions: 0.5 x SSC and 0.1% SDS at 68’C for 15 minutes. Specific 
hybridisation was detected by enhanced chemiluminesence following the manufacturers 
instructions (Roche).
4.2.8. Preparation of crude enzyme extracts
Crude enzyme extracts were prepared according to Honer zu Bentrup et al. (1999) with minor 
modifications. Cells were harvested, washed three times with ice cold PBS and resuspended in 
MOPS buffer (50mM MOPS (morphilinepropane sulfonate), pH 6.8, 5 mM MgCIa, 5mM L-cysteine, 
1 mM EDTA) supplemented with protease inhibitors (Complete™, Roche). The cells were disrupted 
using a Ribolyser (Hybaid) (speed setting 6.5 for 30 s) with careful cooling between each cycle. 
The crude enzyme extract was harvested after centrifugation for 30 minutes at 300 000 x g. The 
cell extract was stored at -80°C. Protein content was determined using PlusOne 2-D Quant Kit 
(Amersham) according to the recommended protocol.
Chapter 4. The survival of isocitrate lyase mutants 78
Hind\\\
Pac
Pst\ MCS
p2-NIL 
4753 bp
OrlE
Kan R-
Pac I
Amp R-
OrlE sacB
Pac I pGOAL19 
10435 bp
Hyg R-
lacZ
B
Clone in HR1 
and HR2
iclHR2
IcIHRI
pUSicI 
13757 bp
Kan R
Hyg R-
Pac I digest
Pac 1
Figure 4.2. Cloning strategy for generating the id  suicide delivery vector pUS/c/. HR1 and HR2 
are cloned into the p2NIL manipulation vector (A). The Pad cassette is excised from pGOALIQ
(B) and cloned into the unique Pad site of p2NIL/c/, resulting in the final knockout plasmid pUS/c/
(C).
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4.2.9. Assay of isocitrate lyase activity
A lactose dehydrogenase (LDH)-coupled continuous method was used to assay isocitrate lyase 
activity (Giachetti etaL, 1984). The assay uses LDH to reduce the glyoxylate formed by isocitrate 
lyase activity to glycolate with the concomitant oxidation of NADH. SOOpt of MOPS buffer (section 
4.28) containing 20 units of LDH from pig heart (Calbiochem-Novabiochem) was mixed with 50 pi 
of crude extract. Then 0.2 mM NADH (Sigma-Aldrich) was added and pre-incubated for 5 minutes 
at 37“C. After the addition of 2 mM threo-D-(s) isocitrate, the mixture was incubated for a further 20 
minutes at 37°C and NADH oxidation was determined spectrophotometrically at 380 nm.
4.2.10. Metabolite analysis
Metabolite analysis was performed as described in section 2.2.6.
4.3 Results
4.3.1. Construction of an A id  mutant
The /c/gene was deleted from M. bovis BCG in order to study the role of isocitrate lyase in 
mycobacterial metabolism using a non-pathogenic model organism. First a suicide delivery vector, 
pUS/c/, was constructed (Fig. 4.2). The plasmid pUS/c/contained two regions flanking the /c/gene, 
/C/-HR1 and /c/-HR2 and hyg, kan and sacB genes for positive selection (Fig. 4.2). UV-pretreated 
pUS/c/ DNA was used to transform M. bovis BCG. Three hygromycin resistant, kanamycin 
resistant, blue putative single crossover transformants were obtained on 7H11 agar supplemented 
with kanamycin and X-gal. DNA was isolated and screened by PCR using primers /c/-HR1F and 
/C/-HR2R to verify the integration of the plasmid. All three clones had the expected mutant single 
crossover genotype. A single crossover colony was grown in media lacking antibiotics to allow the 
second recombination to occur. Following growth the cells were subcultured onto sucrose plates to 
select for sucrose resistant white colonies, which had lost the integrated plasmid through a second 
crossover. DNA was prepared from the putative double crossovers and 3/5 of the clones tested 
were shown by PCR to be mutant double crossovers and were designated DB1, DB2 and DB3. 
The other two clones carried the WT id  allele (Fig. 4.4).
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4.3.2. Confirmation of A id  genotype
The id  genotype was verified by Southern analysis. Genomic DNA was isolated from DB1, DB2 
and the parent strain and subjected to Southern analysis using the probes ICL and HR prepared 
from the /c/gene (Fig. 4.3). The ICL probe hybridised with a 3.1 Kb fragment in the DNA from the 
parent strain but not from DB1 or DB2 (Fig. 4.5 and refer to Fig. 4.3). A second probe, HR, was 
made using a set of primers, specific to the regions flanking the id  gene (Fig. 4.3). This probe 
hybridised to the expected sized fragments in the parent and mutated strains (Fig. 4.5). Taken 
together these results clearly showed that the /c/gene was deleted in DB1 and DB2.
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Figure 4.3. A restriction map showing the location of the id  gene and the flanking regions in the 
chromosome of M. tuberculosis H37Rv. The position of the homology regions HR1 and HR2 with 
their corresponding PCR primers is shown. HR1 and HR2 were used to construct the suicide 
vector delivery plasmid pUS/c/. HR and ICL represent the probes used in Southern blot analysis. 
The restriction sites for 8 9 /II and Pvu\ are also indicated.
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Figure 4.4. Characterisation of id  double crossover mutants. Five representative double 
crossover mutants were analysed by PCR. Prepared chromosomal DNA was amplified using the 
primers HR1F and HR2R, which were based on regions flanking the id  gene. The amplified 
products in lane 2 represent a 3.4 Kb region containing the id  gene and its flanking regions, HR1 
and HR2, from WT M. bovis BCG. Lanes 5, 6  and 8  represent double crossover id  mutants DB1, 
DB2 and DB3 with a 1.4 Kb deletion in the chromosome. Lanes 4 and 7 represent single 
crossovers carrying the WT id  allele and the integratediDlasmid containing HR1 and HR2. The 
DNA in lane 1 contains a 1 Kb DNA ladder (Generuler , MBI Fermentas) and lane 3 contains a 
PCR negative control.
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Figure 4.5. Southern analysis to confirm the id  deletion, (a) Chromosomal DNA isolated from id  
mutants DB1 (lane 2) and DB2 (lane 3) and WT M. bovis BCG (lane 4), were digested with Pvu\ 
restriction enzyme, transferred to a nylon membrane and probed with the digoxigenin labeled 
probe ICL containing the M. bovis BCG id  gene. The WT fragment is the expected 3.1 Kb, while 
the genomic DNA from the id  mutants does not contain the id  gene, (b) Lanes 2-4, genomic DNA 
from isocitrate lyase mutants DB1 (lane 2) and DB2 (lane 3) and M. bovis BCG (lane 4) were 
digested with Pvu\ and probed with HR, a M. bovis BCG region containing the /c/ gene and it’s 
flanking regions, HRIand HR2. The WT fragments are the expected 3.1 Kb and 1.6 Kb fragments 
while the genomic DNA from the id  mutants has the expected 1.6 Kb fragment. The sizes of the 
bands were determined from the migration distance of the DNA molecular mass marker Eco RI 
SPP1 (Roche ladder number VII) which is present in lane 1 of both (a) and (b).
4.3.3. Enzymatic activity of the id  mutant
To examine the isocitrate lyase activity M. bovis BCG /c/deletion mutant, DB1 and WT M. bovis 
BCG were grown in Middlebrook 7H9 broth supplemented with OADC until late stationary phase 
(ODeoo > 1.0), conditions which are known to induce isocitrate lyase activity (Seshadri, et al., 1976). 
Crude bacterial extracts were then assayed for isocitrate lyase activity. An LDH-coupled 
continuous method was used and this is based on the two reactions below;
ICL
isocitrate------------------------------ ► glyoxylate + succinate
, , ,  LDHglyoxylate — ► glycolate
NADH + H+ NAD+
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During this assay NADH-dependent LDH converts the glyoxylate formed by isocitrate lyase to 
glycolate. The reduction in NADH was then followed in a spectrophotometer.
The specific total activity of DB1 was 5.04 nmol min-^  mg-'' of protein showing that the id  mutant still 
encodes an active isocitrate lyase. The isocitrate lyase activity of WT M. bovis BCG was tenfold 
higher (56.36nmol min-"' mg-'') than the /c/mutant.
4.3.4. Construction of a single Aace mutant and an A id ” 
ace double mutant
The demonstration that the id  mutant showed a low level of enzyme activity proved that BCG 
possesses another gene encoding an isocitrate lyase. In M. tuberculosis H37Rv there are three 
genes annotated as isocitrate lyase, id, aceAa and aceAb. AceAa/RV1915 and aceAb/Rv1916 are 
adjacent genes, which appear to be pseudogenes (Honerzu Bentrup etaL, 1999). In another 
strain of M. tuberculosis, CSU93, aceA (incorporating aceAa and aceAb) is a single ORF and 
results in an active enzyme (Honer zu Bentrup et al., 1999). The aceA gene is arranged in an 
identical manner to CSU93 in M. bovis, and it seems likely from the results presented here that the 
arrangement of M. bovis BCG Is the same. This result was also confirmed by a BLAST search of 
the un-annotated M. bovis BCG sequence. In order to compare the effect of mutations in id and 
aceA, the aceA gene was deleted from the parental WT strain and the id  mutant.
The pUSace suicide vector was constructed and used to introduce an aceA mutation into both the 
WT BCG strain and the /c/strain using an identical approach as described in section 4.2.5 (Fig. 
4.2). This mutagenesis strategy successfully generated a double ace-ici mutant and a single ace 
mutant. PCR (Fig. 4.8) and Southern blotting (Fig. 4.7) were used in order to verify the genotype of 
all 3 mutant strains generated during this study. Genomic DNA was isolated from (1) WT BCG, (2) 
Aid, (3) Aace and (4) Aicl-ace and subjected to Southern analysis using probes prepared from 
the ace gene (ACE) and the id  gene (HR). The ace probe hybridized with 1.9 Kb and 1.6 Kb 
fragment in the DNA from WT BCG and A id  but not from Aace or Aid-ace (Fig 4.7). The strains 
carrying the /c/deletion {A id  and Aid-ace) lost the WT band of 3.99 Kb and gained a band of 2.6 
Kb. Genotypes were further verified by PCR (Fig. 4.8). PCR using the primers id F and id R 
(designed to amplify a 1 Kb fragment from strains containing the /c/gene) amplified the expected 
product only in the strains Aace and WT and not in A/c/or Aid-ace. An identical experiment 
using the primers aceHRI F and aceHR2R specific for the homology regions flanking the ace gene
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(Fig 4.8a) amplified a 3.7 Kb region from the WT and the A/c/strain whereas the strains Aace and 
Licl-ace lost the WT band and gained a band of 1.7 Kb, reflecting the loss of the ace gene. Taken 
together these results clearly confirmed the genotype of the mutant strains.
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Figure 4.6. A restriction map showing the location of the aceA gene and the flanking regions in 
the chromosome of M. bovis. The position of the homology regions HR1 and HR2 with their 
corresponding PCR primers is shown. HR1 and HR2 were used to construct the suicide vector 
delivery plasmid pUSace. ICL2 represent the probe used in Southern blot analysis. The 
restriction sites for Sma\ are also indicated.
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Figure 4.7. Southern analysis of mutant strains. Chromosomal DNA isolated from WT M. bovis 
BCG (lane 2) and mutants A/c/ (lane 3), Aace (lane 4) and A/c/-ace (lane 5) and were digested 
with (a) Bgl\\ and (b) Smal transferred to a nylon membrane. Gel (a) was probed with the 
digoxigenin labeled probe HR containing the id gene and it’s flanking regions, HRIand HR2. The 
W T fragments are the expected 3.99 Kb and 1.9 Kb fragments while the genomic DNA from the 
A/c/ and A/c/-ace mutants had the expected 2.62 Kb and 1.92 Kb fragment. Gel (b) was probed 
with ACE, a M. bovis BCG region containing a portion of the ace gene. The W T fragments are 
the expected 1.9 Kb and 1.6 Kb fragments while the genomic DNA from the Aace and A/c/-ace 
mutants did not contain the ace gene. The sizes of the bands were determined from the migration 
distance of the DNA molecular mass marker EcoRI SPP1 (Roche ladder number VII) which is 
present in lane 1 of both (a) and (b).
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Figure 4.8. PCR characterisation of mutant strains. Chromosomal DNA from WT BCG (lane 2), 
àici (lane 4), Aace (lane 5) A/c/-ace (lane 6 ) were used as templates in PCR reactions using the 
primers ace-HR1F and ace-HR2R, which were based on regions flanking the ace gene (a) and id  
F and id  R (b). No template controls from the PCR reaction are shown in lane 3 and a 1 Kb DNA
ladder in lane 1 (Generuler™, MBI Fermentas).
4.3.5. Batch culture growth of Aid, Aace and Aicl- 
ace mutants
To investigate the effect of deleting id or ace genes on the catabolism of acetate or glycerol, the 
growth of the Aid, Aace and Aicl-ace mutants were compared with the WT parent strain of 
BCG (Fig. 4.9). Cells were cultured in Roisin’s minimal medium containing glycerol or acetate as 
the carbon source. Growth rates on glycerol were significantly higher than those on acetate for all 
four strains. It was also found that when cultured on either glycerol or acetate A id  and Aace 
strains grew slower than the WT strain, which is in accordance with previous observations 
(Sassetti and Rubin, 2003). On glycerol the slowest growth rate was observed with the Aicl-ace 
mutant and this strain was unable to grow on acetate.
Chapter 4. The survival of isocitrate lyase mutants 88
(a) (b)
O  0.6 
(£> 0.4
Q  0.2o
Time (days)
1 2 3 4 5
Time (days)
O  0.4
Time (days)
Ü 105
2 3 4 5
Time (days)
Figure 4.9. Growth curves of WT and mutant strains of M. bovis BCG on glycerol and actetate. 
M. bovis BCG (red line) and mutant strains A id  (blue line), Aace (green line) and A id-ace  
(yellow line) strains on glycerol (a) and acetate (b). The data are the averages of three 
independent experiments.
4.3.6. Survival of A /c / in the chemostat model of TB 
persistence
In order to test ttie validity of the chemostat model of TB persistence developed during this study 
(see section 2.3.4) the phenotype of the A id  mutant strain was characterised in the chemostat. It 
was predicted that deleting the A/c/gene from M. bovis BCG will effect the survival and growth of 
this strain at the dilution rate of 0.01 h -i (td = 69 h) but will not affect survival at the dilution rate of 
0.03 h'i (td = 23h). To test this hypothesis the biomass and carbon dioxide production was 
measured during chemostat culture at a dilution rate of 0.01 h -i (td = 69h). During the initial batch 
phase of growth in the chemostat /c/was indistinguishable from the WT (Fig. 4.10; 4.11). The loss
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of /c/did not therefore affect the growth of the bacillus in the bioreactor. However, once the flow of 
medium from the feed reservoir was begun at a dilution rate of 0.01 h-i (day 4) the two strains 
behaved very differently (Fig. 4.11). WT BCG reached a steady state after 5.76 volume changes 
and little variation occurred in the carbon dioxide and biomass production after this point. At day 42 
the steady state WT BCG cells were harvested for analysis. In contrast to the WT, the biomass and 
carbon dioxide production of A/c/declined continuously from day 16 until day 59 when the culture 
stopped growing completely and the experiment was terminated. Consumption of glycerol also 
differed between the two strains during the course of the experiment. The id  mutant consumed 
glycerol much more slowly than the WT BCG and this was reflected in the amounts of glycerol 
detected in the supernatant. Growth of the A/c/was identical to the WT strain up to the point at 
which glycerol became limited which occurred at day 16 for A/c/ and at day 10 for the WT strain. 
After this the WT adjusted to the rate of nutrient supply to reach the steady state whereas the cell 
density and carbon dioxide production of A/c/decreased continuously until the strain was almost 
completely flushed out from the vessel.
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Figure 4.10. Batch cultivation of M. bovis BCG (green squares) and A id  in a bioreactor (red 
circles). Average value and standard deviations are shown from two independent experiments.
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Figure 4.11. Continuous culture of M. bovis BCG (a) and A id  (b). A 10% late log phase culture 
was prepared and inoculated into the bioreactor. The cultures were operated as a batch until day 
4. Continuous culture was then begun at a dilution rate of 0.01 h '\ Samples were removed and 
assayed for biomass (red line) and filtered supernatants were assayed for glycerol (blue line). 
Carbon dioxide production in the waste gas was measured using a dual tandem sensor gas 
analyser (green line). Average value and standard deviations are shown.
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In accordance with expectations A id  behaved identically to the WT strain at the dilution rate of 
0.03 h-1. Steady state conditions were obtained after 5.19 volume changes and the average 
characteristics of steady state A/c/cells were very similar to those of WT BCG (Table 4.3). The 
survival of the Aicl-ace mutant was also investigated in the chemostat model of TB persistence. 
These results show that deleting both isocitrate lyase genes had no effect on the survival of BCG 
at a dilution rate of 0.03 h'i (Table 4.3).
Table 4.3. Steady state characteristics of WT, A id  and A id-ace  strains of 
M.bovis BCG grown in a glycerol-limited chemostat at the dilution rate of 0.03 h'^
Strain WT A id  A icl-ace
Biomass (g dry weight T)
CPU (X lO^mM)
OD (600nm)
Specific CÜ2 formation rate (mmol g biomass h'^ )
Values are the averages from three independent measurements.
0.23 0.26 0.21
4.64 25.3 8.93
0.48 0.503 0.427
1.13 0.93 1.15
4.3.7. Isocitrate lyase activity of chemostat grown M. bovis 
BCG strains
Isocitrate lyase activities were assayed for the cells grown in the chemostat. Isocitrate lyase activity 
was not detected in the Aid-ace mutant at the growth rate of 0.03 h-^  which, confirmed the id-ace 
knockout. The activity of isocitrate lyase was also considerably lower in the id  mutant (16 fold) as 
compared with the WT at the same growth rate (Table 4.4). For the WT strain in vitro activities of 
isocitrate lyase were two fold higher in the slow growing chemostat than in the more rapidly 
growing chemostat cultures (Table 4.4).
Table 4.4. In vitro isocitrate lyase activities in crude extracts of 
chemostat cultivated BCG cells
Dilution rate (h^) WT A id  A icl-ace
0.01 42.67 ±2.68 -
0.03 21.20 ±0.69 1.32 ±0.19 0
Results represent the average values with standard deviations 
from three independent measurements. The unit of enzyme 
activity is nmol mln'  ^ mg of protein'T
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4.4. Discussion
Mckinney etal. (2000) demonstrated that /c/deletion strains of M tuberculosis were attenuated for 
persistence in mice but were unable to show an in vitro phenotype. Here it was demonstrated that 
an M. bovis BCG id  mutant was attenuated for survival in the chemostat model of persistent TB. 
Disruption of the id  gene resulted in a loss of viability at the dilution rate of 0.01 h-\ whereas the 
strain behaved like the parental strain at the faster dilution rate of 0.03 h-T These results 
demonstrated that isocitrate lyase is essential for adaptation to slow growth under carbon limiting 
conditions.
The /c/gene was deleted from the chromosome of M. bovis BCG by homologous recombination 
using a suicide delivery vector and a double selection strategy (Parish and Stoker. 2000b). 
Compared with the parental WT M bovis BCG, the id  deletion strain had ten times less isocitrate 
lyase activity. The id  mutant did, however, show a low level of enzyme activity demonstrating that 
M. bovis BCG, expresses another active isocitrate lyase. Two copies of isocitrate lyase exist in 
M. tuberculosis H37Rv(/c/ and aceA) but only one {id) is functional in this strain (Honer zu Bentrup 
et ai, 1999). In M. tuberculosis CSU93, however, both genes encode active enzymes (Honerzu 
Bentrup et ai, 1999). Honer zu Bentrup et ai (1999) showed that AceA has very different properties 
to I d .  In contrast to the id  gene, AceA shares a much lower homology to bacterial isocitrate lyases 
and is more similar to eukaryotic isocitrate lyase genes (Smith et ai., 2004). In addition, it was 
demonstrated that recombinant AceA is more labile and has a higher K m  than I d  (Honerzu 
Bentrup et a!., 1999). I t  is postulated that the two isocitrate lyase enzymes of M. tubercuiosisM 
bovis BCG have distinct functional and regulatory roles. Although the occurrence of isocitrate lyase 
isoenzymes is relatively rare, the genomes of microrganisms such as Saccharomyces cerevisae, 
Yersinia pestis and Pseudomonas species contains two copies of these genes and in some cases 
they are regulated differently (Bellion and Woodson, 1975; Hillier and Charnetzky, 1981; 
Samokhvalov et ai., 2004). Pseudomonas species and Yersinia pestis, for example, are able to 
synthesise two distinct isocitrate lyase enzymes depending on the growth conditions (Bellion and 
Woodson, 1975; Hillier and Charnetzky, 1981). The product of/c/has been shown to be important 
for the persistence of M. tuberculosis, the aceA gene product may prove to have a role during the 
acute stages of disease. Increased transcription of aceA by M. bovis BCG upon phagocytosis by 
macrophages without any increase in id gene expression provides some support for this 
hypothesis (Li et ai, 2004). One form of mycobacterial isocitrate lyase could play an important part
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in one-carbon assimilation whereas the other form may perform an anapleurotic function of the 
glyoxylate shunt. In order to investigate the metabolic consequences of deleting id  and aceA the 
knockout strains Aace and Aid-ace were constructed and the mutant phenotypes investigated 
during growth on glycerol and acetate. The growth curves demonstrated that both genes are 
involved in acetate metabolism as only the double knock out Aicl-ace failed to grow on acetate. 
The observed reduced growth rate of the single knock out strains id and ace on acetate and 
glycerol supports the notion that the two isocitrate lyase isoenzymes have different but 
complementary roles in metabolism.
Isocitrate lyase has been shown to be a pivotal enzyme in the persistence of M. tuberculosis 
(McKinney et ai., 2000). In this study the /c/deletion strain of M. bovis BCG was used as a probe 
for testing the relevance of the chemostat model of TB persistence for the life of M. tuberculosis in 
vivo. In this model carbon-limited chemostats with low concentrations of glycerol are used to 
simulate possible growth rates during the acute and chronic stages of TB. A doubling time of 23 
hours was adopted to represent the acute phase of infection. This growth rate has been 
demonstrated experimentally in the lungs of mice during early infection (Shi et al., 2003). A slower 
dilution rate, equivalent to a doubling time of 69 hours, was used to model mycobacterial 
persistence. The results presented here show that A/c/behaves identically to the WT in the acute 
phase of the model but was gradually flushed out of the chemostat in the chronic stage. This result 
mimics the growth characteristics of an id  mutant strain of M. tuberculosis in mice first observed by 
McKinney ef ai. (2000).
Enzyme activity measurements revealed that isocitrate lyase activity increased in the chemostat 
model of TB persistence. Compared with the fast growth rate chemostat, the in vitro activities of 
isocitrate lyase were twofold higher in WT BCG from the low growth rate chemostat. Together with 
the id  mutant results these data suggest that isocitrate lyase activity is required for slow growth in 
glycerol limiting conditions.
Isocitrate lyase is the gating enzyme into the glyoxylate shunt. The glyoxylate shunt plays an 
essential role in allowing growth on two-carbon compounds like acetate and fatty acids. In its 
anapleurotic mode of operation, the glyoxylate shunt diverts isocitrate from the TCA cycle to 
prevent the quantitative loss of carbons from carbon dioxide and therefore replenish intermediates 
for the biosynthesis of various compounds including amino acids, purines and pyrimidines. The 
glyoxylate shunt is considered to be exclusive to anapleurotic reactions on carbon-two compounds
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(Cozzone, 1998). The demonstration that isocitrate lyase is required for the growth on the three- 
carbon substrate glycerol is therefore surprising. In addition to the chemostat model presented 
here, a variety of environments have been shown to trigger the isocitrate lyase of Mycobacterial 
species in vitro. Increased isocitrate lyase enzyme activity and induction of the /c/gene occurs as 
oxygen becomes limiting in Wayne's hypoxic model of persistence (Wayne and Lin, 1982; 
Muttucumaru et a!., 2004). Oxygen limitation is presumed to be the trigger for isocitrate lyase 
activity in this scenario. However, a comparison of M. tubercuiosis cells grown at the same growth 
rate under low and high oxygen conditions in a chemostat showed no change in the expression of 
/c/(Bacon etal., 2004). Moreover, in human lung tissue Fenhalls etal. (2002a) demonstrated that 
/c/is expressed in the outer edge of the of the TB granuloma, a region unlikely to be starved of 
oxygen. Together these data suggest that oxygen starvation is not the stimulus for the induction of 
id  and perhaps nutrient limitation is the trigger for the changes observed in isocitrate lyase activity. 
Transcriptomic analysis demonstrated increased expression of/c/during extended stationary 
phase growth of M. tubercuiosis and in this study increased isocitrate lyase enzyme activity was 
demonstrated in a slow growing chemostat (Hampshire et ai., 2004). These results support the 
theory that nutrient limitation is the stimulus for increased isocitrate lyase activity. However, Betts 
et al. (2002) showed that the level of the id  gene remained unchanged during nutrient starvation in 
PBS. What is common to the extended stationary phase model, Wayne’s model and the 
chemostat-based model presented here is the presence of Tween 80 in the culture medium.
Tween 80 is a mixture of long chain fatty acids consisting mainly of oleic acid. M. tubercuiosis is 
known to be able to hydrolyse Tween 80 and is also presumed to be able to metabolise this 
compound. It is plausible that as M. tuberculosis!M. bovis BCG gets hungry it starts to metabolise 
the Tween 80 in the medium. This would explain why /c/was not induced during starvation in PBS.
The role of isocitrate lyase in TB metabolism may, however, be more complicated than simply to 
allow this pathogen to grow on fatty acids. Interestingly, a novel bi-functional pathway, 
phosphenoylpyruvate (PEP)-glyoxylate cycle, has been identified in E. coil under conditions of 
hunger in a slow growing chemostat (Fig. 4.11) (Fischer and Sauer, 2003). This pathway utilises 
the enzymes isocitrate lyase, malate synthase and PEP carboxykinase (OK) and catalyses 
complete oxidation of PEP to CO2 with no requirement for an additional anapleurotic reaction (Fig. 
4.11) (Fischer and Sauer, 2003). Unlike the TCA cycle NADPH is not formed and therefore this 
pathway could play a role during conditions such as low growth rates that lead to higher production 
than consumption of NADH (Fischer and Sauer, 2003). Recently a PEPCK enzyme has been
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Figure 4.12. The PEP-glyoxylate cycle. Figure from Fischer and Sauer, 2003.
identified in M. tuberculosis (Liu et al., 2003). This enzyme is required for growth on fatty acids and 
mutants defective in PEPCK expression are attenuated in both macrophages and mice (Liu et al., 
2003). It is interesting to speculate that the phosphenoylpyruvate (PEP)-glyoxylate cycle is 
operational in M. fuberculosis and has a role during the persistent state. Wayne also proposed that 
the role of isocitrate lyase was to mop up excess NADH in preparation for minimal metabolism 
during persistence (Wayne and Sohaskey, 2001). These observations are of interest and require 
further investigation.
The function of the second isocitrate lyase enzyme in M. tubercuiosis remains unknown.
Microarray analysis has shown that the aceA gene was induced in Wayne’s model but only in the 
later stages when the conditions are anaerobic (Muttucumaru et ai., 2004). Betts and co-workers 
(2002) showed that during nutrient starvation the aceAa isocitrate lyase module was upregulated, 
whilst the level of the id  gene remained unchanged (Betts et ai., 2002). All these study were limited 
in that they were performed using M. tubercuiosis H37Rv, a strain unable to produce a functional 
AceA enzyme. Here it was demonstrated that M bovis BCG has two functional copies of isocitrate 
lyase. M. bovis BCG therefore provides an ideal model for studying the function of both 
isoenzymes in a biosafety 2 facility. The double knock out Aicl-ace had an identical phenotype to 
the id  mutant in the chemostat model of TB persistence. Investigating the phenotype of the ace
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mutant in the chemostat model will be an important extension of this work and may help define the 
role of AceA in the metabolism of M. tuberculosis.
It has been demonstrated that the chemostat model of TB persistence reflects some aspects of the 
life of M. tubercuiosis. An /c/deletion mutant was shown previously to be attenuated for 
persistence in mice and was similarly attenuated for survival in the chemostat model of TB 
persistence developed here (McKinney et ai., 2000). It has also been demonstrated that isocitrate 
lyase enzyme activity was induced during slow growth in a carbon-limited chemostat. Further 
examination of the metabolism of the WT and mutant strains of BCG will be a useful extension of 
this work and may help unravel the role of isocitrate lyase in the persistence of M. tubercuiosis.
Chapter Five
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5.1. Introduction
Proteomics is a powerful weapon in the efforts to understand the pathophysiology of 
M. tuberculosis. The completed genome sequence of M. tuberculosis strain H37Rv included 
approximately 4000 genes, many of which had no assigned functions (Cole etal., 1998). Studying 
the complete protein complement of the genome by two dimensional polyacrylamide gel 
electrophoresis (2DE) combined with sensitive protein identification techniques allows further 
dissection of this information and aids functional studies. This approach has been applied to 
mycobacterial species in a wide variety of studies and has detected gene products not predicted by 
the genome (Andersen etal., 1991; Urquhart etal., 1998; Jungblutefa/., 2001; Monahan etal., 
2001). 2DE can be used as a global, holistic approach to surveying protein expression under 
defined environmental conditions. This has great potential in the identification of virulence 
determinants. Proteomics therefore has an important role in the characterisation of complex events 
occurring during mycobacterial persistence.
5.1.1. Proteomic technology
The proteome provides researchers with a challenge by virtue of its incredible complexity and 
diversity. The proteins expressed by a ceil vary in protein concentration, are present in different 
isoforms and have enormous physicochemical diversity and these features make the proteome 
much more complex than the transcriptome. Unlike transcriptomics there is no universal technique, 
which is comprehensive in the analysis of all proteins. The available technologies, which include 
2DE, multi dimensional protein identification technology and protein arrays are all vital and 
complementary and can be applied alone and in combination to different proteomic challenges.
The most widely used core technology for proteome analysis is 2DE. 2DE resolves complex 
mixtures of proteins obtained from cells first by isoelectric point (pi) and then by molecular weight 
(Mr). First dimension isoelectric focusing (lEF) is performed in individual strips consisting of 
immobilised pH gradient (IPG) and the second dimension uses sodium dodecyl suiphate 
polyacrylamide gel electrophoresis (SDS-PAGE). After electrophoresis the proteins are distributed 
across the two-dimensional gel profile and are visualised by staining or autoradiography. 2DE is a 
highly resolving technique, which can separate hundreds of proteins at a time providing a 
tremendous amount of data.
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For proteome analysis it is essential that 2DE generates reproducible high-resolution protein 
separations. Sample preparation is a vital parameter in this process, involving solubilisation, 
dénaturation and reduction to disrupt all the molecular interactions between the sample proteins 
and removal non-protein sample contaminants (Molloy, 2000). One method, however cannot be 
applied universally due to the diverse nature of samples analysed by 2DE and optimisation of the 
protein preparation protocol is the first challenge in the proteomic analysis of bacterial cells. Recent 
introductions of new detergents, chaotropes and reducing agents along with novel strategies for 
protein solubilisation have made this process easier (Rabiiloud, 1998; Herbert, 1999; Gorg et ai, 
2000).
2DE provides information on the abundance, pi and Mr of the separated proteins but gives no clues 
as to the identification or function of the proteins. Protein identification and characterisation using 
mass spectrometry (MS) methods has become increasingly important in proteomics. The primary 
tool for MS is peptide mass fingerprinting (PMF), which is based on the set of peptide masses 
obtained by the MS analysis of a digested protein. This provides a characteristic mass profile or 
fingerprint, which, is then compared with possible masses, either calculated from theoretical 
in siiico digestion of known proteins or predicted from nucleotide database. The proteins are 
ionised using matrix-assisted laser desorbtion (MALDi) or electrospray (ESI) methods and then the 
molecular mass is determined by an analyser such as time-of-of-flight (TOP), quadropole, ion-trap 
or hybrid quadrupole time-of-flight (Q-TOF). The MALDI-TOF instrument is relatively simple to use 
and has a high mass accuracy and is very effective at identifying proteins from bacterial species 
such as M tubercuiosis, which have already been sequenced. If a protein cannot be identified 
reliably by PMF alone a tandem MS experiment using an ion trap MS or a quadrupole MS can be 
performed. During tandem MS an individual peptide isolated from an initial MS scan is fragmented 
during a second step to generate amino acid sequence information. The identity of the intact 
peptide can be obtained by comparing with databases and this provides additional data on the 
identity of the primary protein.
Although 2DE is a vital experimental method for proteomics this technique has some significant 
disadvantages. The 2DE procedure is notoriously difficult to master, time consuming and labour 
intensive and this limits the throughput of samples. Unlike transcriptomic technologies automation 
of 2DE has proved difficult. In addition, 2DE only identifies a modest fraction of the complete 
proteome due to difficulties in detecting: (1) very low or high molecular weight proteins; (2) proteins
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with extreme isoelectric points; (3) hydrophobic proteins and (4) low abundance proteins. 
Consequently researchers have developed some very promising gel free alternatives to 2DE 
including isotope-coded affinity tagging (ICAT) multi dimensional protein identification technology 
and protein microarrays. The first of these methodologies, ICAT, combines accurate quantification 
and concurrent sequence identification of proteins in complex mixtures (Gygi etal., 1999). ICAT 
uses three reagents: (1) An active group that is used to covalently bind amino acids, usually 
cysteines; (2) An isotopicaliy light or heavy linker and (3) An affinity tag such as biotin that allows 
the ICAT labeled peptide to be specifically extracted. In this process the two samples being 
compared are firstly alkylated with either light or heavy reagent. The samples are then combined, 
undergo proteolytic digestion, and the labeled peptides are isolated using the affinity tag. The 
enriched sample of iCAT labeled peptides can then be fractionated by hyphenated strong ion 
exchange into a series of fractions which are individually analysed by liquid chromatography and 
tandem MS to identify the peptides and measure the relative abundance. Relative quantitation is 
based on the ratio of the heavy or light isotopic signals from the tag.
ICAT has advantages over conventional 2DE methodology in terms of sensitivity and throughput 
but also has significant limitations. The method is limited by its inability to resolve post-translational 
protein modifications, problems in detecting proteins with: (1) low cysteine content; (2) acidic pi 
and (3) low molecular weight and also by its relatively small dynamic range for quantifying the 
differences in expression levels {Patton etal., 2002; Rabiiloud, 2002; Schmidt etal., 2004). iCAT 
has been applied successfully to studies into the global expression of proteins in Pseudomonas 
aeruginosa and Saccharomyces cerevisiae and most recently this technique has been applied to 
the analysis of the proteome of M. tuberculosis {Gygi et al., 1999; Guina et ai., 2003; Schmidt et 
al., 2004). The price tag attached to this technology, however, has limited more widespread use.
A second approach to gel free proteomics is the use of protein microarrays, which applies DNA 
chip technology to proteins (Cahill, 2000). Capture probes such as antibodies, proteins, peptides, 
nucleic acids or other small molecules, which are able to select for specific proteins are arrayed 
onto a surface (Templin etal., 2002). The arrays are then exposed to protein samples containing 
the corresponding protein targets. Readout systems based on fluorescence, chemiluminesence, 
MS or electrochemistry can be used to detect the binding of probe with target (Cahill, 2000; 
Templin etal., 2002; Wilson and Nock, 2003). This technique has the advantages of simplicity and
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throughput, however protein microarrays are very expensive to develop on a proteomic scale and 
are currently not commercially available for the proteome of M. tubecuiosis.
Recent technical innovations including more sophisticated protein sample preparation, the use of 
fluorescent staining techniques and increased automation has remedied some of the limitations 
associated with 2DE (Chevallet etal., 1998; Molloy etal., 1998; Lopez etal., 2000; Binz etal., 
2004; Van den Bergh and Arckens, 2004). 2DE combined with MALDI-MS remains a powerful and 
versatile tool for investigating the proteome of mycobacterial species and was therefore employed 
during this research project.
5.1.2. Proteomics of mycobacteria
An important milestone in mycobacterial research is analysis of the complete proteome of 
M. tuberculosis. The application of 2DE to characterise the proteome of mycobacteria 
complements genomic studies and promises new insights into gene expression. Partial 2DE gel 
protein databases are now available for M .tuberculosis and M. bovis BCG through the world wide 
web (Jungblut et al., 1999). These proteome projects are aimed at cataloguing as many 
mycobacterial proteins as possible and will facilitate other proteomic investigations.
In addition to the generation of the complete proteome, 2DE can be used as a biological assay 
determining the differential display of proteins in response to a particular environmental stimuli.
The application of proteomics to the study of mycobacterial pathogenesis is making it possible to 
characterise global alterations in protein expression. Several studies have taken advantage of this 
approach (Andersen etal., 1991; Rowland etal., 1999; Monahan etal., 2001). Proteomics has also 
been applied successfully to models of mycobacterial persistence (Boon etal., 2001; Betts etal., 
2002; Rosenkrands et al., 2002). Although such studies are in their infancy they are likely to result 
in the discovery of proteins, which participate in mycobacterial persistence and therefore lead to 
the development of new therapeutic agents effective against latent tuberculosis.
5.1.3. Aims
The objective of this work was firstly to develop 2DE methodology for the optimum resolution of 
mycobacterial proteins. This method was then employed to analyse the cellular protein 
composition of M. bovis BCG grown continuously in a chemostat. Finally, in order to identify
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proteins upregulated in slowly growing mycobacteria, the proteome of M bovis BCG in the 
chemostat model of mycobacterial persistence was characterised.
5.2. Materials and methods
5.2.1. Cultures
M. bovis BCG strain (ATCC 35748) was cultured in a chemostat as detailed in section 2.2.4. 
Steady state conditions were assumed when the CO2 evolution, ODeoo and dry weight remained 
constant for three consecutive volume changes. 4 x 50 ml samples were collected on ice for 
protein extraction.
5.2.2. Reagents and materials
All equipment for lEF and SDS electrophoresis {Immobiline Dry Strip kit, reswelling cassette and 
reswelling tray, Muititemp II thermostatic circulator, Multiphor™ II horizontal electrophoresis unit. 
Multitemp II thermostatic circulator, IPGphor™, Ettan DALT™ II multiple vertical electrophoresis 
unit and iPG strips), immobiline Drystrips, ExcelGel SDS, TEMED, ammonium persulfate, 
dithiothreitol (DTT), iodacetamide, Trizma base (Tris), Ampholyte 3-10, PlusOne 2-D Clean-Up Kit 
and PlusOne 2-Dquant Kit were purchased from Amersham Biosciences, a Bio-Rad Powerpac 
3000 was purchased from Bio-Rad, Complete™ protease inhibitor cocktail was purchased from 
Roche Molecular Biochemicals. CHAPS (3-3-chloromidopropyldimethylammoniol-proane 
sulphonate), urea, glycerol and all other chemicals for electrophoresis and staining (molecular 
biology grade) were obtained from Sigma.
5.2.3. Protein preparation
Various protein extraction protocols were trialed. Samples of Mycobacteria were harvested by 
centrifugation and washed twice in buffer (1 mM Tris-Hci, pH 7.4,10 mM MgCb with 5% (v/v) 
p-mercacaptoethanol, 5% (v/v) glycerol and 100 |.iM phenylmethylsulfonyl fluoride). Cells were 
disrupted using a Ribolyser (Hybaid) four times for 45 seconds at setting 6.0 with careful cooling in 
between cycles before 50 of 10% SDS was added for complete protein dénaturation and the 
mixture heated at 95°C for 4 minutes. After cooling for 30 minutes on ice the samples were diluted 
in solubilisation buffer (9 M urea, 4% (wt/v) CHAPS, 2% (wt/v) DTT and 2% (v/v) Ampholytes 3-
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10). This was allowed to solubilise on ice for 30 minutes and then centrifuged at 1300 rpm for 1 
hour to remove cellular fragments and unsolubilised protein.
Proteins were also extracted from mycobacteria using a modified version of the method described 
by Jungblut et al. (1999). Cells were harvested by centrifugation for 30 minutes (10 500 x g) at 
10“C. This pellet was washed twice using ice cold PBS or lOmM Tris base. The cell pellet was 
resuspended in lOmM Tris base with Complete™ protease inhibitor cocktail and transferred to a 
2 ml Ribolysor tubes (Sigma). The mixture was vortexed for 30 seconds, cooled on ice for 10 
minutes, and lysed using a Ribolysor (Hybaid) (speed setting of 6.5 for 30s x 4) with careful 
cooling in between cycle. The cell free supernatant containing cytoplasmic proteins was collected 
by centrifugation at 13 000 x g for 30 minutes at 4'C. The cell pellet containing the remaining 
mycobacterial protein was resuspended in IPG buffer (section 5.2.4) with vortexing. After the pellet 
was completely resuspended the sample was incubated at RT for 30 minutes to ensure complete 
solubilisation. To remove any unsolubilsed protein the sample was centrifuged at 13 000 x g for 10 
minutes at 16°C. All protein samples were stored at-80“C
Protein samples were further processed using the PlusOne 2-D Clean-Up Kit (Amersham) 
following the manufacturers instructions. This kit removes interfering substances from protein 
samples destined for 2DE. After processing using this method the proteins were resuspended 
directly Into the IPG rehydration buffer (section 5.2.4). Protein samples were quantified using a 
PlusOne 2-D Quant Kit (Amersham) according to the recommended protocol.
5.2.4. IPG buffer
Various denaturing mixtures were tested. The standard mixture contained 8 M urea, 2% (wt/v) 
CHAPS, 0.5% (v/v) IPG buffer, 65 mM DTT (Jungblut ef a/., 1999). For evaluation of the efficiency 
of the rehydration buffers, the following parameters were investigated either alone or in 
combination. Alteration in the concentrations of IPG buffer (0.5% to 0.8%), urea (5 M -  9 M), DTT 
(0.28-1%) and CHAPS (2-4%). Incorporating thiourea (2 M) and the sulfobetaine surfactant SB 3- 
10 (3-[Decyldmethylammonio] propane sulfonate) (2%) into the IPG buffer was also trialed 
(Chevalletefa/., 1998; Rabilloud, 1998).
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5.2.5. 2DE using Multlphor “ II horizontal electrophoresis 
unit
In preliminary experiments mycobacterial proteins were separated by 2DE using the Multiphor™ II 
horizontal electrophoresis unit. 60-300 jug sample of protein was added to isoelectric focusing 
rehydration buffer (section 5.2.4) to a final volume of 350-450 jal (depending on the length of IPG 
strip). The protein solutions containing a trace of bromophenol blue were used to rehydrate 18 or 
24cms Immobiline Dry IPG strips. Wide-range IPG strips covering a linear pH range of 3-10 and 4- 
7 and narrow pH range IPG 4.5-5.5 were tested. After overnight rehydration the samples were 
subjected to isoelectric focusing as recommended by the manufacturer (Amersham Biosciences 
publication). Focusing was carried out as shown in Table 5.1.
Table 5.1. Multiphor II™ isoelectric focusing
Voltage V MA Time Vh
150 5 30 min 75
300 5 2.5 hours 750
700 5 30 min 350
1500 5 30 min 750
2000 5 30 min 1000
3000 5 30 min 1500
3500 5 Up to 40 hours 95000-100000
IPG strips were equilibrated for 2 x 15 minutes with gentle shaking in a solution containing 
Tris-HCI (50 mM, pH 8.8), 6 M urea, 30% (v/v) glycerol, 2% (wt/v) SDS and a trace of bromophenol 
blue. DTT (1% wt/v) was added to the first and iodacetamide (4% wt/v) to the second equilibration 
step (Gorg et al., 2000). Strips were then overlaid onto Excel SDS slab second dimension gels.
The gels were run at 600 V, 20 mA for 30 minutes and then 600 V 50 mA until the bromophenol 
blue dye front had migrated to the anodic buffer strip (approximately 1 hour).
5.2.6. 2DE using IPGphor™ Ettan DALT TM
Protein samples were pipetted into the strip holder on the IPGphor platform and the IPG Dry strips 
applied. After overlaying silicone oil the IPGphor cover was applied. Rehydration and lEF were
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carried out according to the programmed settings listed in Table 5.2 below and following the 
manufacturers instructions.
Table 6.2. IPGphor™ isoelectric focusing
Step Programme 1 Programme 2 Programme 3
Voltage Time (h) Voltage Time (h) Voltage Time (h)
(V) (V) (V)
Rehydration 50 1 2 - 1 6 50 12-16 50 12-16
1 500 1 100 5h 150 0.5
2 1000 1 200 1 300 2.5
3 8000 8.20 h 500 1 700 0.5
4 - - 1000 1 1500 0.5
5 - - 8000 8. 20 3000 0.5
6 - - - - 6000 0.5
7 - - 8000 10.5
Multiple SDS slab gel casting and vertical SDS electrophoresis were performed as described in the 
Ettan Dalt™ II System Manual (Amersham Pharmacia Publication) and Gorg etal. (2000). Ettan 
DALT™ II pre-cast plastic backed gels were also used in place of home made gels according to 
the manufacturers instruction (Amersham Pharmacia). IPG strips were equilibrated as described in 
section 5.2.5. The equilibrated strips were then overlaid onto large format 12.5% polyacrylamide 
gels and sealed with agarose solution (25 mM Tris-Hcl, pH 8.3,192 mM glycine, 0.1% (wt/v) SDS, 
0.5% (wt/v) agarose, 0.002% (wt/v) bromophenol blue). A maximum of 12 gels were 
simultaneously run at 0.5 W geM for 10 minutes, 2.5 W geMfor 20 minutes and 17 W geH for 4-4.5 
hours.
5.2,7. Staining
A number of different staining procedures were tested. All procedures were carried out following 
either the manufacturers protocols or as described in the publications listed in Table 5.3.
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Table 5.3. Silver staining
stain Reference(s) Operating 
time (h)
Manufacturer Compatatlblllty 
with MS
Coomassle No reference available 1 Pharmacia Yes
PhastBlue
Blum Blum etal., 1987; Mortz, 
2001
3 N/A Yes
Vorum Vorum etal., 1999; Mortz, 
2001
4 N/A Yes
Shevchenko Shevchenko etal., 1996 3 N/A Yes
PlusOne™ Van et a i, 2000 7 - 8 Amersham Yes (with small 
modifications)
Sliver Shevchenko etal., 1996 2 - 3 Invitrogen™ Yes
Xpress™
SYPRO Ruby Lopez et a i, 2000 1.5 Amersham Yes
5.2.8, Image analysis
Silver stained gels were digitalised using the UMAX PowerLook III scanner and the images were 
processed using Adobe Photoshop Version 5.5 software. Protein spots were counted by the Image 
Master II software package (Amersham Biosciences).
5.2.9. In-gel proteolytic digestion of proteins
Protein spots of interest were excised from the 2DE gels using a PDM 1.5 Spot Picker (Gel 
Company). The protocol used in this study for the preparation of the samples was adapted from 
the procedure described by Speicher et al. (2000). Briefly the gel plug was washed twice in 100 |^ l 
of 1:1 acetonitrile: 400 mM NH4HC0 3 for 20 minutes at room temperature (RT). The plug was then 
dehydrated by the addition of 100 pi of acetonitrile, which was then removed, and the gel pieces 
air-dried for 10 minutes. Reduction and alkylation was performed as described by Speicher etal. 
(2000) and followed by a 20 minute wash in 100 pi of 1:1 acetonitrile: 400 mM NH4HC03at RT The 
samples were washed briefly with 100 pi acetonitrile and then dehydrated in 100 pi acetonitrile for 
10-15 minutes. After removing the acetonitrile the plugs were allowed to air dry for 10 minutes. The 
gel pieces were then swollen in a 5 pi solution containing 50 ng of modified porcine trypsin in 
10 mM NH4HCO3 and incubated at 37'C for 2-4 hours. The peptides were extracted by incubating
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for 10 to 15 minutes at RT with 5 pi of 5% formic acid. The sample was then flash frozen in liquid 
nitrogen and stored at -80°C.
5.2.10. MS analysis
The matrix solution contained 4 parts of a saturated solution of a-cyano-4-hydroxy-cinnamic acid 
(CHCA) in acetone mixed with one part of a 1:1 mixture of acetone: 2-propanol. 2.5 pi of the matrix 
solution was pipetted onto a stainless steel MALDI target plate and the solvent evaporated, 0.5 pi 
of the extracted peptides were then pipetted onto the matrix surface and allowed to dry. Samples 
were washed by pipetting 2 pi of 10% formic acid onto the matrix surface. The liquid was left on 
the sample for 5 seconds and removed using chromatography paper, in order to increase the 
number of peptides observed in the MALDI, spectra samples were also applied to the 
Anchorchip™ MALDI target (Bruker Daltonics) using a thin layer method as described by Gobom 
et al. (2001) and a matrix solution consisting of a saturated solution of CHCA in acetone. This 
target concentrates the samples onto the matrix without enriching for salts and other impurities 
(Gobom et al., 2001).
MALDI-TOF MS analysis was performed using a Bruker AUTOFLEX™ instrument (Bruker 
Daltonics) operated in the reflectron mode. Monoisotopic mass values were identified from a total 
of 300 single-shot spectra accumulated for each sample. Accurate mass values were obtained by 
recalibrating the instrument using modified trypsin self digestion product ion peaks as internal 
standards
5.2.11. Database searches
The MALDI-TOF MS PMF data were used to search the National Centre for Biotechnology 
Information (NCBI) database using the programme Mascot (Matrix Science Ltd). Using a species 
limited-search filter the search was restricted to the M tuberculosis complex. The search 
parameters cover protein molecular mass ranging from 2000 to 120,000 Da, trypsin digestion, 
peptide mass tolerance of ±50ppm, monoisotopic mass value, cysteines modified by 
carbamidomethylation and oxidation of methionine.
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Positive protein identification required matched peptides to cover a minimum of 20% of protein 
sequence if the predicted molecular weight and pi of the identified protein were consistent with 
those of the observed spot on the gel (Jungblut et ai, 1999). A second search was routinely 
performed using only unassigned peptide masses to identify additional proteins that may be 
present in the isolated protein spot.
5.3 Results
5.3.1. Protein preparation
In preliminary experiments protein extracts were prepared from mid-logarithmic batch cultured 
M bovis BCG cells. 2DE of total BCG protein, with lEF in immobilised pH gradient 3-10 in the first 
dimension on the Multiphor™ II horizontal electrophoresis unit resulted in very poor protein 
profiles. Resolution of proteins was low and heavy vertical and horizontal streaking on the gels was 
a problem, in order to optimise 2DE separation an alternative protocol for the extraction of 
cytoplasmic protein was devised. The amount of salt in all buffers was minimised by using Tris 
base at concentrations of 10mm or less. High salt concentrations are known to disturb 2DE (Dunn 
and Gorg, 2001). SDS was omitted from the procedure as this chemical has been shown to cause 
horizontal smearing in 2DE gels (Gorg et ai, 2000). The reducing agent p-merccaptoethanol was 
replaced with DTT.
Alternate compositions of the rehydration buffer were investigated. The addition of higher amounts 
of ampholytes (up to 2%) to the solubilisation buffer, claimed to improve protein solubilisation did 
not result in higher quality gels (Adessi et ai, 1997). This approach resulted in low voltages during 
lEF focusing and poor separation of proteins. It was found that replacing the ampholyte solution 
with the sulfabetaine SB 3-10 improved solubilisation and this was optimal when combined with 
urea-thiourea mixture. This is in accordance with previous observations (Chevallet etal., 1998). In 
additon, using the same buffer for protein solubilsation and rehydrating the IPG strips significantly 
improved the 2DE pattern. Typical results shown in Fig. 5.1 indicate that the alternate protein 
preparation combined with a solubilisation/rehydration buffer containing 10 mM Tris base, 5 M 
urea, 2 M thiourea, 2% (wt/v) CHAPS, 2% (wt/v) SB 3-10,0.5% (v/v) IPG buffer, 1% (wt/v) DTT 
greatly improved the solubility of the proteins in the first dimension as well as their transfer onto the 
SDS gel. Horizontal and vertical smearing although significantly reduced was, however still quite
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significant. Initial experiments used 11 and 18cm IPG strips. Extending this separation distance to 
24 cms resulted in a significant reduction in horizontal streaking.
6.3.2. 2DE profile of mycobacterial proteins
Pilot experiments demonstrated that the vast majority of mycobacterial proteins focused within the 
acidic range (pi 4-7), with a large number of molecules with a pi between 4.5 to 5.5. IPG strips 
reflecting this range were chosen for subsequent experiments. Individual spot resolution was 
increased significantly in pH 4-7 gels (Fig. 5.1). The proteins present in the most crowded region of 
pH 4-7 gels were separated using ultra narrow range pH 4.5-5.5 gels (Fig. 5.3).
Protein extracts from continuously cultured BCG were prepared and separated using 2DE. In initial 
experiments it was noted that BCG cells grown at a dilution rate of 0.01 h contained high 
concentrations of lipids that contaminated protein preparations. Lipids are known to interfere with 
the separation of proteins by 2DE and this was reflected in protein profiles from these samples 
(Amersham Biosciences publication). In an attempt to de-lipidate protein preparations a 
commercial kit was employed (PlusOne 2-D Clean-Up). This approach was quite successful, 
improving protein separation in many cases (results not shown). To further optimise 2DE analysis 
of mycobacterial proteins new equipment was purchased for lEF and SDS electrophoresis. The 
IPGphor™ is a first dimension system, which uses high voltages (up to 8000V) to separate 
proteins and the Ettan Dalt™ II system allows 12 large format (26cm x 22cms) second 
dimensional gels to be run simultaneously. The IPGphor™ is an integrated system in which 
rehydration with sample solution and lEF are performed in a one step procedure (unattended 
operation) and this reduces handling time. Although a very laborious procedure 2DE with the IPG- 
Dalt™ system improved both the resolution and reproducibility of experiments. Approximately eight 
hundred proteins were visualised on the gels (Fig. 5.1), a significant increase compared with the 
IPGphor system. The exact number of spots depending on the amount of samples applied to the 
gels and the staining conditions.
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Figure 5 .1 .2DE map of cytoplasmic proteins from M. bovis BCG cellular proteins (pH 4-7). 
Proteins (80 pg) were solubilised in a rehydration buffer (10 mM Tris base, 5 M urea, 2 M 
thiourea, 2% CHAPS, 2% SB 3-10, 0.5% IPG buffer, 1% DTT) and lEF was carried out using a 
linear IPG strip of pH 4-7. Proteins were detected by silver staining. The numbers above the gel 
indicate pi values and the numbers on the right indicate approximate molecular masses.
5.3.3. Staining and MS
A major factor limiting the detection sensitivity of MS is peptide loss due to surface adsorbtion. A 
number of strategies were used in this study to avoid peptide loss: (1) the number of handling 
steps were kept to a minimum; (2) Speed-Vac drying steps were avoided and (3) a high acetonitrile 
peptide extraction method was used (Shevchenko et al., 1996; Speicher et al., 2000).
The available stains for visualising proteins on 2DE gels include silver staining, coomassie blue 
stain and SYPRO fluorescent dyes. Silver staining has been the most widely use stain for 2DE
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because it requires relatively inexpensive equipment and reagents and remains the most sensitive 
methods for permenant staining of proteins. In order to investigate the staining performance of 
different silver staining methods a 2DE gel was cut into four pieces and stained using the silver 
staining protocols of Invitrogen™ (SilverXpress™), Amersham (PlusOne™), Blum (Blum etal., 1987) 
and Vorum (Mortz, 2001). From Fig. 5.2 it can be seen that the Blum protocol is the most sensitive 
and has a reduced background as compared to the gels stained using the Amersham and 
Invitrogen kits. The Vorum protocol is less sensitive, but has very dark spots and low background, 
which is advantageous for image analysis (Fig. 5.2b). For these reasons the Vorum protocol was 
adopted for staining analytical 2DE gels during this study.
Staining 2DE using Coomassie PhastBlue (Pharmacia) and SYPRO Ruby was also investigated as 
alternatives to silver staining. Coomassie PhastBlue staining had very poor detection sensitivity, 
reducing the numbers of proteins detected 10 fold and was therefore not appropriate for this study 
(results not shown). The SYPRO Ruby staining method, although very costly, was simple to 
perform and detected approximately the same number of protein spots as the Vorum silver stain 
(results not shown). Protein spots had high intensities and the background fluorescence was very 
low. However, the fluorescence bleached rapidly under UV transillumination and therefore without 
an automated spot picker these gels were very difficult to process for MS analysis. It was 
demonstrated previously that compared with silver staining SYPRO Ruby Protein Gel stain had a 
better linear dynamic range and enhanced recovery of peptides from in-gel digests for MALDI-TOF 
MS (Lopez et al., 2000). Despite these significant advantages over silver staining the requirement 
for expensive reagents and equipment prevented the SYPRO Ruby Protein Gel Stain from being 
adopted as a routine method for staining 2DE gels at the University of Surrey.
A major disadvantage in applying the silver staining technique to 2DE is that the protocols require 
treatments with chemicals that can cause modifications or destruction of the protein, which will 
impede subsequent MS identification. To determine which staining procedure was most compatible 
with MALDI-TOF MS, mycobacterial proteins prepared from chemostat cultures were separated by 
2DE and stained using a variety of different protocols. These included the silver staining protocols 
of Shevchenko (1996) and Vorum (Mortz, 2001). Several protein spots from different areas of the 
silver stained gels were excised and processed for MALDI-TOF analysis. The results obtained from 
the different staining protocols were compared by the number of peptides found, the sequence
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Figure 5.2. A comparison of silver staining protocols for 2DE. Proteins (80 pg) were solubilised in 
a rehydration buffer (10 mM Tris base, 5 M urea, 2 M thiourea, 2% CHAPS, 2% SB 3-10, 0.5% 
IPG buffer, 1% DTT) and lEF was carried out using a linear IPG strip of pH 4-7. The gel was cut 
into four pieces and stained using th^ silver staininq^protocols of Blum (Blum et al., 1987) (A),^ 
Vorum (Mortz, 2001) (B), Invitrogen™ Silver Xpress staining kit (C) and Amersham PlusOne™ 
Silver Staining kit (D).
coverage of the proteins and ultimately by the numbers of proteins, which were reliably identified. 
Of the staining methods investigated the silver staining protocols of Shevchenko (Shevchenko et 
a!., 1996) and Vorum (Mortz, 2001) were the most compatible with protein digestion and MS 
analysis. Seven spots out of a total of 30 spots excised from the Vorum stained gel were 
successfully identified and 17 spots out of a total of 30 spots were identified from Shevchenko 
stained gels (Fig. 5.3,5.4 and Table 5.4). Overall the number of proteins successfully identified 
from 2DE gels stained using the Vorum protocol was reduced as compared with the Shevchenko 
method. Although this is only a relative comparison of the two methods the difference in peptide 
recovery from Shevchenko stained gels was significant and reproducible and therefore this staining 
method was used routinely for staining preparative gels for subsequent MS analysis.
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Figure 5.3. Identification of cytoplasmic proteins with pi values between 4.5 and 5.5 from 
chemostat grown M. bovis BCG cells. Proteins (120 pg) were solubilised in a rehydration buffer 
(10 mM Tris base, 5 M urea, 2 M thiourea, 2% CHAPS, 2% SB 3-10, 0.5% IPG buffer, 1% DTT) 
and lEF was carried out using an IPG strip of pH 4.5-5.5. Proteins were detected using the silver 
staining protocol of Vorum (Mortz, 2001). The numbers above the gel indicate pi values and the 
numbers on the right indicate approximate molecular masses in KDa. Proteins that were 
identified by MS-MALDI-TOF are indicated.
5.3.4. The proteome of chemostat grown M. bovis BCG
In order to begin to characterise the proteome of BCG in the chemostat model of mycobacterial 
persistence selected protein spots were identified using MALDI-MS. In initial experiments 22 
protein spots representing 23 proteins were identified (Fig 5.3; 5.4). For each protein listed in Table 
5.4 the pi and Mwt, predicted function and any relevant literature reference is indicated. Five of the 
proteins identified appear to be novel identifications and have not been previously identified from 
2DE.
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Figure 5.4. Identification of cytoplasmic proteins (pi 4-7) from chemostat grown M. bovis BCG 
cellular proteins. Proteins (100 pg) were solubilised in a rehydration buffer (10 mM Tris base, 5 M 
urea, 2 M thiourea, 2% CHAPS, 2% SB 3-10, 0.5% IPG buffer, 1% DTT). Proteins were detected 
using the silver staining protocol of Shevchenko (1996). The numbers above the gel indicate pl 
values and the numbers on the right indicate approximate molecular masses in KDa. Proteins 
that were identified by MS-MALDI-TOF are indicated.
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To characterise differentially expressed proteins in the chemostat model of mycobacterial growth, 
BCG was cultivated in a chemostat at a dilution rate of 0.01 h*”* {td = 23 h) and 0.03 h-i (td= 69 h) 
and the steady state level of proteins were analysed by 2DE and silver staining. The results 
presented show a representative example of each culture condition (Fig. 5.5; 5.6). Although the 
2DE patterns were highly comparable, clear differences in the presence or absence of spots and 
spot intensity were detected. MALDI-TOF analysis was used to assign identities to a total of 10 
protein spots that were differentially expressed in two independent experiments (3 of them novel 
identifications) (Table 5.5).
Three spots appeared to be upregulated in fast growing chemostat cells (spots 23-25; Fig. 5.6; 
Table 5.5). Protein gel spot 23 was identified as belonging to the GcpE family of proteins. 
Although the exact biochemical function of this group of proteins is unknown, a GcpE homologue 
of £  co!i has an essential role in the synthesis of isoprenoids (Campos et a/., 2001; Seemann et 
al., 2002). Protein spots numbered 24 and 25 were identified as; (24) AdhB, a zinc binding 
alcohol dehydrogenase and (25) SahH, an adenosyihomocysteinase involved in methionine and 
selenoamino acid metabolism.
A further seven protein spots were exclusively detected in the slower growing chemostat cells 
(spots 26-32; Fig. 5.5; 5.6; Table 5.5). Spot 26 was identified as Lpd, a NADH oxireductase with a 
central role in the Krebs cycle and also in the synthesis of acetyl coenzyme A from endogenous 
precursors, it has also been demonstrated that Lpd is one part of a four-component nicotinamide 
adenine dinucieotide - dependent peroxidase and peroxynitrite reductase, which, may have a role 
in antioxidant defense (Bryk et a!., 2002). In addition to Lpd, gel spot 26 was found to contain 
another protein identified as MmsA. The equivalent spot from fast growing cells had a reduced 
intensity and contained only MmsA, therefore only Lpd was considered to be spot difference 
between the two growth rates.
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Figure 5 .5 .2DE maps of cytoplasmic proteins (pl 4-7) from chemostat cultured M. bovis BCG 
grown at a dilution rate of (A) 0.01 h’’ and (B) 0.03 h '\ Proteins (200 |ig) were detected by silver 
staining. Open circles and open squres represent the approximate position of protein spots 
increased or decreased under each condition respectively. The numbers above the gel indicate 
pl values and the numbers on the right indicate approximate molecular masses in KDa.
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Figure 5.6. 2DE maps of cytoplasmic proteins (pl 4 5-5.5) from chemostat cultured M. bovis 
BCG grown at a dilution rate of (A) 0.01 h'^  and (B) 0.03 h '\ Proteins (200 pg) were detected by 
silver staining. Open circles and open squares represent the approximate position of protein 
spots increased or decreased under each condition respectively. The numbers above the gel 
indicate pl values and the numbers on the right indicate approximate molecular masses in KDa.
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MALDI-MS analysis of spot 27 led to the identification of HspX, the a-crystallin homologue with 
84% coverage. Three conserved hypothetical proteins were also identified. Protein Rv2623 (spot 
28) is an ATP binding protein that contains domains unique to a family of universal stress 
proteins (USB). Evidence suggests that the UspA protein from £  coli is involved in environmental 
gene regulation under conditions that induce growth arrest (Freestone et al., 1997). Spot 29 was 
identified as the conserved hypothetical protein Rv2626c that has some similarity to IMP 
dehydrogenase, a key enzyme in the de novo synthesis of purine nucelotides (Rosenkrands et 
al., 2002). Another protein involved in purine biosynthesis, PurH, was also identified (spot 32). 
Protein spot 30 and 31 were identified as antigen 84 and EchA8 respectively. EchA8 is a 
probable enoyl-CoA hydratase involved in fatty acid oxidation and the function of antigen 84 is 
unknown.
5.4. Discussion
A necessary step in understanding latent TB is the characterisation of the proteins carrying out 
essential roles in the persistent cell. Towards this goal an optimised protocol for the separation of 
proteins from chemostat cultured M. bovis BCG has been developed and a 2DE map of the 
chemostat model of mycobacterial growth is presented. Only a very small fraction of the M. bovis 
BCG proteins have been identified in proteomic studies. MALDI-MS analysis led to the 
identification of 33 proteins, 9 of which were new to the M. bovis BCG database. Comparative 
analysis of BCG cells growing in the chemostat model of mycobacterial growth revealed 10 spots 
differentially regulated in the model. According to Sassetti et a/.(2003) 6 of the 10 proteins 
identified are specifically required for mycobacterial growth in vitro (Sassetti and Rubin, 2003). 
The proteins identified as upregulated in slowly growing BCG may perform specific mycobacterial 
functions in persistent mycobacteria and will require further characterisation.
Differential proteome analysis of mycobacteria requires 2DE methodology that is able to resolve 
a large number of polypeptides and is reproducible. Initial studies were directed towards 
optimisation of sample preparation. In an attempt to increase the solubilising power of the 
extraction buffer the concentrations of chaotropes and detergents were varied. The results show 
that mycobacterial proteins were better solubilsed in a mixture containing 10 mM Tris base, 5 M 
urea, 2 M thiourea, 2% (wt/v) CHAPS, 2% (wt/v) SB 3-10,0.5% (v/v) IPG buffer, 1% (wt/v) DTT. 
Improved gels were also observed when solubilisation was conducted in the same solution as the
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rehydration buffer used for lEF. This has been reported in other studies (Molloy et ai, 1998). The 
presence of high concentrations of lipids in chemostat cultured BCG was found to be a hindrance 
in the resolution of mycobacterial proteins. The protocol for protein extraction established here 
minimises these and other contaminants and permitted the display of a significant portion of the 
mycobacterial proteome. While this protocol has permitted a high resolution of mycobacterial 
proteins, further improvements remain possible. Sequential extraction processes have been 
reported which allow the rapid and effective extraction of proteins present in various subceilular 
locations, including cell wall and membrane proteins (Molloy etal., 1998; Rosenkrands etal., 
2000b). The use of new surfactants and chaotropes are also likely to benefit the extraction of 
mycobacterial proteins (Herbert ef a/., 1998; Rabilloud, 1998).
2DE using IPG-DALT allowed the resolution of approximately 800 spots in the pH range 4-7. This 
is only a fraction of the complete proteome predicted by the gene sequence of M tuberculosis but 
is comparable to other studies (Cole ef a/., 1998; Boon ef a/., 2001 ; Betts ef a/., 2002; 
Rosenkrands ef a/., 2002). 2DE on a single wide-range pH gradient reveals only a small 
percentage of the whole proteome because of insufficient spatial resolution. Researchers have 
overcome this problem by increasing the size of the gel to at least 20 cm x 30 cm (Jungblut ef a/., 
1999). Approximately 2000 M. tuberculosis protein species have been resolved from using large 
gel formats (Mattow ef a/., 2001a). However, technical problems in handling such giant gels 
preclude their use. A composite proteome map can be generated by using several overlapping 
narrow pH-range IPG’s, thus increasing the virtual distance of the gel. The preliminary analysis of 
the M. bovis BCG proteome was performed here using narrow range pH 4-7 IPG strips. These 
2DE gels were extremely difficult to analyse in the high molecular weight acidic range of the gel 
where the majority of proteins clustered. This 2DE pattern is highly similar to other studies (Boon 
ef a/., 2001; Betts ef ai, 2002). The use of pH 4.5-5.5 IPG strips in this study proved invaluable in 
improving the spatial resolution of the proteins in the acidic region.
This project demonstrates the utility of combining chemostat culture with 2DE. It has been 
demonstrated that subtle differences in culture conditions has significant consequences in 
proteomic profiles. The presence of media additives on 2DE gels hinders the resolution of 
mycobacterial proteins (Urquhart ef a/., 1997). In addition standing and shaking cultures of 
mycobacteria have disparate 2DE maps (Florczyk ef a/., 2001). Such factors may impact 
experiments into mycobacterial protein expression. The chemostat provides cells in a defined
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state and therefore is not prone to these variations. Accurate and reproducible polypeptide maps 
were generated in this study and these were used to assess and compare the levels of protein 
expression in the chemostat model of mycobacterial growth. Levels of at least 7 proteins 
increased, and those of 3 proteins decreased, in the slowly growing relative to the faster growing 
chemostat culture. PMF using the MALDI-TOF was used to assign putative identities to a total of 
10 of these protein spots.
Steady state levels of the protein SahH were upregulated in the fast growth rate cells and 
transcription of sa/iH was previously shown by DNA microarray experiments to be downregulated 
in a nutrient starvation model of mycobacterial persistence (Betts et al., 2002). SahH is an 
essential protein involved in methionine/selenoamino acid metabolism 
(http://genolist.paseur.fr/TubercuList). Another protein involved in cellular metabolism was also 
shown to be upregulated in the fast growth chemostat cells. AdhB is a zinc binding alcohol 
dehydrogenase and the increased expression of this protein and SahH may simply reflect a 
general increase in metabolism at the higher growth.
The identification of the hypothetical protein GcpE previously unidentified in 2DE gels confirms 
that this protein is a real member of the M. bovis BCG proteome. Althought the function of this 
protein is unknown, GcpE proteins are thought to have a role in the 2-c-methyl-D-erythritol-4- 
phosphate (MEP) pathway essential for the synthesis of isoprenoids (Altincicek etal., 2001; 
Campos etal., 2001). In addition to having a role in metabolism, cellular architecture and 
signaling, isoprenoids may be particularly important in the density dependent regulation of cell 
wall biogenesis (Dover et al., 2004). There is strong evidence that the MEP pathway is active in 
M, tuberculosis and this pathway is likely to be essential in the biosynthesis of the mycobacterial 
cell wall (Dover et al., 2004). Since this pathway is absent in humans, GcpE provides a very 
attractive drug target (Rohdich etal., 2001).
Low molecular mass proteins are notoriously difficult to identify by MALDI-MS because they only 
yield few peptides following enzymatic cleavage, particulary when digestion is carried out on 
small amounts of protein. Two 16kDa proteins corresponding to spots 27 and 29 were shown to 
be upregulated during the slow growth in this study. Both of these proteins were unambiguously 
identified as HspX and Rv2626c.
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The M tuberculosis 16kDa persistence protein a-crystallin (HspX) was reported to be induced by 
hypoxia (DesJardin etal., 2001; Sherman et al., 2002; Muttucumaru etal., 2004). The production 
of this protein by aerobic stationary phase cells demonstrated that this protein is not specific to 
hypoxic cultures, but others dispute this result (Yuan etal., 1996; Hu and Coates, 1999a; Wayne 
and Sohaskey, 2001; Hampshire etal., 2004). Additional factors may be contributing to the 
induction of HspX and discrepancies in the reported results are probably due to differences in the 
culture conditions. The effect of oxygen limitation on M. tuberculosis was recently studied in a 
chemostat (Bacon et ai., 2004). In this study M. tuberculosis was grown under aerobic or low 
oxygen conditions at a growth rate equivalent to the fast growth rate chemostat presented here 
(Bacon etal., 2004). Transcriptomic analysis showed that hspX was induced in the low oxygen 
conditions (Bacon et al., 2004). Here 2DE analysis of proteins from chemostat-cultured 
mycobacteria demonstrated that HspX is induced during slow growth under carbon-limited 
conditions. HspX was shown to possess a chaperone function that prevents protein aggregation 
through non-specific weak interactions with folded proteins. Alpha-crystallins have been 
implicated in biological states associated with low metabolic rates and dormant conditions such 
as encystement in other organisms and may play a similar role in M. tuberculosis (Liang and 
Macrae, 1999). Evidence suggests that HspX is an important protein in the pathogenic strategy of 
M. tuberculosis. 85% of patients with active TB have antibodies to HspX demonstrating that this 
protein is expressed in vivo (Wilkinson et al., 1998; Quinn et al., 2002). HspX was also 
upregulated during the growth of M. tuberculosis in macrophages and mice (Shi etal., 2003; 
Schnappinger et al., 2003). A gene replacement mutant for hspX in M. tuberculosis had no 
phenotype in vitro but was unable to grow in macrophages (Yuan et al., 1998). These studies 
indicated that HspX has an important role in the maintenance of long term viability and also in the 
early stages of adaptation to intracellular growth. The demonstration that HspX was induced at 
slow growth rates in a carbon-limited chemostat futher dissects the complex environmental 
triggers that modulate the expression of this important mycobacterial protein.
The 16kDa protein Rv2626c was expressed more strongly in the slow growth chemostat (this 
study), in activated macrophages and in a mouse model of TB (Schnappinger et al., 2003; Shi et 
al., 2003). Increased levels of gene expression have also been demonstrated during Wayne’s 
model of non-replicating persistence, during the growth of M. tuberculosis in 1% and 5% oxygen 
and in the stationary phase of aerobic growth (Muttucumaru etal., 2004; Voskuil etal., 2004).
The function of this protein is unknown but it contains two cystathionine beta synthase (CBS)
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domains found in a large number of functionally diverse proteins such as inosine monophosphate 
(IMP) and chloride channels (Bateman, 1997). The exact function of the CBS domains is 
unknown but they may be involved in protein-protein interactions and protein regulation (Boon et 
al., 2001 Bateman, 1997). Interestingly, it has been proposed that a CBS containing protein of 
yeast, SNF4 functions in low glucose to regulate other proteins (Johnston, 1999). It has been 
demonstrated here that the M. bovis BCG CBS containing protein Rv2626c is upregulated during 
low growth rates in glycerol limited cultures and it is postulated that this protein may also be 
involved in protein regulation. Further studies into the enzymatic and structural properties of 
Rv2626c are required to determine the function of this protein.
Evidence suggests that Rv2623 is an ATP-binding protein that may, like RV2626c be involved in 
environmental gene or protein regulation (DiRusso et ai, 1999). Rv2623 contains two domains 
unique to a family of universal stress proteins (Florczyk et ai., 2001). The most studied member 
of this family is the UspA protein of E. coli, which has a protective function during growth arrest 
caused by starvation (Freestone etal., 1997). UspA mutants have abnormalities in carbon 
utilisation and an altered proteomic profile, providing evidence that UspA effects gene expression 
(Nystrom and Gustavsson, 1998). In addition the regulation of UspA by the fatty acid responsive 
transcription factor, FADR demonstrated that this protein has a role in lipid metabolism (DiRusso 
et al., 1999). Recent findings demonstrated that Rv2623 is upreguated in M tuberculosis during 
growth and persistence in mice, in vitro under reduced oxygen tension and in the stationary 
phase of growth (Shi et ai, 2003; Bacon et ai., 2004; Voskuil et al. 2004). Here increased steady 
state levels of the protein Rv2623 were identified by MALDI-TOF MS during growth of BCG in the 
chemotat model of persistence. The function of this protein in M. tuberculosis is unknown but its 
upregulation during slow growth in carbon-limited chemstats poses the intrigueing possibility that 
this protein, like UspA, is involved in the transcriptional regulation of genes during conditions of 
slow growth and growth arrest. Investigations into the proteomic, transcriptomic and metabolic 
consequences of deleting Rv2326 from M. tuberculosis may help unravel the function of this 
gene.
The upregulation of dihydrolipoamide dehydrogenase (Lpd) during slow growth in the chemostat 
model is of interest. This protein has an essential role in the Krebs cycle and also in the synthesis 
of acetyl-coA as the E3 component of pyruvate dehydrogenase, a-ketoglutarate dehydrogenase, 
and branched-chain a-keto acid dehydrogenase complexes (Bryk et al., 2002). Formation of
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acetyl-coA is essential to the glyoxylate shunt that is thought to be important during mycobacterial 
persistence {McKinney etal., 2000). The upregulation of this metabolic enzyme during slow 
growth in a carbon-limited chemostat may therefore reflect an increased cellular demand for 
acetyl-coA into the glyoxylate shunt. Some evidence for the requirement for an active glyoxylate 
shunt during the chemostat model was already provided in this study (chapter 4). Isocitrate lyase, 
a key enzyme involved in the shunt is upregulated during slow growth in the chemostat model 
and an isocitrate lyase mutant was severely attenuated for survival in the model. The increased 
expression of Lpd provides further support to this hypothesis. In addtion to the crucial role of Lpd 
in intermediary metabolism, Lpd may also contribute to the antoxidant defense mechanisms of 
M. tuberculosis (Bryk etal., 2002; Koshkin etal., 2004). This makes Lpd unique to mycobacterial 
species and therefore a potential drug target.
Examination of the other proteins with increased protein expression during the slow growth rate in 
the chemostat system was less instructive. Increased expression of EchA8, a putative enoyl-coA 
hydratase was also observed during starvation of M. tuberculosis and may reflect an overall 
increase in lipd metabolism associated with slow growth rate (Betts et al., 2002). Antigen 84 is an 
essential hypothetical protein of unknown function. Upregulation of this protein may reflect 
alterations in the antigenic properties of the cells in the chemostat model. It was demonstrated in 
a mouse model that the antigenic profile of M. tuberculosis changed during the course of the 
infection (Talaat etal., 2004). PurH is an essential gene in de novo purine biosynthesis. Rv2626c 
shows some homology to IMP dehydrogenase, another key enzyme in the synthesis of purine 
nucleotides (Cole et al., 1998). Together this data suggests an increased demand for purines in 
the slow growth rate.
The application of proteomics to the study of mycobacteria in the chemostat model has made it 
possible to identify alterations in protein expression in slow growing BCG. These proteins may 
perform specific functions in persistent mycobacteria. It remains unclear to what extent these 
results can be extrapolated to the In vivo situation. The relevance of these results will be 
investigated by constructing knockout mutants incapable of producing these putative persistence 
proteins and studying the survival of these mutants in vitro and in vivo. Studies such as this one 
are making it possible to characterise global alterations of protein expression in response to 
environmental signals, promise new insights into the mechanisms of mycobacterial disease and 
may lead to the identification of novel drug targets.
Chapter Six
Microarray analysis of the chemostat 
model of TB persistence
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6.1. Introduction
The use of DNA microarrays to monitor gene expression is a rapidly evolving technology that has 
enhanced and accelerated Investigations in functional genomics and made a very significant 
impact on mycobacterial research. DNA microarrays are a series of microscopic spots consisting 
of unique nucleotide sequences immobilized on a solid surface at fixed locations. Each array or 
chip may consist of thousands of DNA spots, which can be used to quantitatively measure the 
abundance of labelled transcripts from a particular experiment. DNA microarrays are very 
versatile and have been used in a variety of applications including drug discovery, diagnostics, 
molecular phylogeny and vaccine development (Behr et al., 1999; Ye et al., 2001; Wilson et al., 
1999; Serruto et ai, 2004; Long et ai, 2004). The study of the transcriptome is complementary to 
the proteome. It has been shown that a detailed understanding of the control of gene networks 
requires information on both mRNA and protein expression levels (Hatzimanikatis and Lee,
1999). Combining proteomics and transcriptomics offers a significant potential to analyse and 
interpret the interactions of mycobacteria species with their environment and will therefore 
facilitate a greater understanding of the pathogenic strategies of M tuberculosis.
6.1.1. Microarray technology
Although other techniques such as serial analysis of gene expression (SAGE) and massively 
parallel signature sequencing (MPSS) exist, hybridisation based microarrays have become the 
transcriptomic tool of choice (Veiculescu et ai, 1995; Brenner et ai, 2000). DNA microarray 
production is a highly automated process using modern high throughput robotic technology.
There are two well-established techniques for the generation of array elements. The first 
technique, pioneered by Affymetrix GeneChips™, uses very short oligonucleotides which are 
synthesized in situ by a combination of photolithography and combinatorial chemistry (Lockhart et 
ai, 1996). The arrays are then hybridized to a single biotinylated nucleic acid sample and the 
intensity of each gene is computed. Affymetrix GeneChip™ technology has been applied to 
M. tuberculosis but it is not very accessible to academic researchers due to the high cost of the 
system and therefore will not be discussed any further (Salamon et ai, 2000). The alternative 
technology differs in that larger probes consisting of PCR products, isolated cloned DNA or 
synthesized oligonucleotides are spotted onto glass slides using robots. A control and test 
sample are then labelled with two different fluorescent dyes, most commonly Cy3 and Cy5 and 
co-hybridised to the same array (Fig. 6.1). The ratio between the two dyes indicates the relative
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abundance of a gene in these two samples. The second approach has been used to generate 
both oligonucleotide and ampiicon whole genome microarrays for M. tuberculosis (Fisher et al„ 
2002; Stewart et ai, 2002). Arrays developed and produced by the Bacterial Microarray Group at 
St Georges Hospital Medical School (BuG@S), consisting of PCR-amplified DNA fragments 
representing 3924 of the ORF’s identified in the M. tuberculosis H37Rv genome, were used 
during this research project (Stewart etal., 2002).
In order to make appropriate biological sense of the vast quantity of data generated by DNA 
microarray experiments, careful analysis is required, using computational biology or 
bioinformatics. Bioinformatics has a crucial role at all stages of the DNA microarray experiment. 
Software and database systems are required for the design of microarrays, image processing, 
storage and preservation of the hybridisation readout profile and statistical analysis of the data.
6.1.2. Benefits and pitfalls
The ease of use and wide commercial availability has made DNA microarray based approaches 
increasingly popular in bacterial research projects. DNA microarrays allow researchers to probe 
the entire genomes of pathogens without any bias towards a particular gene or pathway. This 
technique therefore has significant advantages over other techniques such as quantitative real 
time (QRT) PCR and Northern blots that are used more frequently to confirm rather than 
generate hypothesis. However, DNA microarrays do not replace these more conventional 
molecular techniques and often must still be used in conjunction with these tools to validate and 
extend the findings of microarray experiments. Although the ability of DNA microarrays to 
compare thousands of genes is an obvious benefit of this technique it also provides researchers 
with a set of analytical issues. The large numbers of simultaneous comparisons can lead to 
spurious data. Excellent experimental design and repeated independent biological replicas are 
required to reduce the incidence of false results.
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Figure 6.1. Schematic representation of the steps involved in DNA microarray experiments
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6.1.3. RNA preparation
Microarray experiments require sufficiently large amounts of high quality mRNA. Bacteria react 
very quickly to changes in the environment and also have very efficient degradation systems for 
destroying RNA transcripts. Therefore the bacterial mRNA population is constantly changing and 
has a very short half-life. In order to obtain biologically relevant bacterial RNA preparations 
samples must be quenched in conditions that stop any more transcription occurring and prevent 
RNA degradation. The use of stabilization agents such as phenol/ethanol for Gram negatives and 
guanidine thiocyanate (GTC) for Gram positives guarantees the purification of transcripts that 
accurately represent the response to the environment being investigated. A method specifically 
designed for the stabilization and extraction of mycobacterial RNA has been developed that 
involves the immediate addition of GTC to the bacteria (Butcher et al., 1998). It has been 
demonstrated that within one minute the GTC penetrates the mycobacterial cell wall, blocks 
transcription and protects mRNA (Butcher ef a/., 1998; Mangan etaL, 2002).
6.1.4. Applications
There are two common applications of DNA microarrays. In comparative genomic studies DNA- 
DNA microarrays are used to determine the similarities and differences in gene content among 
bacterial strains. This strategy has proved useful for understanding the genetic differences 
between the closely related organisms M. tuberculosis and the vaccine strain M. bovis BCG 
(Behr et al., 1999). By contrast expression microarrays provide the ability to perform functional 
genomics by examining RNA levels in bacteria subjected to different conditions. Transcriptomic 
technology has been employed successfully in a wide variety of mycobacterial projects and has 
already been applied to several in vitro models of mycobacterial persistence (Betts et al., 2002; 
Hampshire etaL, 2004; Kendall etaL, 2004b; Voskuil et al., 2004). By integrating the 
transcriptomic data from several In vitro models of persistence Voskuil et al. (2004) generated a 
very useful compendium of genes that potentially have a role in mycobacterial persistence.
6.1.5. Experiments types
DNA microarrays measure the relative gene expression of paired samples. In type I experiments 
two samples of RNA are labeled with different fluorescent dyes and then compared directly on 
one microarray chip. After standardising the average intensity over the entire array the relative
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abundance of transcripts under the two conditions can be deduced from the ratio of fluorescence 
for the two dyes. This type of experiment does not allow direct comparison between lots of 
different array experiments. To overcome this many researchers are now using a fixed amount of 
common reference sample, such as genomic DNA against which experimental treatments are 
compared. These type II experiments allow the amount of spotted cDNA to be determined and 
normalised among many different array experiments. A disadvantage of using a common 
reference is that twice the number of microarray hybridization reactions are required for each 
experiment and this has obvious cost implications. Both types of experiments have been applied 
to mycobacterial research {Betts etaL, 2002; Stewart etaL, 2002; Schnappinger ef a/., 2003; 
Voskuil etaL, 2004). To minimise cost it was decided to perform type I experiments in this study.
6.1.6. Normalisation
Before comparing microarrays from multiple experiments the results must be normalised to make 
them comparable. This is necessary in order to correct for variation introduced into the data as a 
result of differences in the amounts of cDNA, background fluorescence, labelling efficiencies and 
standard handling errors. Normalisation is a very important part of microarray data analysis as 
improper normalisation will skew the results and therefore reduce the credibility of the data. The 
most common methods of normalising microarray data assume that the majority of gene 
expression is relatively constant between experiments. Experimental data has demonstrated that 
this is true in the majority of situations (Cheadle et al„ 2003). Occasionally this may not be a valid 
assumption. For example during a study investigating the transcriptional response of 
M. tuberculosis during stationary phase Voskuil et ai. (2004) observed that most genes were 
repressed in comparison with cells in the log phase of growth. In this situation alternative non- 
global methods of normalisations must be performed.
For the type I experiments performed during this research a global locally weighted scatter plot 
smoothing lowess normalisation is a good choice (Dudoit, 2002). In this procedure fluorescence 
intensities are measured from both Cy5 and Cy3 channels for all elements on the array. R-l 
(ratio-intensity) scatter plots of the logz ratio for each spot are represented as a function of the 
logio (Cy5*Cy3) product intensities. Lowess allows the deviation from a value of zero to be 
detected and corrected for by performing a local weighted linear regression for each data point in 
the R-l plot and subtracting the average ratio from the experimentally observed ratio. Lowess
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normalisation and other methods of correcting microarray data are undertaken using 
bioinformatic programmes such as GeneSpring™ (Silicon Genetics) used to process the data 
generated during this study,
6.1.7. Significance
The assessment of the statistical significance of microarray data is an area of controversy and 
intense debate. Although microarray technology is well established, statistical methods tailored 
to the analysis of microarray data are not routine and continue to be adapted and developed. A 
plethora of different statistical approaches have been applied to microarray data, however without 
the general acceptance and validation of standard methods, deciding which changes are 
statistically significant remains a major challenge.
Fold change cut-offs have been widely used in microarray assays to identify differentially 
expressed genes. Early publications of DNA microarray studies chose a two-fold up or down 
regulation to define differential expression. This approach identifies genes that are highly 
sensitive to changes in the environment but could miss important genes that are modulated less 
severely but have important biological significance. In addition fold-change cut-offs are 
statistically inefficient and might increase the proportion of false results. A better method for 
analysing microarray data is the calculation of a statistic based on replicated array data for 
ranking genes according to their probability of differential expression and selection of a cut-off 
value for rejecting the null hypothesis that the gene is not differentially expressed. Statistical 
analysis methods such as Student’s t-test, ANOVA (Analysis of Variance), Bayesian method or 
Mann-Whitney test can be used to rank the genes from replicated data (Leung et al., 2001;
Leung, 2002; Leung and Cavalieri, 2003). In order to control the false discovery rate inherent in 
multiple hypothesis testing, individual p-values can be altered using multiple testing correction 
methods like the Benjamlni-Hochberg multiple testing correction (Benjamin!, 1995). These tests 
are also features of the GeneSpring™ microarray analysis software package.
6.1.8. Reproducibility
The power of transcriptomic studies is dampened by the systemic and biological variations that 
occur during a microarray experiment. Although a number of strategies have been developed in 
order to minimise systemic variations, the variability introduced by the experimental conditions
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has proved more difficult to resolve. One strategy to minimise variability introduced by the 
experimental conditions is to use chemostat instead of batch culture to grow organisms. With the 
use of chemostat cultivation, investigators are able to grow organisms in a controlled environment 
at a defined growth rate making this technique invaluable for transcriptome wide studies. It has 
been demonstrated that microarray analysis of organisms grown in the chemostat is significantly 
more reproducible than batch culture DNA-array data (Hayes et ai, 2002; Piper et al., 2002; 
Bacon et al., 2004). A combination of chemostat culture and DNA microarrays was recently used 
to study the effects of oxygen limitation on the gene expression profile of M. tuberculosis (Bacon 
et al., 2004). This study demonstrated that the chemostat provides a reliable and reproducible 
environment for culturing mycobacteria and is therefore a very useful tool for quantitative 
transcriptome analysis using DNA microarrays.
6.1.9. Transcriptomics vs. proteomics
The measurement of transcribed mRNA using DNA microarrays has proved to be a very powerful 
tool in studying M, tuberculosis and has the advantage over proteomic approaches in the ability 
to globally characterise all of the gene products of M. tuberculosis. Transcript levels do not 
however reflect all regulatory processes in the cell, as post-transcriptional operations such as 
phosphorylations, méthylations and interactions with metabolites that alter the amount of active 
protein are not considered. The central dogma in molecular biology is that genetic information in 
the DNA is transcribed to mRNA, which is translated into proteins. Within this theory was the 
assumption that the expression of a gene is directly proportional to the amount of protein. This 
assumption is proving to be invalid. Significant differences have been shown between the 
abundance of mRNA transcripts and corresponding protein products (Griffin et al., 2002; Lee et 
al., 2003; Mehra et al., 2003). The techniques of two-dimensional gel electrophoresis and mass 
spectrometry (2DE-MS) play an important role in elucidating protein function that is 
complementary to microarray analysis. By combining data from microarray and 2DE-MS 
experiments researchers can more accurately characterise biological systems and processes 
under different environmental conditions.
6.1.10. Aims
2-DE-MS analysis was used to identify proteins that were differentially regulated in the chemostat 
model of mycobacterial growth. In order to further describe the adaptation of M. bovis BCG to
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slow growth in a carbon-limited chemostat the transcriptional response was monitored using DNA 
microarrays.
6.2. Materials and methods
6.2.1. Chemostat culture.
Chemostat culture was performed as described in chapter 2.
6.2.2. RNA isolation
In order to stabilise the mRNA population 20 ml of culture sample was rapidly withdrawn from the 
chemostat by a tube submerged in the culture broth and directly injected into a sterile bottle 
containing 80 mi of GTC solution (5 M guanidinium thiocyanate, 0.5% sodium N-lauryi sarcosine, 
25 mM tri-sodium citrate and 0.1 M DTT). This protocol has been shown to stabilise and protect 
cellular mRNA (Mangan et al., 2002). RNA was prepared essentially as described by Stewart et 
al. (2000). The extraction protocol was modified slightly to include additional chloroform 
extractions to remove lipid contamination. RNA integrity was monitored by gel electrophoresis 
and concentrations were measured by spectrophotometry.
6.2.3. Preparation of labelled cDNA
Fiuorescently labelled cDNA were produced by reverse transcription of total M. tuberculosis RNA 
with Superscript III (Invitrogen) in the presence of CyS-dCTP or Cy5-dCTP (Amersham 
Pharmacia) using random hexamer oligonucleotides to prime cDNA synthesis. Each 25 1^ 
labelling reaction consisted of 2-10 pig of total RNA, 3 pig random primers (Invitrogen), 1 mM 
each of dATP, dTTP and dGTP, 0.4 mM dCTP, 10 mM DTT, 500 units of Superscript III reverse 
transcriptase, 1 x First Strand Buffer provided by the manufacturer and 2 nmol of either Cy3- 
dCTP or Gy5-dCTP (Amersham Pharmacia). The RNA and primers were preheated to 95°C for 5 
minutes and snap cooled on ice prior to adding the remaining reaction components. The reverse 
transcription reactions proceeded in the dark for 10 minutes at 25°G followed by 90 minutes at 
42“G.ln order to remove unincorporated dyes the appropriate pairs of Gy3 and Gy5 were mixed 
and purified using a MiniElute kit (Qiagen), eluting in water. RNA samples prepared from 
chemostat cultures at a dilution rate of 0.03 h-'* (td = 23 h) were directly compared to RNA
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samples from chemostat cultures at a dilution rate of 0.01 h-'* (td = 69 h) by competitive microarray 
with both dye arrangements.
6.2.4. Microarrays and hybridisations
The DNA microarrays provided by BuG@S of PCR-amplified ORF-specific DNA fragments, 
representing all of the predicted open reading frames from the M tuberculosis H37Rv genome 
robotically spotted onto a poly-L-lysine-coated glass microscope slide. For a detailed description 
of the construction of the M. tubercuiosis chip see www.sgms.ac.uk/depts/medmicro/bugs.
Probes were hybridised in 4 x SSC, 0.3% SDS in a final volume of 23 pi under a 22 x 22cm 
LifterSlip (VWR) at 65°C for 16-20 hours in a humidified slide chamber at 65°C. Prehybridization 
and washing was performed as described by Stewart et al. (2003).
6.2.5. Data processing and statistical analysis
Microarrays were scanned using a GenePix 4000B (Axon Instruments) at a level just below 
saturation of the most intensely fluorescent spot on each array. Fluorescence intensity data from 
each array were quantified using GenePixPro software (Axon Instruments) and bad spots were 
removed. The resulting images were analysed with GeneSpring™ 5.1 (Silicon Genetics) software 
tools. Hybridisation intensity values were normalised using lowess local regression, averaged and 
plotted. Following this the values were compared using a Student’s t-test and were also subjected 
to the Benjamini-Hochberg correction to take into account multiple testing. By setting the 
Benjamini Hochberg False Discovery Rate to 0.005 the number of false positives identified was 
limited to 0.5%. Differential regulated genes were identified among the significantly changed 
genes as those having a greater that 1.6 fold expression ratio in comparison with the fast growth 
rate.
All microarray experiments were technically replicated four times with cells from two independent 
chemostat experiments resulting in 8 sets of microarray data.
6.3. Results and discussion
A comparison of gene expression between slow and fast growing M. bovis BCG cells was 
performed in order to identify the genes most important for slow growth. It was found that 353
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genes representing 8.7% of the genome were differentially expressed in the slow growing cells 
adapting to carbon-limited conditions. The numbers of differentially expressed genes under the 
two growth rates and their corresponding functional categories are summarised in Table 6.1. For 
genes with known functions it was observed that slow growth rates upregulated genes involved in 
ceil-wall and cell processes and intermediary metabolism whereas the faster growth rate induced 
information pathway genes. See Appendix 1 for the full data set for all deregulated genes.
Sassetti etaL (2003) demonstrated using transposon site hybridisation (TraSH) that 614 
M. tuberculosis genes are essential for growth In vitro. A comparison of the TraSH data with the 
data from this study showed that 20 essential genes were specifically upregulated during slow 
growth rate in the chemostat model (Appendix 2; Fig. 6.2). Of these 20 genes 57% have no 
annotated function and therefore may perform mycobacterial specific roles (Cole etaL, 1998).
The products of these genes may prove to be potential targets for novel drugs that kill both the 
acute and persistent phase M. tuberculosis and therefore require further investigation.
Table 6.1. Summary of genes deregulated during growth in a carbon limited chemostat culture 
of M. bovis BCG at a dilution rate of 0.01 h'^  (to = 69 h) as compared with a dilution rate of 0.03 
h'^  (td= 23 h). Annotations are from TubercuList (http://genolisy.pasteur.fr/TubercuList); (Cole et 
al., 1998). CHP and HP indicate conserved hypothetical and hypothetical proteins respectively.
Functional Classification Total in genome
Total on 
array
Up
regulated
Down
regulated
Whole genome 4056 3924 226 127
Virulence, detoxification, adaptation 99 98 5 5
Lipid metabolism 233 232 11 8
Information pathways 229 226 10 40
Cell-wall and cell processes 708 697 46 20
Stable RNA’s 50 0 0 0
Insertion sequences and phages 149 143 7 1
PE and PPE proteins 170 168 10 3
Intermediary metabolism and 894 888 50 20
respiration
Proteins of unknown function 272 258 1 0
Regulatory proteins 189 186 14 7
Conserved hypothetical proteins 1063 1028 72 23
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6.3.1. Comparison with other models of persistence
In order to identify any similarities between the model presented here and other published 
persistence models DNA expression profiles were compared between; (1) the chemostat model 
of persistence presented in this study; (2) a PBS starvation modei (Betts et a/., 2002); (3) a 
standard stationary phase model (Voskuil et a!., 2004); (4) an extended stationary phase model 
(Hampshire etaL, 2004); (5) two projects exploring Wayne’s model of persistence (Muttucumaru 
et aL, 2004; Voskuil et ai., 2004). In addition, in order to establish whether the requirements for 
survival in the chemostat model had any similarities to the requirements for growth in vivo, gene 
expression data from a recent analysis of M. tuberculosis growing in macrophages was also 
compared with the data from this study (Schnappinger et aL, 2003). The comparison was 
performed by downloading gene lists that were provided as tables supplementary to the original 
publications. The extraction of comparable data from these publications was complicated by the 
different formats used for presenting the data and also differences in criteria for including genes 
in the lists and therefore the analysis presented (Fig. 6.2) is only preliminary in its nature. The 
problems associated with comparing DNA expression data from different studies has been 
highlighted in a recent review article by Kendall et al. (2004).
The transcriptional profile of carbon-limited chemostat grown BCG cells had the most in common 
with the standard stationary model of persistence (Fig. 6.2). Expression of 27.6% of the genes 
deregulated in the chemostat model of persistence were similarly deregulated in a standard 
stationary phase model. This is in accordance with previous observations that the stationary 
phase response was induced in £  coll at low dilution rates in carbon-limited chemostats (Notiey 
and Ferenci, 1996). Surprisingly the transcriptional profile from the chemostat model of 
persistence showed very little correlation with the extended stationary phase model (Hampshire 
et aL, 2004). During this model gene expression was monitored during 100 days of growth in a 
fermenter, which enabled the oxygen, pH and temperature conditions to be maintained. It is 
difficult to interpret this observation, as there is also a lack of correlation between the two 
stationary phase models themselves. This may be further evidence for the poor reproducibility 
associated with this stage of growth (section 2.2.2). Some similarity was observed between the 
expression response of M bovis BCG to the chemostat and Wayne's model of persistence 
reported by Voskuil et al. (2004). In contrast, a much lower correlation was observed with 
Wayne’s model of persistence reported by Muttucumaru et al. (2004). The discordance between
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these two published studies is quite alarming as both projects used identical culture techniques 
and probably reflects the problems associated with reproducing this model in different 
laboratories.
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Figure 6.2. A comparison of the expression profiles from the chemostat model of persistence 
with other published microarray studies. Green bars represent the proportion of genes 
differentially expressed under the conditions in the chemostat model of persistence that were 
also differentially expressed in other microarray studies. The proportion of genes regulated 
concordantly in the chemostat model of persistence and in other microarray studies are 
represented by orange bars and yellow bars represent the percentage of genes discordantly 
regulated between the chemostat model of persistence and other published models. As a 
baseline the percentage of the genome deregulated in the chemostat model of persistence is 
shown (black bar). The percentage of the deregulated genes which are essential genes are also 
shown (grey bar). The data was obtained from Sassetti et al. (2003) (essential genes), Betts et 
al. (2002) (starvation), Voskuil et al. (2004) (standard stationary), Muttucumaru et al. 
(2004)(Wayne 1), Voskuil et al. (2004) (Wayne 2) and Schnappinger at at. (2003)
(macrophage).
The most interesting result of this comparative analysis was that 61 genes (Appendix 3) induced 
in M. tuberculosis after macrophage infection were also induced in BCG growing in the chemostat 
model of persistence (Schnappinger et al., 2003). This result provided evidence that the
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chemostat model recapitulates some of the conditions experienced by M. tuberculosis whilst 
growing inside the host.
6.3.2. Correlation between changes in mRNA and protein 
expression
Proteomic analysis by 2DE MS identified 10 proteins that were differentiaily expressed in the 
chemostat model of persistence (Table 6.2). The response measured at the mRNA ievel was in 
accord with the response at the protein level for three of these proteins. HspX, Rv2623 and 
Rv2626c all showed significantly increased relative abundance at the protein and mRNA ievels. 
The E3 component of the pyruvate dehydrogenase complex encoded by Ipd showed an 
increased abundance at the protein levei, while showing a smali but significant decrease at the 
mRNA levei. The remainder of the genes all showed increased abundance at the protein level but 
no significant changes at the mRNA level. The discrepancy between the mRNA and protein 
levels for these genes is of interest and may indicate that these proteins are post-translationally 
modified or regulated. One possible post-translational mechanism of regulation is the degradation 
of proteins by proteases. Interestingly genes encoding the proteases CIpX and HtrA were shown 
to be downregulated in the slow growth rate ceiis. These results provided further evidence that 
the measurement of mRNA response is not predictive of the corresponding protein response and 
validates the idea that information is required at several levels to accurately describe the state of 
M. tuberculosis.
6.3.3. Isocitrate lyase and the giyoxylate shunt
The genes encoding isocitrate lyase remained unchanged during the slow growth rate. This result 
was unexpected as it was demonstrated that isocitrate lyase enzyme activities were upregulated 
under these growth conditions (chapter 4). In addition, an isocitrate lyase mutant strain of BCG 
was attenuated for survival at the slow growth rate suggesting that this enzyme plays an essential 
role in the survival of slowly growing BCG cells. A possible explanation of these results is that, in 
addition to transcriptional regulation, isocitrate lyase activity is also being regulated allosterically. 
The control of isocitrate lyase activity and glyoxyiate pathway activation has not been fully 
elucidated in M. tuberculosis but in £  coli allosteric inactivation of the isocitrate lyase competitor 
isocitrate dehydrogenase (iCDH) channeis the metabolic flow into the glyoxyiate shunt (Cozzone, 
1998). As ICDH plays an important role in glyoxyiate shunt activation it would be useful to
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investigate this enzymes activities in carbon-limited cultures of M. bovis BCG. The gene glcB 
encoding the second glyoxyiate shunt enzyme malate synthase was downregulated at the slow 
growth rate and was also downregulated in M tuberculosis cells starved in PBS (Betts et al., 
2002). The significance of this is difficult to interpret as malate synthase and isocitrate lyase 
activities have been shown to be regulated differentially and independently from one another in 
M. tuberculosis (Wayne and Lin, 1982; Florczyk et al., 2001; Smith et al., 2003).
Table 6.2. Correlation between mRNA level and protein 
levels in the chemostat model of TB persistence. The up 
or down regulation of proteins and genes In the slow 
growth rate (D = 0.01 h'^ ) as compared with the faster 
growth rate (D = 0.03 h'^ ) is indicated. NC represents 
genes that were not differentially expressed In the model.
Protein Name Rv no Change in expression
Protein mRNA
GcpE Rv2868c Down NC
AdhB Rv0761c Down 2.05
SahH Rv3248c Up NO
Lpd Rv0462 Up 0.60
HspX Rv2031c Up 7.51
TB31.7 RV2623 Up 1.66
Rv2626c Up 4.10
Wag31 Rv2145c Up NC
EchAB Rv1070c Up NC
PurH Rv0957 Up NC
6.3.4. Translational apparatus
The down regulation of more than 50% of the ribosomal proteins during slow growth of M. bovis 
BCG further demonstrated growth rate dependent control of ribosome number and was also 
observed in other models of persistence (Betts et al., 2002; Voskuil et al., 2004). Ribosomal 
proteins function in stabilising rRNA and facilitating the catalytic roles of ribosomes and therefore 
are crucial to the translational apparatus. Three ribosomal protein genes, rpsN, rpmS and rpmG 
were significantly upregulated at the slow growth rate. These genes are arranged on an operon
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and separated from the majority of ribosomal genes. This pattern of gene expression was not 
observed in either starvation or hypoxic models of persistence but was demonstrated during the 
stationary phase of growth (Betts etaL, 2002; Muttucumaru etaL, 2004; Voskuil etaL, 2004). 
Evidence suggests that the RpmB and RpmG proteins of E. coli have related roles in ribosome 
synthesis and function (Maguire and Wild, 1997). Ribosome synthesis is defective and not very 
weil coordinated when these proteins are absent from E. coli (Maguire and Wild, 1997). The fact 
that these ribosomal proteins are regulated independently from their other family members in 
slow growing M. bovis BCG indicates that these proteins may also have a related and specialised 
function in M. tuberculosis. Voskuil etal. (2004) speculated that RpsN, RpmB and RpmG may 
increase ribosomal fidelity but further work is required to establish the function of these proteins.
A number of other genes involved in translational processes were down regulated in the slow 
growing cells. The ribosomal recycling factor and elongation factor G are responsible for 
dissembling the post termination complex and recycling the ribosome. The down regulation of 
these genes during slow growth rate is probably just a reflection of a general reduction in protein 
synthesis.
RecA is an inducer of the error prone DNA repair mechanism (SOS response) and is a key player 
in homomologous recombination. RecA, LexA and Ssb are all involved in this response and the 
genes encoding these proteins were down regulated in the slow growth BCG cells and therefore 
the SOS response does not appear to contribute to the survival of slow growing carbon-limited 
cells (Rand et al., 2003). Studies using reck deleted strains of M. bovis BCG demonstrated that 
the SOS response was not required for survival in Wayne’s modei of persistence and was also 
unnecessary for the establishment and maintenance of TB infection In vivo (Sander et al., 2001). 
It was demonstrated that the RecA system is not the only DNA repair mechanism operative in 
M. tuberculosis (Rand et al., 2003). DNA microarray experiments identified a number of genes 
responsive to DNA damage in a recA knockout strain of M tuberculosis. Of the genes identified, 
three were also identified on the gene list presented here as being down regulated in the slow 
growth rate cells (Rand et al., 2003). These results suggest that the fast growth rate chemostat 
provided a more DNA damaging environment than the slow growth rate chemostat. However, 
several genes involved in protecting DNA were also upregulated in the slow growth rate cells. 
These included d/np and three genes containing the universal stress protein (Usp) domain 
(Rv2623, Rv2624c and Rv3134c). Usp proteins of E. coli have been implicated in protecting DNA
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from UV irradiation and mytomycin 0 and DinP is a DNA damage inducible protein (Gustavsson 
et ai, 2002). In addition, the exonuclease V and recC were also upregulated in the slow growing 
cells. A recC homologue of M. marinum was activated specifically in host granulomas of 
chronically infected frogs (Ramakrishnan et a/., 2000).
Expression levels of the principal sigma factor, s/gA, were significantly down regulated in the slow 
growth cells. SigA has recently been shown to influence the intracellular growth rate of 
iW. tuberculosis (Wu etal., 2004). Transformants overexpressing s/gA grew more rapidly in 
macrophages and mice as compared with control strains. In contrast, transformants expressing 
reduced levels of s/gA due to the expression of antisense s/gA grew more slowly (Wu et ai,
2004). The results stress the importance of SigA during the acute phase of TB. In vitro sigA has 
been reported as growth rate independent and this has resulted in a number of researchers using 
sigA as a control in QRT PCR experiments (Hu and Coates, 1999b; Boshoff etal., 2003;
Downing et al., 2004). The results presented here confirm the in vivo data that sigA is correlated 
to growth rate and is therefore an unsuitable control for QRT PCR experiments.
The sigJ sigma factor was also upregulated during the slow growth rate. Previous researchers 
have demonstrated increased s/gJ expression of M. tuberculosis during the late stationary phase 
of growth (Hu and Coates, 2001). Deleting this gene, however, has no effect on the survivai of 
M. tuberculosis in vivo (Hu et ai., 2004; Manganelli et al., 2004).
6.3.5. T ransport systems
Thirty five genes involved in membrane transport were found to have differential expression in 
BCG cells grown in the chemostat model of persistence. The slow growth rate significantly 
induced the transcript levels of a number of genes that encode membrane transporters for 
carbon, metal ions, nitrogen and iron containing metabolites. These included nine genes involved 
in ABC (ATP- binding cassettes) transporter systems (Fig. 6.3). ABC transporters are multi 
subunit primary pumps that transport molecules across biological cytoplasmic membranes in an 
ATP dependent fashion (Braibant ef al., 2000). They function as either exporters or importers of 
various substrates and consist of two hydrophobic membrane-spanning domains (MSD) and two 
cytoplasmic nucleotide-binding domains (NBD). ABC importers are also associated with a high 
affinity extra-cytoplasmic substrate binding proteins (SBP). Genes encoding the membrane
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Figure 6.3. ABC transporters deregulated in the chemostat model of TB persistence. Genes in 
red are significantly up-regulated in slow growing cells, genes in green are significantly down­
regulated and genes in blue are unchanged.
transporter proteins that putatively facilitate the uptake of glycerol (UgpE), sugars (UspA and Rv 
2039c), peptides (DppB and DppC), phosphate (PstC) and glycine/betaine (ProW and ProZ) were 
significantly upregulated in the slow growth rate. One of these genes, proZ, was recently shown 
by microarray analysis to be regulated only whilst M. tuberculosis was growing in BALB/c mice 
and not during growth in broth or in SCID mice indicating that this gene could contribute to 
mycobacterial survival in vivo (Talaat et ai, 2004).
The putative SBP for iron (III) dicitrate import was also upregulated. FecB2 is an orphan SBP as 
genes encoding the associated MSD and NBD have not yet been found in the genome of 
M. tuberculosis (Braibant et al., 2000). FecB2 protein could assist iron transport by interacting 
with the M. tuberculosis iron chelating siderophores or maybe associated with some other aspect 
of controlling iron levels (Sutcliffe and Harrington, 2004).
The dipeptide transporter system genes induced in the slow growth rate was also induced during 
starvation in PBS. Peptides may provide alternative carbon sources for M. tuberculosis during 
carbon limitation. In addition to the ABC type glycine-betaine importers (proW and proZ) another 
importer of stress protectants was also induced {beP). Evidence suggests that slow growing
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bacteria require stress protectants and this is further supported by the induction of a trehalose 
biosynthesis gene, freY, in the slow growing BCG cells (Ferenci, 2001), Recent data has also 
demonstrated that trehalose production is essential for survival of M. smegmatis in the stationary 
phase of growth (Woodruff ef a/., 2004).
Other transporters induced by the slow growth rate included genes involved in the uptake of 
magnesium, potassium and copper ions. One of these genes, cfpV is induced when 
M. fi/berculosis is cultivated in macrophages and is also highly expressed in mice (Schnappinger 
ef al., 2003; Taiaat ef al., 2004). Overail the elevated expression of several of ABC type importer 
systems in response to the sub-optimal levels of nutrients in the chemostat illustrated the 
potential of M. tuberculosis to scavenge nutrients from the environment.
The only exporters induced at the slow growth rate were genes involved in drug efflux systems. 
These systems limit the access of antimicrobial agents to their targets and therefore may be very 
important in reducing the sensitivities of slow growing mycobacterial cells to antibiotics.
Only seven transporter genes were downregulated in slow growth rate cells. These included 
three genes encoding components of the putative phosphate importers and one component of 
the sulphate transporter. As the cultures were carbon-limited and sufficient for these two . 
substrates this resuit was unsurprising. Interestingiy M. tuberculosis strains unable to import 
sulphate are not attenuated for survival in mice indicating that methionine ieveis in the host 
provide sufficient suiphur for this pathogen (Wooff ef al., 2002). Sulphate replete conditions are 
therefore appropriate for modelling mycobacterial disease. In contrast, the presence of three 
putative organic phosphate importers in the genome of M. tuberculosis suggests that phosphate 
limitation may be a characteristic of the host environment (Braibant ef al., 2000). investigating the 
effects of phosphate iimitation at different growth rates would therefore be a useful extension of 
this work. Comparing the effects of phosphate and carbon limitation for both fast and siow 
growing celis would provide further information on the physiology of mycobacteria and would also 
identify the genes most important to nutrient limited growth.
Tig, a gene down regulated in slow growing cells, encodes a trigger factor invoived in exporting 
proteins. This gene is also down regulated in PBS starved cells and may reflect a general 
reduction in the export of proteins (Betts ef al., 2002). This could be a mechanism for limiting 
antigen presentation during persistence in the host. Down regulation of the T-cell antigen TB9.4
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and four genes of the ESAT-6 like family in slow growth cells supports this notion. The primordial 
ESAT-6 protein and its associated genes lie within the RDI region of the M. tuberculosis 
genome, a region absent in M. bovis BCG strains (Behr et al., 1999). Evidence suggests that the 
ESAT-6 family members were derived from gene duplications of the originai ESAT-6 gene cluster 
(Brodin etal., 2004). The ESAT-6 cluster of proteins are powerful immunogens and could 
potentially function as a secretion system (Fallen, 2002). Another gene repressed in the slow 
growing cells, secE, is also involved in secreting proteins from the cell.
6.3.6. Cell membrane genes
In addition to the transporter genes a further 26 membrane proteins were induced in the slow 
growth rate BCG cells. Membrane proteins are involved in the interactions between bacteria and 
their hosts and modification of the cell wall is likely to be an important survival strategy for 
M. tuberculosis. These genes included the lipoproteins IpqC, IpqJ and IpqK. The function of /pgJ 
is unknown. IpqC is an esterase involved in the metabolism of lipids and IpqK is a peptidase 
involved in peptidogiyan cross linking and also required for optimal growth in defined medium 
(Sutcliffe and Harrington, 2004). The function of the other upregulated membrane proteins is 
unknown but this data indicates that slow growth rate induced some remodelling of the cell 
envelope of M bovis BCG.
6.3.7. The DosR regulon
A puzzling feature of the data is the upregulation of 16 out of the 48 genes controlled by the DosR 
two component response regulator. The DosR system has been shown to be responsive to 
hypoxia in pathogenic and non-pathogenic mycobacteria (Mayuri etal., 2002; Park etal., 2003). 
More recently it was demonstrated that dosR is also induced by nitrogen oxide and a number of 
other stresses in M. tuberculosis (Voskuil et al., 2003; Kendall et al., 2004a). Only a smali subset 
of the regulon were upregulated in carbon-limited slow growing M. bovis BCG ceils. Interestingly 
cfosR was not significantly induced in this system although the gene Rv3134c, which is presumed 
to be a member of the same operon as dosR was upregulated 1.8 times. It is not uncommon for
the first gene in an operon to be upregulated to a greater extent than the downstream genes.
Possible explanations for the upregulation of members of the DosR regulon include a drop in 
oxygen due to high cell density of the culture. This seems unlikely as the oxygen levels in the
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vessel were monitored continuously and maintained at 70 to 100%. Three genes (frc/A, fdhD and 
/VarJ) encoding proteins involved in anaerobic respiration were upregulated in the slow growth 
rate, however the upregulation of frdk and several other anaerobic genes has been 
demonstrated previously under oxygen sufficient conditions (Hampshire etal., 2004).
Alternatively the environmental signals triggering the DosR regulon may be more complex than 
just hypoxia. Slow growth rates and nutrient limitation may also trigger genes of the DosR 
regulon. This notion is supported by recent experimental data. As M. tuberculosis entered the 
stationary phase of growth a subset of the DosR regulon were shown to be upregulated by DNA 
microarrays and two members of the regulon were also induced during 100 days of culture in a 
bioreactor (Hampshire et al., 2004; Voskuil et al., 2004). In addition, one member of the DosR 
regulon, HspX, was expressed in a DosR independent fashion by M. smegmatis growing under 
carbon starvation conditions (O'Toole etal., 2003). A third possibility Is that additional 
mechanisms are operative that control subsets of the DosR regulon.
6.3.8. Regulatory proteins
In order to adapt effectively M. tuberculosis must be able to coordinate the expression of 
appropriate proteins in response to changes in the environment. This regulation occurs mainly at 
the level of transcription and involves a complex array of different regulatory proteins including 
two-component regulators and serine threonine kinases. Four genes encoding the sensor part of 
two component regulators were upregulated in the slow growth rate BCG cells (Rv0260,
Rv0600c, Rv0601c and tcrX). Few functional clues are available for these genes. The expression 
of tcrX is induced after 110 hours in macrophage culture and a tcrX knock out strain is 
hypervirulent in mice (Parish et ai., 2003; Haydeland Clark-Curtiss, 2004). These results suggest 
an important role for tcrX gene in vivo. Three serine/threonine kinases pkn\, p/c/?J and p/cnK were 
also induced in siow growing celis. P/cnl may have a role in the regulation of cell division as it is 
located in close proximity to several genes that are potentially involved in this process (Av-Gay 
and Everett, 2000). P/cnJ is situated downstream of several transposon genes, two of which are 
also upregulated in the chemostat model. PknJ may therefore have a role in regulating the 
expression of these genes (Av-Gay and Everett, 2000).
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Two members of the whiB family of transcriptional regulators, whiB2 and whiBZ were also down 
regulated in the slow growth cells. WhiB3 mutants grow normally in the organs of mice during the 
acute or chronic stages of TB but the mice survive much longer than animals infected with 
wildtype strains (Steyn etal., 2002). The absence of whIBZ therefore prolonged the persistence 
of M. tuberculosis. WhiB2 is an essential gene of M. smegmatis and is thought to be involved in 
septum formation and cell division (Gomez and Bishai, 2000). Down regulation of WhiB2 as cells 
grow more slowly is therefore predictable. A number of other transcriptional regulators were also 
significantly altered in the two growth rates demonstrating that the change in growth rate 
triggered regulatory networks to moderate appropriate gene expression during slow growth.
6.3.9. PE/PPE family
Genes of the PE and PPE family were differentially regulated between the slow and fast growing 
chemostat celis. Four of the ten genes induced in slowly growing cells were also induced during 
the stationary phase of growth and in Wayne's model of non-replicating persistence (Voskuil et 
al., 2004).
6.3.10. Conserved hypotheticals
27% of the genes with an altered expression profile were conserved hypotheticals and this group 
included several members of the DosR regulon. Amongst the most interesting genes in this group 
were Rv3130c, Rv3088 and Rv3087 encoding enzymes with triacylgiyceroi synthase (tgs) activity 
(Daniel etal., 2004). Synthesis of triacylgiyceroi (TAG) may prove to be an important energy 
store during periods of nutritional stress and resource depletion and may therefore prove to be 
crucial to persisting M. tuberculosis in the host. TAG containing inclusion bodies have previously 
been identified in M. tuberculosis isolated from sputum and induction of TAG synthesis was also 
demonstrated in M. smegmatis during growth in nitrogen limiting conditions (Garton etal., 2002). 
The upregulation of these genes during slow growth in carbon-limited conditions suggests that 
M. bovis BCG may be sequestering triacylgiyceroi in preparation for more lenient times.
6.3.11. Lipid metabolism
Slow growth rate down regulated two genes (mas and fad2S) involved in the production of 
pthioceral dimycocerosate (PDIM), a call wall associated lipid found exclusively in pathogenic
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mycobacteria. These genes are upregulated in macrophages and are thought to be important in 
the virulence and host susceptibility of M. tuberculosis (Schnappinger et al., 2003). 
Downregulation of these genes was aiso reported in two other models of persistence and may 
reflect general changes in the cell wall composition, which occur in response to nutrient limitation 
and slow growth (Voskuil etal., 2004). Several other genes involved in iipid biosynthesis and 
modification were also upregulated during slow growth and these results therefore support the 
notion that siow growth induced modifications in the mycobacterial cell envelope.
Although fadA and fadA2 were down regulated in slow growing BCG cells, four genes involved in 
the R oxidation of lipids were induced. As these genes reflect a very small proportion of the 
lipolytic genes encoded by the genome of M. bovis BCG it is very difficult to assess the 
significance of this.
6.3.12. Intermediate metabolism
Making predictions about the metabolism of an organism from gene expression data is 
complicated by the fact that there is not necessarily a correlation between changes in gene 
expression and changes in protein levels, enzyme activities or metabolic fiux levels (ter Kuile and 
Westerhoff, 2001; Griffin et al., 2002). In the absence of any additional data only very tentative 
conclusions can therefore be made. 70 genes involved in intermediate metabolism and 
respiration were dereguiated in slow growth BCG cells. These genes were involved in a number 
of different pathways including glycolysis, pentose phosphate pathway and amino acid 
metabolism.
Several genes involved in the de novo biosynthesis of amino acids were induced in slow growth 
rate BCG cells. Three genes involved in glutamine biosynthesis [glnE, g/nA3 and aspB) were 
upregulated whilst the gene encoding glutamate dehydrogenase was down regulated. GlnE, 
regulates glutamine synthetase activity (Parish and Stoker, 2000a). As weil as being responsible 
for the incorporation of ammonia into glutamine in iow ammonia concentrations to make 
giutamate, glutamate synthetase is also involved in the formation of a poly-L-glutamate- 
glutamine structure in the cell walls of M. tuberculosis and other pathogenic mycobacteria and 
therefore is an attractive drug target (Parish and Stoker, 2000a).
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6.4. Conclusions
The transcriptional response of M bovis BCG to the changes in growth rate in carbon-limited 
chemostats was analysed in this study. In this system the BCG cells are actively growing at sub- 
optimal growth rates and in nutrient limited conditions. This system therefore differs from other/n 
vitro models of mycobacterial growth in that the bacteria were neither starving nor feasting and 
the emphasis was therefore on the transcriptional consequences of carbon limitation in actively 
growing but hungry cells. Without further experimentation generalised conclusions can only be 
speculative but there appears to be a common theme to help the cell survive nutrient limitation 
and slow growth rates. A generalised shift was observed in metabolism to scavenging nutrients, 
induction of transport systems, stimulating nutrient acquisition and protection of the cell by the 
production of stress osmoprotectants such as trehalose accompanied by a more general 
reorganisation of the cell membrane.
There was some overlap between the transcriptional responses of M. bovis BCG in the 
chemostat model and the responses reported for M. tuberculosis in other models of persistence 
(Betts et ai., 2002; Voskuil et al., 2004). A group of 61 genes identified in this study as induced in 
the chemostat model of persistence were also induced after infection in an In vitro macrophage 
model indicating that some similarities exist between the environmental conditions in the 
chemostat and within the macrophage (Schnappinger et al., 2003). In addition, 20 essential 
genes have also been identified in this study as upregulated in the chemostat model. Targeting 
essential genes that also have a role in the persistence of M tuberculosis provides an attractive 
approach to treating TB. This research provides a unique insight into the transcriptional profile of 
mycobacteria whilst growing at reduced growth rates in carbon-limited chemostats and the results 
presented will serve as a useful set of data for other researchers investigating persistence in 
M. tuberculosis.
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7. Final discussion and future work
The control of TB is complicated by the amazing ability of M. tuberculosis to persist within the 
human host. Efforts to design interventions that specifically target latent TB are frustrated by a lack 
of information about the biology of mycobacterial persistence. This study describes a model 
system for studying mycobacterial persistence in vitro. The model permits the establishment of 
defined and reproducible conditions for investigating the effects of nutrient limitation and reduced 
growth rates on mycobacterial species. As these are conditions that may prevail in vivo this model 
is a valuable tool for investigating the events occurring during the prolonged residence of 
M. tuberculosis in the human host. The demonstration that the persistence factor isocitrate lyase 
was essential for survival in the model provided further justification for this approach to modelling 
TB disease. In addition, proteomic and transcriptomic profiling results generated useful information 
about the survival mechanisms available to M. tuberculosis.
This report describes the first chemostat model for mycobacterial persistence. The chemostat 
culture system provided allows the growth rate and environmental parameters such as 
temperature, pH and dissolved oxygen concentration to be monitored and controlled and therefore 
bacteria are cultivated in a defined environment. This has significant advantages over other models 
of mycobacterial persistence, which rely on batch cultivation. The fluctuating environment of batch- 
cultured bacteria complicates the interpretation of experiments and may affect transcriptomic and 
proteomic analysis. Two growth rates were investigated in the model to represent possible 
bacterial growth rates in vivo at different stages of infection. In contrast to other models of 
persistence this model assumes that during mycobacterial persistence there is ongoing replication 
during persistence. There is some data to support this (Pai etal., 2000; Chan etal., 2002; Hu et 
al., 2002).
Fats are likely to be the dominant carbon source for M. tuberculosis in vivo. Experiments using 
acetate instead of glycerol in the chemostat model will provide important new information about the 
physiology of this bacterium, which may relate directly to mycobacteria growing in the host. The 
physiology of M. bovis BCG at low pH could also be easily explored in the model. Mycobacteria are 
able to survive low pH in the phagosome and acidification may induce the expression of specific 
genes required for persistence in these conditions. The chemostat can be employed to maintain 
the pH of the culture medium from 8.2-6.3, the pH of the mycobacterium containing vacuole
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(Russell, 2001). Investigating the effects of alternative limiting substrates and growth rates is also a 
useful extension of this work. A comparison of the effects of carbon and phosphate limitation may 
provide valuable information about the adaptation of M. tuberculosis in vivo, whilst investigating the 
effects of very slow growth rates may provide further information about persistent mycobacteria.
The pathogenic mechanisms underlying mycobacterial persistence are still largely unknown, but it 
is likely that significant alterations in gene and protein expression underlie the disease process.
The application of proteomics to the study of mycobacteria in the chemostat model of persistence 
has made it possible to characterise alterations in protein expression in slow growing carbon- 
limited BCG. MALDI-TOF analysis identified a total of 10 proteins that were deregulated during the 
chemostat model of persistence, however the 2DE patterns comprised numerous additional 
variants, which await further evaluation. This study therefore illustrated the limited throughput of 
2DE technology. ICAT LC-MS provides an alternative more high throughput proteomic approach. 
Applying both 2DE and ICAT to the analysis of the proteome of M bovis BCG growing in the 
chemostat model of persistence would contribute to a more complete understanding of the model.
Of the 7 proteins identified as upregulated during the chemostat modei of persistence, the 
universal stress protein (Usp), Rv2623 is an attractive target for further work. In addition to 
Rv2623, genes encoding two other members of the Usp familiy (Rv2624c and Rv2623c) were also 
upregulated in slowly growing M. bovis BCG, emphasising the importance of this group of genes 
for survival in the model. Although the role of universal stress proteins in M. tuberculosis remains 
uncharacterised the UspA protein of £  coli has a function related to the growth arrest caused by 
starvation and may also be involved in environmental gene regulation (Freestone et ai, 1997). it is 
postulated that these proteins may play a specific role in the survival and gene regulation of 
mycobacteria during persistence. Investigating the phenotype of Usp knock out strains in the 
chemostat model of persistence and also in vivo will help test this hypothesis. In addition, 
microarray comparisons between wild type and knock out strains will identify any genes regulated 
by these proteins. This is also a useful strategy for determining the function of these proteins.
The mRNA expression data presented in this study demonstrated the capabilities of mycobacteria 
species to scavenge nutrients from the environment through elevating the expression of a number 
of transporter genes. Several of these genes were also induced by M tuberculosis in response to 
phagocytosis by macrophages suggesting that the mycobacterial macrophage is carbon-limited
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(Schnappinger et ai, 2003). In total there were 61 genes upregulated in the chemostat model of 
persistence that were also upregulated by M. tuberculosis growing in macrophages and 18 genes 
that were upregulated after 21 days of growth In a mouse model (Schnappinger et ai, 2003; Talaat 
et al., 2004). These genes are likely to be important to the intracellular survival of this pathogen 
during the late stages of disease and demonstrated that the chemostat model recapitulated some 
of the conditions experienced by M. tuberculosis in vivo. There was also some overlap between the 
transcriptomic profile of BCG in the chemostat model of persistence and other published in vitro 
models of persistence and therefore slow growth rates and carbon limitation are likely to be 
common features of all these models.
This study has further demonstrated the limitations of transcriptomics to predict the protein levels 
or functional activities within an organism. There was an incomplete correlation between mRNA 
levels and protein levels in the chemostat model. Several proteins that were predicted by two 
dimensional electrophoresis to be deregulated in the chemostat model either remained unchanged 
at the mRNA level or were discordantly regulated. In addition, at the mRNA level there was no 
significant change in the transcription of genes encoding the enzyme isocitrate lyase. However, at 
the functional level isocitrate lyase activity was increased and experiments using isocitrate lyase 
deletion strains demonstrated a crucial role for this enzyme in the survival of M. bovis BCG in the 
chemostat model. As isocitrate lyase is required for the persistence of M. tuberculosis in vivo this 
was an important finding of this study.
Measurements of mRNA and protein levels combined with enzymatic activities provided a more 
comprehensive analysis of the chemostat model of persistence that would not have been apparent 
from measurements at either the protein or mRNA level alone. A powerful adjuvant to this 
information is the measurement of metabolism wide fluxes, the fluxome. The fluxome is the 
functional output of the genome, transcriptome, proteome and metabolome (Fig. 7.1). Metabolic 
flux analysis (MFA), the most popular method for modelling the fluxome, allows metabolic 
phenotypes to be defined in terms of the carbon flux through a metabolic network using 
mathematical modelling and computer simulation. MFA will be very useful in dissecting the 
metabolic processes crucial to the development and maintenance of persistence of M. 
tuberculosis.
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Figure 7.1 Interactions within and between the “omes”.
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The preliminary steps in applying MFA to mycobacteria have been performed during this research 
project. A suitable system has been established and appropriate experimental measurements of 
the uptake of glycerol and ammonia, the production rates of carbon dioxide and the rate of 
synthesis of the key macromolecular pools external metabolites have been made. In collaboration 
with T. Hooper a provisional metabolic flux network for the central metabolism of M. tuberculosis 
was constructed using genome sequence annotation and complementary enzymatic and 
biochemical data. The measurements of inputs and outputs for the continuous culture model of TB 
persistence presented in this study were inserted into the metabolic flux model to solve the network 
(Fig. 7.2). The resultant metabolic flux map shows an estimate of the steady state rate at which 
each reaction in the flux occurs (Fig. 7.2). The MFA showed an increased flux of carbon through 
the glyoxylate shunt in the slow growing BCG cells compared to the faster growing cells and is 
therefore in agreement with the enzyme assay data for isocitrate lyase. These results, although 
provisional in their nature, provide an important foundation for future investigations using MFA. 
Isocitrate lyase activity is a rate-limiting step during persistence of mycobacteria. Using MFA to 
model the metabolism of the isocitrate lyase mutants generated during this study would help 
unravel the metabolic consequence of deleting this gene. This promises new Insights into the role 
of isocitrate lyase in metabolism and persistence.
It is an important goal of future work to test the growth and survival of M. tuberculosis in the 
chemostat model system. To facilitate these studies a biosafety level III containment facility 
incorporating a purpose built class III microbiological cabinet designed to house the bioreactor has 
been built. This provides a suitable environment for the continuous cultivation of M. tuberculosis in 
the chemostat model of TB persistence.
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Understanding how M. tuberculosis remains indolent in the host for decades is proving to be a 
formidable challenge to mycobacteriologists. The biology of persistence is poorly understood and 
this is stalling efforts to design therapeutic agents effective against iatent TB. It is iikeiy that a 
combination of techniques and approaches wili be necessary for the generation and interpretation 
of data to help scientists understand the processes involved in mycobacterial persistence. The 
results presented here describe a novel model for studying the persistence of mycobacteria in vitro 
and the mRNA and protein responses of M bovis BCG in this model. By integrating these data and 
data from other studies into mathematicai models understanding mycobacterial persistence will be 
a realisable achievement.
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Appendix 1. Summary of M. bovis BCG genes 
deregulated in the chemostat modei of TB 
persistence
Gene Name Rv No. Function Fold change p value
Virulence detoxification, adaptation
freY Rv1563c Trehalose biosynthesis 1.69 0.000194
jbcpB Rv1608c Antioxidant protein 0.59 0.000157
ephB Rv1938 Epoxide hydrolase 2.05 0.000018
hspX Rv2031c Alpha-crystallin 7.51 0.000110
Rv3269 Rv3269 Heat shock protein 0.32 0.000337
Rv3661 Rv3661 CHP (regulation of cellular 0.58 0.000080
differentiation)ProZ Rv3756c ABC transporter of glycine/proline 2.60 0.000022
(osmoprotectant)
proW Rv3757c ABC transporter of glycine/proline 1.80 0.000122
(osmoprotectant)sodA Rv3846 Superoxide dismutase 0.47 0.000000
groBS Rv3418c 10 kDa chaperone 0.43 0.000199
Lipid metabolism
fadA2 Rv0243 Acetyl-coA acyl transferase (lipid 0.56 0.000002
degradation)fadE5 Rv0244c Acyl-CoA dehydrogenase (lipid 0.26 0.000228
degradation)umaA^ Rv0469 Mycolic acid methyl transferase 0.51 0.000012
(mycolic acid modification or
biosynthesis) •PimB Rv0557 LAM biosynthesis 0.53 0.000266
fadA Rv0859 Acyl-coA thiolase (lipid 0.55 0.000007
degradation)pks3 Rv1180 Polyketide metabolism (important 1.63 0.000033
for stationary phase survival)
p/sBI Rv1551 Acyl transferase (Lipid metabolism) 1.64 0.000146
Rv1722 Rv1722 Probable carboxylase (lipid 1.85 0.000310
metabolism)
Rv1867 Rv1867 Acyl coA synthase (lipid 1.61 0.000042
degradation)mas Rv2940c Mycocerosic acid synthase (lipid 0.62 0.000092
synthesis)
fadD28 Rv2941 Pthioceral dimycocerosate 0.53 . 0.000499
biosynthesis-transfer of
mycoserosic acid from mas
fadD29 Rv2950c Acyl-coA synthase (polyketide or 0.52 0.000115
fatty acid synthesis)
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Gene Name Rv No. Function Fold change p value
fadE22 Rv3061c Acyl coA dehydrogenase (lipid 
degradation)
2.36 0.000031
AgpS Rv3107c Ether lipid biosynthesis 1.85 0.000063
acrAI Rv3391 Multifunctional enzyme with acyl 
coA reductase
1.67 0.000172
idsAI Rv3398c Biosynthesis of membrane ether- 
linked lipids
1.68 0.000444
fadETl Rv3505 Acyl coA dehydrogenase (Lipid 
degradation)
1.93 0.000281
fadE31 Rv3562 Acyl-coA dehydrogenase (lipid 
degradation)
1.80 0.000005
fadE33 Rv3564 
Information pathways
Acyl-coA dehydrogenase, (lipid 
degradation)
1.96 0.000101
Pp/A Rv0009 Peptidyl-prolyl cis-trans isomerase 
(accelerates folding of proteins)
0.42 0.000248
PpsF Rv0053 308 ribosomal protein 86 0.49 0.000004
Ssb Rv0054 8ingle strand binding protein (DNA 
recombination and repair)
0.60 0.000397
RpsR Rv0055 308 ribosomal protein 818 0.44 0.000089
rpl\ Rv0056 508 ribosomal protein L9 0.44 0.000003
def Rv0429c Polypeptide deformylase 0.62 0.000440
recC Rv0631c Exonuclease V 2.20 0.000469
nusG Rv0639 Transcription antitermination protein 0.39 0.000398
rplK Rv0640 508 ribosomal protein L11 0.36 0.000070
rplA Rv0641 508 ribosomal protein L1 0.41 0.000134
rpsL Rv0682 308 ribosomal protein 812 0.49 0.000755
rpsG RV0683 Ribosomal protein 87 0.57 0.000087
fusA Rv0684 Elongation factor G 0.62 0.000674
rpsJ Rv0700 308 ribosomal protein 810 0.48 0.000193
rpIC Rv0701 508 ribosomal protein L3 0.44 0.000006
rpID Rv0702 508 ribosomal protein L4 0.44 0.000020
rpl\N Rv0703 508 ribosomal protein L23 0.44 0.000007
rpsS RV0705 308 ribosomal protein 819 0.40 0.000238
rpmC Rv0709 508 ribosomal protein L29 0.43 0.000071
rplM Rv0714 508 ribosomal protein LI 4 0.42 0.000001
rplX Rv0715 508 ribosomal protein L24 0.30 0.000009
rplE Rv0716 508 ribosomal protein L5 0.42 0.000263
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rpsH Rv0718 308 ribosomal protein 88 0.36 0.000153
rp/F Rv0719 508 ribosomal protein L6 0.38 0.000069
rp/R Rv0720 508 ribosomal protein L18 0.47 0.000120
rpIO Rv0723 508 ribosomal protein LI 5 0.41 0.000033
greA Rv1080c Transcription elongation factor G 0.48 0.000015
rho Rv1297 Transcription termination factor rho 0.44 0.000226
rpmE Rv1298 508 ribosomal protein L31 0.43 0.000227
rpoZ Rv1390 DNA directed RNA polymerase 0.51 0.000009
priA Rv1402 Primosome replication factor 2.01 0.000321
mpg Rv1688 Base excision repair 1.89 0.000046
rpsN2 Rv2056c Ribosomal protein 814 4.98 0.000011
rpmGI Rv2057c Ribosomal protein L33 3.07 0.000056
rpmB2 Rv2058c Ribosomal protein L28 4.89 0.000057
helY Rv2092c ATP dependent DNA helicase 1.68 0.000025
SigA Rv2703 Sigma factor A 0.38 0.000310
recA Rv2737c Regulation of excision repair 8 0 8 0.56 0.000614
rpsO Rv2785c 308 ribosomal protein 815 0.37 0.000001
InfB Rv2839c IF2 translation initiation factor 0.61 0.000014
frr Rv2882c Ribosomal recycling factor 0.56 0.000360
rpsP Rv2909c 308 ribosomal protein 816 0.39 0.000549
dInP RV3056 DNA metabolism and mutagenesis 1.85 0.000021
s/gJ Rv3328c Sigma factor J 1.83 0.000220
rpsi Rv3442c 308 ribosomal protein 89 0.52 0.000573
rp/M Rv3443c 508 ribosomal protein LI 3 0.38 0.000044
rpsD Rv3458c 308 ribosomal protein 84 0.48 0.000155
rpsM Rv3460c 30S ribosomal protein 813 0.42 0.000116
dnaZX Rv3721c DNA polymerase III 1.90 0.000065
hns Rv3852 HU-histone protein 0.48 0.000049
Cell-wall and cell processes
Rv0227c Rv0227c Membrane protein 0.60 0.000313
fecB2 Rv0265c ABC transport of iron 1.78 0.000028
Rv0290 Rv0290 Transmembrane protein 1.90 0.000048
Rv0292 Rv0292 Transmembrane protein 2.10 0.000059
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InB Rv0341 CHP 0.58 0.000132
Rv0342 Rv0342 CHP 0.52 0.000649
IpqJ Rv0344c Lipoprotein of unknown function 1.85 0.000629
Rv0359 Rv0359 Conserved integral membrane protein 1.89 0.000026
mgtE Rv0362 Magnesium transport 1.64 0.000364
IpqK Rv0399c Lipoprotein involved In cell wall 
metabolism
1.87 0.000671
Rv0446c Rv0446c Conserved transmembrane protein 1.94 0.000008
Rv0473 Rv0473 Conserved transmembrane protein 2.54 0.000014
Rv0559c Rv059c Secreted protein 0.51 0.000780
Rv0585c Rv0585c Conserved integral membrane protein 1.68 0.000552
Rv0621 Rv0621 Function unknown, possible membrane 
protein
2.15 0.000285
Rv0622 Rv0622 Function unknown, possible membrane 
protein
1.86 0.000029
secEl Rv0638 SecE preprotein translocase 0.39 0.000318
mmpS5 Rv0677c Conserved small membrane protein 0.52 0.000193
Rv0736 Rv0736 Probable conserved membrane protein 1.68 0.000015
IpqS Rv0847 Lipoprotein of unknown function 0.31 0.000040
ctpE Rv0908 Metal cation transporter 1.73 0.000108
betP Rv0917 Glycine/betaine transport 1.97 0.000064
phoS2 Rv0928 ABC transport component of phosphate 
uptake
0.44 0.000000
pstSI Rv0932c ABC transport component of phosphate 
uptake
0.49 0.000074
pstB Rv0933 ABC transport component of phosphate 
uptake
0.59 0.000513
pstCI Rv0935 ABC transport component of phosphate 
uptake
2.00 0.000188
cfpV Rv0969 Metal cation transporter 1.70 0.000153
kdpB Rv1030 Pottassium transport 2.16 0.000008
esxl Rv1037c ESAT-6 like protein 0.41 0.000284
esxJ Rv1038c ESTAT-6 like protein 0.50 0.000094
Rv1139c Rv1139c Conserved membrane protein 1.77 0.000617
Rv1159 Rv1159 Conserved transmembrane protein. 1.77 0.000044
TB8.4 Rv1174c T-cell Antigen 0.55 0.000473
Rv1250 Rv1250 Drug export 1.89 0.000002
Rv1258c Rv1258c Macrolide transporter 2.08 0.000701
Rv1672c Rv1672c Membrane transport protein 1.75 0.000008
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Rv1733c Rv1733c Conserved transmembrane protein 2.35 0.000050
Rv1735c Rv1735c Hypothetical membrane protein 1.63 0.000001
naiK2 Rv1737c Nitrate/nitrite transporter 1.92 0.000019
esxM Rv1792 ESAT-6 like protein 0.44 0.000189
esxH Rv1793 ESAT-6 like protein 0.49 0.000270
Rv1999c Rv1999c Transporter of cationic amino acids 2.16 0.000069
Rv2039c Rv2039c ABC transport component of sugar 1.61 0.000006
Rv2053c Rv2053c Transmembrane protein 0.62 0.000058
Rv2075c Rv2075c Exported or envelope protein 1.79 0.000055
Rv2180c Rv2180c Conserved integral membrane protein 1.64 0.000254
uspA Rv2316 ABC transport component of sugar 2.42 0.000552
cysT Rv2399c ABC transport component of sulphut 
uptake
0.60 0.000719
tig Rv2462c Trigger factor involved in protein export 0.56 0.000004
Rv2477c Rv2477c ABC transport component of 
macrolides
0.56 0.000236
Rv2571c Rv2571c Transmembrane protein 1.84 0.000198
Rv2625c Rv2625c T ransmembrane protein 1.96 0.000076
Rv2687c Rv2687c ABC transport component of drugs 1.76 0.000097
ugpE Rv2834c ABC transport component of sugar 1.84 0.000003
Rv2968c Rv2968c Conserved integral membrane protein 1.62 0.000258
Rv3162c Rv3162c Integral membrane protein 1.84 0.000175
Rv3163c Rv3163c Unknown, conserved sectreted protein, 
down at low pH
1.67 0.000078
ctpC Rv3270 Metal cation transporter 0.43 0.000234
Rv3278c Rv3278c Conserved transmembrane protein 0.55 0.000600
IpqC Rv3298c Lipolytic esterase 2.62 0.000062
sug\ Rv3331 Sugar transporter 1.99 0.000288
Rv3335c Rv3335c Conserved integral membrane protein 1.61 0.000028
Rv3447c Rv3447c Conserved membrane protein 2.37 0.000028
ofppB Rv3665c ABC transport component of dipeptide 
uptake
1.84 0.000019
dppC Rv3664c ABC transport component of dipeptide 
uptake
1.66 0.000057
Rv3887c Rv3887c Conserved transmembrane protein 1.78 0.000734
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Insertion sequences and phages 
Rv0094c Rv0094c CHP 2.74 0.000168
Rv0797 Rv0797 Transposase for 181547 1.93 0.000200
Rv1041c Rv1041c Probable transposase 1.71 0.000629
Rv2085 Rv2085 CHP, similar to IS986 1.65 0.000687
Rv2086 Rv2086 CHP, homology to transposase 1.88 0.000083
Rv2812 Rv2812 Transposase for IS 1604 1.90 0.000142
Rv2961 Rv2961 Transposase 0.56 0.000109
Rv3467 Rv3467 13E12 repeat family protein 2.78 0.000058
PE and PPE
PE
proteins
RvOieOc PE protein 2.51 0.000013
PPE3 Rv0280 PE/PPE protein 5.24 0.000004
PE PGRSÔ Rv0297 PE/PGRS protein 0.46 0.000171
PPE11 Rv0453 PPE protein 1.99 0.000002
PEPGPS17 Rv0978c PE protein 1.80 0.000395
PPE20 Rv1387 PPE protein 2.00 0.000022
PPE21 Rv1548c PE protein 0.62 0.000449
PEI 9 Rv1791 PE protein 0.47 0.000087
PE PGRS46 Rv2634c PE/PGRS protein 1.65 0.000280
PPE48 Rv3022c PPE protein 1.85 0.000402
PE_PEGRSe
3
1 Rv3097c Triacylglycerol lipase 1.76 0.000407
PE^ PGRSAQ Rv3344c PE/PGRS protein 1.69 0.000622
PE34 Rv3746c PE protein 1.89 0.000254
Intermediary metabolism and respiration
hycD Rv0084 Formate hydrogenylase 1.74 0.000689
pntAA Rv0155 NADP transhydrogenase 1.63 0.000213
bgIS Rv0186 Beta-glucosidase (degradation of 0.50 0.000429
cobQI Rv0255c
glucose)
Cobalamin biosynthesis 1.81 0.000003
purT Rv0389 Purine biosynthesis 2.21 0.000607
metZ Rv0391 Methionine biosynthesis 1.81 0.000157
Rv0457c Rv0457c Function unknown, hydrolyses peptides 1.70 0.000497
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Ipd RV0462 Probable dihydrolipoamide 
dehydrogenase
0.60 0.000359
hemD Rv0511 Uroporphyrin-Ill c-methyltransferase 
(biosynthesis of cobalamin)
0.49 0.000099
menA Rv0534c Menaquinone biosynthesis 1.70 0.000657
Rv0575c Rv0575c Oxireductase 2.01 0.000011
Rv0696 RV0696 Membrane sugar transferase 1.93 0.000246
Rv0697 Rv0697 Possible dehydrogenase 2.44 0.000757
xy/B Rv0729 Xylulose kinase 1.68 0.000071
pip Rv0840c Poline iminopeptidase 1.85 0.000003
Rv0843 Rv0843 Probable dehydrogenase 1.83 0.000165
moaC2 RVÛ864 MIybdoterin (molybdenum cofactor 
biosynthesis)
0.61 0.000022
fprB Rv0886 Adrenodoxin reductase 1.80 0.000076
Rv0939 Rv0939 Function unknown 1.94 0.000102
prsA Rv1017c Ribose phosphate pyrophosphate 
kinase (involved in various biosynthetic 
pathways such as formation of purines 
and pyrimidines)
0.56 0.000055
narj Rv1163 Nitrate reductase 2.09 0.000640
fdxC Rv1177 Ferredoxin 0.52 0.000265
rocA Rv1187 Arginase pathway 1.83 0.000330
Rv1188 Rv1188 Proline dehydrogenase (oxidises 
proline for a possible carbon or nitrogen 
source)
2.17 0.000001
htrA Rv1223 Serine protease 0.50 0.000125
amiBl Rv1263 Probable amidase 1.66 0.000297
Rv1333 Rv1333 Probable hydrolase 1.66 0.000011
metK Rv1392 S-adenosyl methionine synthetase 
(activated methyl cycle)
0.54 0.000054
Rv1432 Rv1432 Probable dehydrogenase 1.96 0.000011
tkt Rv1449c transketolase, provides the link 
between glycolytis and PP pathway, 
essential, differentailly expressed in 
host cells
0.61 0.000694
adh Rv1530 Alcohol dehydrogenase. 2.05 0.000132
frdA Rv1552 Fumurate reductase (anaerobic 
respiration)
2.20 0.000469
trpC R v ie il Tryptophan biosynthesis 0.52 0.000069
cydB Rv1622c Cytochrome D ubiquinol oxidase 2.07 0.000026
moeX Rv1681 Molybdomoptenum cofactor 
biosynthesis
1.72 0.000017
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Rv1703c Rvl703c Catechol-o-methyltransferase 0.58 0.000202
glcB Rvl837c Malate synthase 0.49 0.000589
Rvl856c Rvl856c Probable oxireductase 0.52 0.000716
gInAZ R v l878 Glutamate synthetase 1.77 0.000021
R v l936 R v l936 Monooxygenase 1.76 0.000316
Rvl 937 R v l937 Oxygenase 1.72 0.000570
cobL Rv2072c Cobalamin biosynthesis 1.88 0.000285
pepE Rv2089c Hydolysis of peptide bonds 1.61 0.000000
prcA Rv2109c Proteosome 0.57 0.000308
gInE Rv2221c Regulation of glutamine synthetase 
activity
1.65 0.000122
aceE Rv2241 E l of pyruvate dehydrogenase 0.58 0.000536
rocDI Rv2322c Arginine metabolism 1.66 0.000274
hemH Rv2388c Porphryn biosynthesis 1.77 0.000369
cIpX Rv2457c Protease, chaperone 0.62 0.000661
gdh Rv2476c Glutamate dehydrogenase 0.62 0.000058
ribf Rv2786c FAD synthetase (riboflavin 
biosynthesis)
2.03 0.000045
fdhD Rv2899c Neccessary for formate dehydrogensae 
activity
2.15 0.000442
thL Rv2977c Thiamine monophosphate kinase 2.14 0.000728
fixA Rv3029c Electron transfer flavoprotein 0.57 0.000016
Rv3032 Rv3032 Possible transferase 1.73 0.000390
Rv3057c Rv3057c Alcohol dehydrogenase/reductase 
(polyketide synthesis)
1.99 0.000009
Rv3174 Rv3174 Short chain dehydrogenase/reductase 1.62 0.000321
pcd Rv3293 Involved in alpha aminoapididtic acid 
biosynthesis
2.07 0.000401
pmmB Rv3308 Phosphomannose mutase 1.72 0.000064
odd Rv3315c Cytidine deaminase (scavenges 
citidine)
1.62 0.000206
Rv3352c Rv3352c Probable oxireducase 1.95 0.000636
gadB Rv3432c Glutamate decarboxylase 1.97 0.000034
rmlB Rv3464 dTDP-glucose 4,6-dehydratase 
(rhamose biosynthesis)
0.50 0.000077
rmIC Rv3465 Involved in rhamnose biosynthesis 0.56 0.000204
Rv3552 Rv3552 Subunit of a CoA transferase 1.76 0.000000
aspB Rv3565 Glutamate biosynthesis 1.85 0.000016
Rv3700c Rv3700c CHP (cell metabolism) 1.77 0.000717
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gshA Rv3704c Glutathionine biosynthesis 1.90 0.000412
Rv3729 Rv3729 Probable transferase 1.81 0.000028
Rv3829c 
Proteins of
Rv3829c 
unknown function
Dehydrogenase 1.71 0.000041
R v l742 
Regulatory
R v l742 
proteins
HP 2.30 0.000074
RVÛ196 Rv0196 Involved in transcriptional mechanisms 1.86 0.000052
Rv0260c Rv0260c Response regulator of a two 
component regulator
1.72 0.000176
RV0348 Rv0348 Involved in transcriptional mechanisms 0.52 0.000091
Rv0474 Rv0474 Transcriptional regulator 0.50 0.000396
RvOeOOc Rv0600c Sensor part of a two component 
regulator
2.47 0.000003
Rvoeoic Rv0601c Sensor part of a two component 
regulator
1.98 0.000032
Rv0737 Rv0737 Transcriptional regulatory protein 1.67 0.000322
Rvl 019 R v l019 Transcriptional regulatory protein 1.62 0.000047
R v l626 R v l626 Sensor part of a two component 
regulator
0.55 0.000737
R v l719 R v l719 Transcriptional regulatory protein 1.98 0.000018
pknJ Rv2088 Serine/throenine protein kinase 
transcriptional regulation
1.62 0.000000
/exA Rv2720 Involved in the repression of SOS 
repair of DNA
0.57 0.000007
pkn\ Rv2914c Seine/thronine protein kinase (cell 
division and differentiation)
1.76 0.000344
Rv2989 Rv2989 Transcriptional regulatory protein 0.60 0.000011
pknK Rv3080c Serine/throenine protein kinase 
transcriptional regulation
2.17 0.000135
moxRd Rv3164c Regulates methonol dehydrogenase 1.66 0.000028
whB2 Rv3260c Transcriptional regulatory protein 0.59 0.000291
whBZ Rv3416 Transcriptional mechanism 0.60 0.000253
Rv3575c Rv3575c Transcriptional regulatory protein 2.32 0.000108
tcrX Rv3765c Sensor part of a two component 
regulator
2.49 0.000244
menG Rv3853 Binds to RNase E and prevents 
endonucleolytic cleavage
0.57 0.000027
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Conserved hypothetical proteins
Rv0019c Rv0019c CHP 0.54 0.000301
Rv0047c Rv0047c CHP 0.62 0.000000
Rv0079 Rv0079 HP 2.42 0.000049
RvOOBO Rv0080 CHP 2.13 0.000005
Rv0106 Rv0106 CHP 5.66 0.000112
Rv0177 Rv0177 MCE associated protein 0.59 0.000404
Rv0239 Rv0239 CHP 0.48 0.000014
Rv0241c Rv0241c CHP 0.51 0.000198
Rv0259c Rv0259c CHP 2.00 0.000055
Rv0264c Rv0264c CHP 1.66 0.000097
Rv0272c Rv0272c HP 1.64 0.000023
Rv0329c Rv0329c CHP 1.77 0.000287
Rv0395 Rv0395 HP 2.29 0.000683
Rv0493c Rv0493c CHP 1.78 0.000144
Rv0498 Rv0498 CHP 2.18 0.000098
Rv0552 Rv0552 CHP 1.65 0.000003
Rv0572c Rv0572c HP 1.68 0.000085
Rv0574c Rv0574c CHP 2.30 0.000485
Rv0635 Rv0635 CHP 0.60 0.000012
Rv0636 Rv0636 CHP 0.51 0.000363
Rv0699 Rv0699 HP 1.70 0.000001
Rv0762c Rv0762c CHP 1.61 0.000664
Rv0784 Rv0784 CHP 0.47 0.000003
Rv0836c Rv0836c HP 2.31 0.000023
Rv0837c Rv0837c CHP 1.71 0.000006
Rv0863 Rv0863 CHP 0.49 0.000270
Rv0991c Rv0991c CHP 0.51 0.000194
Rvl051c Rvl051c CHP 1.78 0.000221
Rvl109c Rvl109c CHP 0.62 0.000129
R v l156 R v l156 CHP, 0.51 0.000020
Rvl186c Rvl186c CHP 1.89 0.000027
R v l208 R v l208 CHP 1.65 0.000082
R v l429 R vl429 CHP 1.62 0.000137
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Gene Name Rv No. Function Fold change p value
R vl455 R vl455 CHP 1.92 0.000651
R vl682 R vl682 HP 1.88 0.000070
R vl709 R v l709 CHP 0.53 0.000376
Rvl725c Rvl725c CHP 2.26 0.000039
R v l794 R v l794 CHP 0.49 0.000726
R v l887 R v l887 HP 0.59 0.000560
Rvl894c Rvl894c CHP 0.61 0.000277
Rvl930c Rvl930c CHP 1.91 0.000439
Rv2050 Rv2050 CHP 0.45 0.000078
Rv2059 RV2059 CHP 2.43 0.000011
Rv2166c Rv2166c CHP 0.54 0.000011
Rv2182c Rv2182c Transfer of fatty acyl groups 0.60 0.000232
TB 16.3 Rv2185c CHP 0.58 0.000060
Rv2300c Rv2300c CHP 1.62 0.000577
Rv2319c Rv2319c HP 2.75 0.000312
Rv2327 Rv2327 CHP 0.58 0.000201
Rv2336 Rv2336 CHP (maybe involved in virulence) 1.91 0.000057
Rv2407 Rv2407 CHP 1.81 0.000082
Rv2414c Rv2414c CHP 1.99 0.000611
Rv2415c Rv2415c CHP 2.33 0.000013
Rv2425c Rv2425c CHP 1.82 0.000089
Rv2426c Rv2426c CHP 1.64 0.000051
Rv2432c Rv2432c HP 1.65 0.000048
Rv2529 Rv2529 HP 1.68 0.000427
Rv2566 Rv2566 HP 1.64 0.000300
Rv2569c Rv2569c CHP 1.82 0.000018
TB31.7 Rv2623 ATP-bindIng protein 1.66 0.000301
Rv2624c Rv2624c CHP 2.35 0.000094
Rv2626c Rv2626c CHP 4.10 0.000312
Rv2627c Rv2627c CHP 2.43 0.000108
35kd ag Rv2744c 35-kda antigen 0.49 0.000501
Rv2759c Rv2759c CHP 1.76 0.000511
Rv2797c Rv2797c CHP 2.02 0.000277
Rv2923c Rv2923c CHP 2.09 0.000656
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Gene Name Rv No. Function Fold change p value
Rv2949c Rv2949c CHP 0.61 0.000211
Rv2990c Rv2990c HP 2.52 0.000507
Rv3040c Rv3040c CHP 1.67 0.000023
Rv3079c Rv3079c CHP 2.07 0.000055
Rv3087 Rv3087 CHP 2.00 0.000023
Rv3088 Rv3088 CHP 1.63 0.000161
Rv3128c Rv3128c CHP 2.16 0.000124
Rv3130c Rv3130c CHP 2.43 0.000052
Rv3134c Rv3134c CHP 1.83 0.000194
Rv3165c Rv3165c HP 2.19 0.000004
Rv3166c Rv3166c CHP 1.74 0.000497
Rv3188 Rv3168 CHP 1.66 0.000522
Rv3172c Rv3172c HP 0.59 0.000705
Rv3178 Rv3178 CHP 1.91 0.000001
Rv3195 Rv3195 CHP 1.89 0.000037
Rv3284 Rv3285 CHP
Rv3446c Rv3446c HP 2.17 0.000053
Rv3529c Rv3529c CHP 1.89 0.000119
Rv3553 Rv3553 CHP 1.70 0.000017
Rv3577 Rv3577 CHP 1.68 0.000345
TB11.2 Rv3592 CHP 0.56 0.000316
Rv3703c Rv3703c CHP 2.33 0.000132
Rv3770c Rv3770c HP 1.71 0.000000
Rv3839 Rv3839 CHP 2.41 0.000003
RV3845 RV3845 HP 1.62 0.000020
Rv3866 RV3866 CHP (ABC transporter family signature) 0.62 0.000135
Rv3867 Rv3867 CHP 0.51 0.000006
Rv3903c Rv3903c CHP 2.05 0.000360
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Appendix 2. Summary of essential genes Induced In the 
chemostat model of TB persistence
Gene Name Rv No. Function
Rv0290 Rv0290 Transmembrane protein
Rv0292 RVÜ292 Transmembrane protein
/pqK Rv0399c Lipoprotein involved in cell wall metabolism
Rv0697 Rv0697 Possible dehydrogenase
RV0736 Rv0736 Probable conserved membrane protein
Rv1186c Rv1186c CHP
rocA Rv1187 Arginase pathway
Rvl 188 R v l188 Proline dehydrogenase (oxidises proline for a possible carbon or 
nitrogen source)
R v l208 R v l208 CHP
cydB Rvl622c Cytochrome D ubiquinol oxidase
gInE Rv2221c Regulation of glutamine synthetase activity
Rv2319c Rv2319c HP
Rv2623 Rv2623 ATP-binding protein
ribP Rv2786c FAD synthetase (riboflavin biosynthesis)
Rv2812 Rv2812 Transposase for 181604
Rv2968c Rv2968c Conserved integral membrane protein
thiL Rv2977c Thiamine monophosphate kinase
Rv3032 Rv3032 Possible transferase
idsA Rv3398c Biosynthesis of membrane ether- linked lipids
fadEZZ Rv3564 Acyl-coA dehydrogenase, (lipid degradation)
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Appendix 3. Summary of genes induced in macrophages 
and in the chemostat model of TB 
persistence
Gene Name Rv No. Function
Rv0079 Rv0079 HP
RvOOBO RvOOBO CHP
hycD Rv0084 Formate hydrogenylase
Rv0094c Rv0094c CHP
Rv0196 Rv0196 Involved in transcriptional mechanisms
Rv0260c Rv0260c Response regulator of a two component regulator
Rv0446c Rv0446c Conserved transmembrane protein
Rv0473 Rv0473 Conserved transmembrane protein
Rv0572c Rv0572c HP
Rv0574c Rv0574c CHP
Rv0575c Rv0575c Oxireductase
Rv0797 Rv0797 Transposase for IS1547
Rv0836c Rv0836c HP
Rv0837c Rv0837c CHP
Rv0843 Rv0843 Probable dehydrogenase
fpiB Rv0886 Adrenodoxin reductase
betP Rv0917 Glycine/betaine transport
Rvl186c Rvl186c CHP
rocA 
R v l188 
Rv1258c
R v l187 
R v l188 
Rvl258c
Arginase pathway
Proline dehydrogenase (oxidises proline for a possible carbon or 
nitrogen source)
Macrolide transporter
frdA R v l552 Fumurate reductase (anaerobic respiration)
Rvl725c Rvl725c CHP
Rvl733c Rvl733c Conserved transmembrane protein
Rvl735c Rvl735c Hypothetical membrane protein
narK2 Rvl737c Nitrate/nitrite transporter
Rvl999c Rvl999c Transporter of cationic amino acids
Rv2059 Rv2059 CHP
uspA Rv2316 ABC transport component of sugar
rocDI Rv2322c Arginine metabolism
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Gene Name Rv No. Function
hemH Rv2388c Porphryn biosynthesis
Rv2414c Rv2414c CHP
RV2425C Rv2425c CHP
RV2566 Rv2566 HP
Rv2624c Rv2624c CHP
Rv2625c Rv2625c Transmembrane protein
Rv2626c Rv2626c CHP
Rv2627c Rv2627c CHP
Rv2687c Rv2687c ABC transport component of drugs
ugpE Rv2834c ABC transport component of sugar
Rv2990c Rv2990c HP
fadE22 Rv3061c Acyl coA dehydrogenase (lipid degradation)
Rv3128c Rv3128c CHP
Rv3130c Rv3130c CHP
Rv3134c Rv3134c CHP
RV3174 Rv3174 Short chain dehydrogenase/reductase
Rv3178 Rv3178 CHP
Rv3195 Rv3195 CHP
Rv3335c Rv3335c Conserved integral membrane protein
Rv3467 Rv3467 13E12 repeat family protein
facE27 Rv3505 Acyl coA dehydrogenase (Lipid degradation)
Rv3529c Rv3529c CHP
Rv3552 Rv3552 Subunit of a CoA transferase
/acE31 Rv3562 Acyl-coA dehydrogenase (lipid degradation)
Rv3577 Rv3577 CHP
dppC Rv3664c ABC transport component of dipeptide uptake
proZ Rv3756c ABC transporter of glycine/proline (osmoprotectant)
Rv3770c Rv3770c HP
Rv3829c Rv3829c Dehydrogenase
Rv3839 RV3839 CHP
RV3845 RV3845 HP
